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1 G e n e r a l  in t r o d u c t io n
In the beginning Qf the twentieth century, Sir Francis GaltQn CQnsidered 
intelligence as a single hereditary entity, regulating CQgnitive processing which 
CQuld be m easured through biQlQgical tests (e.g. the reactiQn test). A lfred Binet 
develQped in 1905 a methQd tQ measure intelligence, which is nQw a standard. 
W illiam  Stern introduced the term  intelligence quQtient (IQ), which is the ratiQ 
betw een mental age (MA) and chrQnQlQgical age (CA), 100 tim es m ultiplied 
(IQ=(M A/CA)*100) (Eysenck and Evans 1996). The IQ  is generally subdivided 
intQ verbal and perfQrmance tasks. The IQ  in the pQpulatiQn fQllQws approximately 
a nQrmal Gaussian distributiQn, with pQpulatiQn mean ^=100 and standard deviatiQn 
sigma=15 (DumQnt 1980).
1.1 De f in it io n  and  c l a ssific a t io n  o f  m e n t a l  r et a r d a t io n
Mental retardatiQn (MR) is a lifelQng human disability characterised by impaired 
CQgnitive and adaptive skills. The definitiQn Qf M R is difficult tQ fQrmulate since 
several categQries Qf im pairm ent are invQlved.
The mQst widely used definitiQn, was propQsed by the Am erican Psychiatric 
AssQciatiQn (1994) and 3 criteria were included: 1. Significantly sub-average 
general intellectual functiQning (IQ=< 70), 2. Significant limitatiQns in adaptive 
functiQning in at least twQ Qf the fQllQwing skill areas: CQmmunicatiQn, self care, 
ability tQ live independently, sQcial and interpersQnal skills, use Qf public services, 
decisiQn taking, functiQnal academic skills, wQrk, leisure, health and safety, 3. 
Onset befQre age 18 years.
O n basis Qf the IQ  level, several subclasses are distinguished. Assum ing that IQ 
is a nQrmally distributed CQntinuQus variable, with pQpulatiQn m ean Qf 100 and 
standard deviatiQn Qf 15, M R may be classified w ithin approxim ate IQ  ranges as 
m ild in the range 50 tQ 70 (-2.0 tQ -3.3 SD), Qr severe w hen the IQ  is less than 50 
(WHO, 1985). Table 1 presents an histQrical Qverview Qf M R classificatiQn. The 
classificatiQn Qf the WQrld Health OrganisatiQn (WHO, 1980) and Qf the DiagnQstic 
and Statistical M anual Qf M ental DisQrders, 4th editiQn (DSM  IV; American 
Psychiatric AssQciatiQn, 1994) are currently mQst used (Table 2). Besides the 
intellectual impairment, the DSM  IV takes the adaptive behaviQur intQ accQunt.
14 IntrQductiQn
Table 1: HistQrical Qverview Qf the classificatiQn Qf the mental level
1948 terminQlQgy 
(WHO)
1968 terminQlQgy 
(WHO)
IQ level (WHO 
criteria, 1980)
IQ  level
(DSM  IV, 1994)
BQrderline BQrderline 70 tQ 85 70 tQ 85
Feebleminded/mQrQn M ild 50 tQ 70 50-55 tQ 70
L qw degree imbecile MQderate 35 tQ 50 35-40 tQ 50-55
High degree imbecile Severe 20 tQ 35 20-25 tQ 35-40
IdiQt PrQfQund <20 <20-25
1.2 P r e v a l e n c e  and  sex  d ist r ib u t io n  o f  m e n t a l  r et a r d a t io n
In Europe and the USA it is generally accepted that M R Qccurs in 2% tQ 3% Qf 
the general pQpulatiQn (Schaefer and BQdensteiner, 1992; Pulsifer, 1996). AbQut 
85% are mildly, 10% mQderately, 3 tQ 4% severely and 1 tQ 2% profQundly 
m entally retarded (DSM  IV, Am erican Psychiatric AssQciatiQn, 1994). A  lQwer 
prevalence Qf M R Qf 1 tQ 1.5% was repQrted by Claes (1997), M atilainen et al 
(1995) (1.38%), Baird and SadQvnik (1985) and Turner (1996).
M ild M R is estim ated tQ Qccur at 20 tQ 30 per 1000 and severe M R at 3 tQ 4 per 
1000 (Schaefer and BQdensteiner, 1992). RQeleveld et al (1997) critically reviewed 
the literature Qn the prevalence Qf MR, and CQncluded that the mQst likely 
prevalence Qf M R is 3% in schQQl aged children. The prevalence rate fQr severe M R 
(IQ Qf =<50) varies around value Qf 3.8 per 1000 (RQeleveld et al 1997), and this 
agrees w ith the W HO rate Qf 3 tQ 4 per 1000 (W HO 1986,1968). The prevalence 
rate fQr severe M R is age dependent: up tQ the age Qf 15 years there is an increasing 
prevalence, indicating that severe M R is nQt fully assessed in the first years Qf life. 
Prevalence estim ates fQr m ild mental retardatiQn varies mQre widely with a range 
Qf 0.4 tQ 8.0%, which is tQQ wide tQ allQw valid CQnclusiQns, and the "true" average 
prevalence Qf m ild M R was calculated 29.8 per 1000 in schQQl-aged children 
(RQeleveld et al 1997). This value agrees with the W HO Qverall figure Qf 3% fQr 
M R (W HO 1986, 1968).
M aas et al (1988) studied the prevalence rates Qf M R in the Netherlands and 
fQund that bQth m ild (IQ>50) and severe (IQ=<50) M R were 0.4%.
AccQrding tQ RQeleveld et al (1997), the m ale tQ fem ale ratiQ in severe M R 
shQws an excess Qf males Qf 20% (m ale tQ fem ale ratiQ = 1.20), probably due tQ
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sex-linked genetic factQrs. In m ild MR, the m ale tQ fem ale ratiQ ranges from  an 
excess Qf males Qf 40 tQ 80% (male tQ fem ale ratiQ: 1.40-1.80) (RQeleveld et al
1997). In the Netherlands, the male tQ fem ale ratiQ in D utch pupils, under the age 
Qf 12 years, decreases w ith increasing severity Qf M R (Ham el 1999). In schQQls fQr 
children whQ need special educatiQn fQr specific educatiQnal needs the m ale tQ 
fem ale ratiQ is estim ated 2.73, in schQQls fQr children with learning difficulties 1.60, 
and in schQQls fQr children w ith severe learning difficulties 1.54. In institutiQns fQr 
m entally handicapped the male tQ fem ale ratiQ is estim ated 1.37 (Hamel 1999).
1.3 E t io l o g ic  r e s e a r c h  in  m e n t a l  r e t a r d a t io n : a  c h a l l e n g e
1.3.1 E tio log ical stud ies
The search fQr the etiQlQgy Qf M R is difficult and represents a CQntinuQus 
challenge fQr clinicians and Qther professiQnals in this field. BQth genetic and 
environm ental factQrs can cause MR.
Recently, Curry et al (1997) evaluated the ratiQnal approach tQ the individual 
with M R and fQrmulated the recQmmendatiQns Qf the Am erican CQllege Qf M edical 
Genetics: 1. The individual w ith m ental retardatiQn, the family, and medical 
care-prQviders benefit from  a fQcused clinical and labQratQry evaluatiQn aim ed at 
establishing causatiQn and in providing CQunselling, prQgnQsis, recurrence risks, and 
guidelines fQr management. 2. Essential elem ents Qf the evaluatiQn include a 
three-generatiQn pedigree, pre-, peri-, and pQst-natal histQry, CQmplete physical 
examinatiQn fQcused Qn the presence Qf minQr anQmalies, neurolQgical examinatiQn, 
and assessment Qf the behaviQural phenQtype. 3. Selective labQratQry testing shQuld, 
in mQst patients, include a banded karyQtype. Fragile X  testing shQuld be strongly 
CQnsidered in bQth males and fem ales w ith unexplained mental retardatiQn, 
especially in the presence Qf a pQsitive fam ily histQry, a CQnsistent physical and 
behaviQural phenQtype and absence Qf majQr structural abnQrmalities. MetabQlic 
testing shQuld be initiated in the presence Qf suggestive clinical and physical 
findings. N euro-im aging shQuld be CQnsidered in these patients withQut a knQwn 
diagnQsis especially in the presence Qf neurolQgical symptQms, cranial CQntQur 
abnQrmalities, microcephaly, Qr macrQcephaly. In mQst situatiQns M RI is the testing 
mQdality Qf chQice. 4. Sequential evaluatiQn Qf the patient, QCcasiQnally Qver several 
years, is Qften necessary fQr diagnQsis, allQwing fQr delineatiQn Qf the physical and 
behaviQural phenQtype, a lQgical approach tQ ancillary testing and appropriate 
prQgnQstic and reproductive CQunselling.
Several large systematic etiQlQgical surveys CQncluded that the cause Qf M R remains
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Table 2: Overview Qf published systematic etiQlQgical surveys
Study Number Level MR Unknown Chromosomal 
(Down syndrome) (1)
Czeizel et al 
1980
1364 Mild/mod/
severe
172 (12.6%) 72(5.3 %) 
(47 (3.4 %))
Thoene et al 
1981
727 Moderate/
severe
ND 72 (9.9%) 
(42 (5.8 %))
Fryns et al 1986 173 Severe 20 (11.56%) 26 (15.1%) 
(22 (12.7%))
Dereymaeker et 
al 1988
158 Mod/severe 29 (18.4%) 21 (13.3%) 
(14 (8.9%))
Fryns et al 1990 262 Moderate 80 (30.5%) 46 (17.5%) 
(43 (16.4%))
Fryns et al 1990 114
(52F)
Mod/severe 35 (30.7%) 26 (22.8%) 
(20 (17.5%))
Volcke et al 
1990
274
(0F)
Moderate 142 (51.8%) 9 (3.3%) 
(4(1.5%))
Haspeslagh et al 
1991
307
(0F)
Severe 180 (58%) 23 (7.4%) 
(19 (6.2%))
Volcke et al 
1991
57 (44F) Mild/border­
line
31 (54.4%) 1 (1.8%) 
(0)
Farag et al 1993 400 Severe
(IQ<50)
40 (10%) 37 (9.25%) 
(34 (8.5%))
Temtamy et al 
1994
116 Borderline/
mild/severe
32 (27.6%) 4 (3.4%) 
(3(2.6%))
Schaap et al 
1995
116 Mod/severe 59 (50.9%) 11 (9.5%) 
(7 (6%))
Claes 1997 454 (166F) Mild/mod 318 (84%) 21 (6%) 
(7(1.5%))
Devriendt et al 
1998
66
(19F)
Mild/mod/
severe
32 (48.5%) 22 (33%) 
(19 (29%))
Félix et al 1998 202 Severe/Mild 70 (34.65%) 69 (34.2%) 
(65 (32.15%))
Lantigua-Cruz et 
al 1999
512
(206F)
Severe 66 (12.9%) 213 (41.6%) 
(205 (40%))
(1) Total number of patients with a chromosomal abnormality, including Down syndrome. 
(): number of patients with Down syndrome.
(2) Number of patients with idiopathic MR and with a positive family history of non-specific 
MR.
(3) Number of patients with idiopathic MR and with family data compatible with X-linked 
MR.
F: number of females.
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Monogenic
disorders
MCA/MR CNS Acquired (2)Unknown 
MR / nonspec 
fam MR
(3) Unknown 
MR / X-L fam 
MR
96 (7%) - - 396 (29%) 540 (39.6%) ND
30 (4.1%) ND ND ND ND ND
34 (19.5%) 7 (4%) 8 (4.6%) 75
(43.4%)
9 (5.2%) -
36 (22.8%) 8 (5.1%) 6 (3.8%) 51
(32.3%)
7 (4.4%) ND
44 (16.8%) 5 (1.9%) 4 (1.3%) 83
(31.7%)
24 (9.2%) 11 (4.2%)
21 (18.4%) 
3 FRAXA
4 (3.5%) 1 (0.9%) 27
(23.7%)
18 (15.8%) 3 (2.6%)
44 (16%) 5 (1.8%) 9 (3.3%) 65
(23.7%)
22 (8%) 22 (8%)
43 (13.9%) 6 (1.9%) - 57
(18.4%)
53 (17.3%) 13 (4.2%)
3 (5.3%) - - 23
(40.4%)
ND 6 (10.5%)
137 (34.25%) 22 (5.5%) 7 (1.75%) 175
(39.25%)
ND ND
13 (11.2%) 28
(24.1%)
15
(12.9%)
6 (5.2%) ND ND
16 (13.8%) 4 (3.4%) - 26
(22.4%)
6 (5.2%) 3 (2.6%)
39 (10%) - - - 46 (10.1%) 23 (5.1%)
4 (6%)
4 FRAXA
2 (3%) 3 (4.5%) 3 (4.5%) 5 (7.6%) 2 (3%)
25 (12.37%) 8 (3.96%) 8 (3.9%) 21
(10.39%)
8 (4%) -
28 (5.5%) ND 5 (0.9%) 200 (39%) ND ND
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Table 3: Overview Qf system atical surveys with attentiQn tQ cytQgenetic 
abnQrmalities
Study Number Mental level ChrQmQsQmal 
(ÜQwn syndrQme)
Remarks
MQunQud et al 1976 82
(39F)
Mild/PrQÍQund 25 (30.5%) 
(18 (22%))
Speed et al 1976 2770
(1205F)
MR 297 (10.7%) 
(250 (9%))
Sutherland G 1976 588
(258F)
BQrderline/PrQÍQund 90 (15.3%) 
(73 (12.4%))
JacQbs et al 1978 475
(191F)
BQrderline/PrQÍQund 57 (12%) 
(40 (8.4%))
Ally and Grace 1979 512
(136F)
MR 57 (11.1%) 
(42 (8.2%))
Gripenberg et al 1980 1062 MR 350 (33%) 
(305 (28.7%))
KandQ et al 1980 449
(188F)
Mild/PrQÍQund 37 (8.1%) 
(33 (7.3%))
NelsQn and Smart 1982 720
(?F)
MR 148 (20.5%) 
(127 (17.6%))
Br0ndum-Nielsen et al 
1983
476
(227F)
Mild/PrQÍQund 76 (16%)) 
(58(12.2%))
2 (0.4%) FRAXA
Fryns et al 1984 1991
(937F)
MQderate/Severe 423 (21.2%) 
(295 (14.8%))
57 (2.9%) FRAXA
Schreppers-Tijdink et 
al 1988
1170
(449F)
Severe/PrQÍQund 258 (22.1%) 
(167 (14.3%))
21 (6.8%) FRAXA
English 1989 512
(0F)
MR 110 (21.5%) 
(65 (12.7%))
30 (5.9%) FRAXA
F: number of females
unknQwn in abQut 50% (variatiQn from  10% tQ 84%) Qf the individuals (Tables 2 
and 3). In severe M R a single factQr can be identified in mQre than 50% Qf the 
cases. In mildly mentally retarded patients an etiQlQgical factQr is fQund in less than 
20%, but there is an increased incidence Qf familial MR. AIsq, persQns from sQcially 
disadvantaged backgrounds are Qver-represented in mild M R (Crow and TQlmie
1998).
1.3.1.1 C h rom osom al ab n o rm alitie s
ChrQmQsQmal abnQrmalities are the mQstrecQgnisable CQmmQn cause Qf severe 
MR. DQwn syndrQme Qr trisQmy 21 is the mQst frequent chromQsQmal abnQrmality
General intrQductiQn 19
and accQunts fQr 2/3 Qf the ChrQmQsQmal abnQrmalities assQciated with MR. 
Structural ChrQmQsQmal abnQrmalities are mQre rare. RQutine ChrQmQsQmal studies 
include GTG-banding techniques Qn metaphases Qf cultured peripheral 
lymphQcytes. AdditiQnal ChrQmQsQmal banding techniques include reverse-, C- and 
Q-banding techniques Qn metaphases Qr prQmetaphases (high resQlutiQn banding 
techniques) Qn cultured peripheral lymphQcytes Qr Qther cultured tissue cells. 
MQlecular cytQgenetic techniques (FluQrescence in situ hybridisatiQn; FISH) are 
CQmplementary tQ detect submicrQscQpic interstitial Qr subtelQmeric deletiQns and 
cryptic translQcatiQns.
DiagnQsis Qf num erical Qr structural ChrQmQsQmal abnQrmalities has an 
impQrtant im pact Qn genetic CQunselling, as they m ay be the unbalanced result Qf 
a ChrQmQsQmal rearrangement, such as a translQcatiQn Qr inversiQn, in Qne Qf the 
parents.
1.3.1.2 M onogenic d iso rd ers
MutatiQns in Qne single gene accQunt fQr 20 tQ 25% in severe and fQr 5 tQ 10% 
in m ild M R (Hamel and Smeets 1997). New labQratQry techniques have recently 
becQme available tQ study metabQlic disQrders e.g. Sm ith-Lem li-Opitz syndrQme 
and  C Q ngenita l D isQ rders Qf G lycQ sylatiQ n (Jaek en  syndrQ m e, 
carbQhydrate-deficient glycQprQtein syndrQme, CDG syndrQme). The study Qf M R 
in CQmbinatiQn with dysmQrphic features has resulted in the delineatiQn and 
recQgnitiQn Qf an increasing num ber Qf sq called M CA/M R syndromes. W ith the 
advent Qf mQlecular biQlQgy many Qf the underlying disease genes have been 
identified, and mutatiQn analysis is nQw available fQr diagnQsis, and genetic 
CQunselling Qf the families.
X -linked mental retardatiQn (XLMR) is estim ated tQ affect 20 tQ 25% Qf all 
mentally retarded males and 10% Qf mildly mentally retarded females (Turner 1996; 
Turner and Turner 1974). XLMRcQnditiQns are categQrised as syndromic (MRXS), 
w hen assQciated with characteristic clinical features, Qr nQn-specific (MRX), when 
nQ clinical features Qther than M R are present. The mQst frequent disQrder in the 
group Qf M RXS is the fragile X  syndrQme (FRAXA), which accQunts fQr abQut 15 
tQ 20% Qf all male X LM R patients (Claes 1997; StevensQn 2000). In M RX, which 
accQunts fQr twQ thirds Qf all XLM R, Qnly 8 genes have been identified until nQw, 
and these accQunt each fQr Qnly 0.5 tQ 1% Qf all M RX patients (Chelly, 2000; Carrié 
et al, 1999; Zem ni et al, 2000; M erienne et al, 2000; Kutsche et al, 2000; D'AdamQ 
et al, 1998; Billuart et al, 1998; Allen et al, 1998; Gecz et al, 1996; Gu et al, 1996).
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1.3.1.3 CN S m alfo rm atio n s
PreviQus studies shQwed Iqw percentages Qf M R patients w ith CNS 
malfQrmatiQns, the figures varying betw een 0.9%  and 12.9%. This probably 
represents an underestim ate due tQ the small propQrtiQn Qf patients whQ received 
brain-im aging studies.
1.3.1.4 A cq u ired  d iso rd ers
Acquired disQrders include pre-, peri- Qr pQstnatal events such as trauma, tQxic 
agents Qr infectiQns. MQst probably, they accQunt fQr 30 tQ 35% Qf patients with 
severe and 15% Qf patients with m ild M R (Ham el and Smeets 1997).
1.3.1.5 Id io p a th ic  M R
In abQut 50% Qf patients the etiQlQgy Qf M R rem ains unknQwn. In the group Qf 
patients w ith severe M R this percentage is estim ated as 20% and in m ild M R as 80 
tQ 85%. In this group Qf patients with idiQpathic MR, fam ilial nQn-specific M R was 
estim ated betw een 4% and 39.6% (Table 2). The percentages Qf patients with 
idiQpathic M R and fam ily data CQmpatible with X-linked MR, with nQ affected 
fem ales and nQ father-tQ-sQn transmissiQn, were betw een 2.6%  and 10.5% (Table 
2).
1.3.2 A im  o f the  p re se n t stu d y
Fqt m any years, etiQlQgical research in mental retardatiQn, and especially in 
X-linked mental retardatiQn, has been a specific interest at the Centres fQr Human 
Genetics in Nijm egen and Leuven-M aastricht. These resulted in several PhD theses 
(Nijmegen: Renier 1983, Smeets 1992, Smits 1996, van der M aarel 1997, Hamel 
1999; Leuven-M aastricht: Fryns 1986, Curfs 1989, BQrghgraef 1991, M aes 1993, 
Schrander-Stum pel 1995, Claes 1997).
The first aim Qf this thesis was tQ recQrd etiQlQgical diagnQses explaining the 
cause Qf the mental handicap in all residents, by means Qf a systematic 
genetic-etiQlQgical survey, Qf the institutiQn "Huize Assisie", accQrding tQ the 
present knQwledge Qf dysmQrphQlQgy and technical investigatiQns, including 
standard cytQgenetic, mQlecular and biQchemical techniques. After the systematic 
screening, a group Qf patients was selected, tQ study subtelQmeric ChrQmQsQmal 
rearrangem ents with new mQlecular cytQgenetic techniques. Twq metabQlic 
disQrders were further studied in selected groups Qf patients using new techniques 
(Sm ith-Lem li-Opitz and CDG syndromes). Since the majQrity Qf residents in this 
institutiQn were males, a selected group Qf m ale patients was included in the
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research project Qn X-linked mental retardatiQn Qf the European XLM R CQnsQrtium 
(Chelly J (Paris), Fryns J-P (Leuven), Hamel B (Nijmegen), MQraine C (Tquts), 
RQpers H-H (Berlin), M andel J-L (Illkirch)). Especially in the group Qf male 
patients w ith sq called idiQpathic M R, data Qn fam ilial Qccurrence Qf MR, 
dysmQrphic findings, neurolQgical abnQrmalities and abnQrmal biQmetric data were 
recQrded.
The secQnd aim  Qf this study was the determinatiQn Qf medical CQmplicatiQns, 
the lQng-term fQllQw-up and prQgnQsis in the different diagnQstic subgroups (i.e. 
ChrQmQsQmal disQrders, X-linked m ental retardatiQn, inbQrn errors Qf metabQlism, 
and dysmQrphQlQgy-mental retardatiQn syndromes). In additiQn, the general 
practitiQners Qf this institutiQn Qften received questiQns frQm fam ily members, whQ 
asked fQr genetic CQunselling. In this institutiQn mQst residents were Qlder mentally 
retarded adults. The phenQtypical presentatiQn Qf mQst syndromes is well knQwn in 
children, but w ith advancing age features may change, which renders the clinical 
diagnQsis mQre difficult. New m edical CQmplicatiQns may Qccur in Qlder age 
groups, and these are Qften nQt well described in the literature. TherefQre, there was 
need fQr adequate strategies tQ prevent these m edical CQmplicatiQns. A  reliable 
diagnQsis can be Qf help in interventiQn planning, which includes the provisiQn Qf 
procurem ent Qf essential services resulting in increased independence, productivity 
and CQmmunity integratiQn (SchalQck et al 1994). It was thusjustified tQ extensively 
investigate each resident.
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2 M a t e r ia l s  a n d  M e t h o d s
2.1 P a t ie n ts
A system atic diagnostic-etiological survey was started in 1992 in the institution 
"Huize Assisië - Stichting Prisma". This is located in the southern central part of the 
N etherlands and was founded in 1904 when 21 mentally retarded males 
accom panied by 4 Fathers "Penitenten" arrived at Biezenm ortel, The Netherlands 
(Bouwens and Hoek 1994). Historically, only m ale patients were living in the 
institute. Presently 591 patients (mean age: 46 years) live in the institution, 552 
males (93.4%) (m ean age: 47 years) and 39 females (6.6%) (m ean age: 33 years). 
Table 1 presents an overview o f the age distribution and sex distribution. Table 2 
presents an overview o f the level o f M R according to age and sex.
Table 1: Distribution of age and mean age o f the patients
Age
(years)
N um ber of 
males (n)
M ean age
males
(years)
N um ber of
females
(n)
M ean age
females
(years)
Total (n) M ean age 
(years)
0 - 9 1 8 1 3 2 (0.3%) 6
1 0 - 19 11 15 7 14 18 (3.05%) 15
2 0 - 2 9 20 25 7 25 27 (4.6%) 25
3 0 - 3 9 81 34 15 35 96 (16.2%) 34
4 0 - 4 9 188 45 3 44 191 (32.3%) 45
5 0 - 5 9 193 54 4 55 197 (33.3%) 54
6 0 - 6 9 49 63 2 64 51 (8.6%) 63
7 0 - 7 9 8 72 - - 8 (1.4%) 72
>= 80 1 80 - - 1 (0.3%) 80
Total 552
(93.4%)
47 39
(6.6%)
33 591 46
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Table 2: Distribution of m ental level according to age and sex
Age (years) Borderline Mild Moderate Severe Profound Total (n)
0 - 9 M - - - - 1 1
0 - 9 F - - - - 1 1
1 0 -1 9 M - 1 4 4 2 11
1 0 -1 9 F - 1 - 2 4 7
2 0 -2 9 M - 2 9 9 - 20
2 0 - 2 9 F - 5 2 - - 7
3 0 -3 9 M - 21 41 14 5 81
3 0 -3 9 F 3 6 5 - 1 15
4 0 -4 9 M 1 25 60 51 51 188
4 0 - 4 9 F - 1 2 - - 3
5 0 -5 9 M 1 23 63 57 49 193
5 0 - 5 9 F - 2 2 - - 4
6 0 -6 9 M - 8 25 7 9 49
6 0 - 6 9 F - 2 - - - 2
7 0 -7 9 M 1 2 4 1 - 8
7 0 - 7 9 F - - - - - -
>= 80 M - - 1 - - 1
>= 80 F - - - - - -
Totals M 3 (0.5%) 82 (14.9%) 207 (37.5%) 143 (25.9%) 117 (21.2%) 552
Totals F 3 (7.7%) 17 (43.6%) 11 (28.2%) 2(5.1%) 6 (15.4%) 39
Total 6 (1.02%) 99 (16.8%) 218 (36.9%) 145 (24.5%) 123 (20.8%) 591
M: males
F: females
2.2 M eth o d s
2.2.1 Selection o f p a tien ts  an d  genera l p ro ced u re
The medical records o f each patient were studied and data on fam ily history and 
pedigree, pre-, peri- and postnatal period, psychom otor developm ent and mental 
functioning, early medical history, m edical complications, vision and hearing and 
specialised clinical exam inations and technical investigations were collected.
A different strategy was used for 1. residents with the clinical diagnosis o f Down 
syndrom e and 2. w ithout Down syndrome.
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2.2.1.1 R esiden ts w ith  the  clinical diagnosis o f D ow n syndrom e (n=96)
The medical records o f these residents were studied, to record whether 
chrom osom al studies were perform ed to rule out an inherited type o f trisom y 21. 
Data on mental functioning, dementia, neurologic abnormalities, epileptic seizures, 
ophthalm ologic and hearing functioning and thyroid function were collected. In 40 
DS patients (38 males and 2 females), chromosomal studies had been performed in 
the past. In the group o f 56 residents w ithout chrom osom al studies, a written 
perm ission to obtain blood for cytogenetic studies was asked o f the parents or the 
legal representative. W hen there was no perm ission to collect blood, no 
investigations were perform ed. If there was no reaction within 3 months to the first 
request, a second letter for perm ission was sent. In 47 o f these 56 residents, the 
parents or the legal representative consented to blood samples being taken and 
cytogenetic studies being perform ed. A written report o f the result was sent to the 
family. In the case of a translocation type o f trisom y 21, the fam ily was investigated 
and counselling was given.
2.2.1.2 R esiden ts w ith o u t D ow n syndrom e (n=495)
In 63 patients (61 males and 2 females) the diagnosis made in the past was 
re-evaluated. In the group o f patients w ithout a diagnosis a written perm ission to 
participate in the study, together with a questionnaire, asking for anam nestic and 
fam ily data, was sent to the parents or to the legal representative. Based on data 
from  the medical records, an attempt was made to establish the m ost likely 
etiological diagnosis. W hen there was no perm ission to participate in the present 
study, no further investigations were perform ed. If there was no reaction on the first 
request within a period o f 3 months, a second, more detailed request was sent. As 
soon as a written permission was received, patients were clinically examined. Blood 
and urine samples were obtained for cytogenetic studies and m etabolic screening. 
M olecular studies o f the FM R -1 gene were perform ed, based on clinical phenotype 
and fam ily data in a selected group o f patients (n=244). W hen a definitive diagnosis 
could not be established, the fam ily or legal representative was inform ed on all 
perform ed investigations in a standardised letter. W hen a diagnosis was found, 
parents or fam ily members were invited to the institution for counselling, and the 
results were summarised in a written report. Families were visited and investigated 
in the group o f patients with chromosomal abnormalities, X -linked mental 
retardation and m etabolic disorders.
W ritten consent for the publication o f clinical photographs and clinical and 
technical data, was obtained from  the parents or legal representative.
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The 591 patient records were studied in detail. In 103 residents (17.4%) (40 
residents with Down syndrom e and 63 with another diagnosis) a diagnosis 
previously made was re-evaluated. Four patients died before the investigation was 
started. In 32 patients there was no reaction from  parents or legal representative and 
therefore no investigation was performed. In another 84 patients no perm ission was 
given. Finally, 471 residents (436 males and 35 females) participated in the present 
study and could be investigated.
2.2.2 M ethodology 
2.2.2.1 M en ta l function ing
The educational psychologists o f the institution perform ed studies on mental 
level in all patients (Table 2). Several psychological tests, adapted for the Dutch 
population, were used, depending on the level o f mental functioning. In the patients 
with a developm ental level between 7 and 11 years (mildly mentally retarded 
(IQ-level 50-55 to 70)) the W echsler Intelligence Scale for Children-Revised 
(W ISC-R) (Van Haasen et al 1986) was used. The W echsler Prim ary Pre-school 
Scale o f Intelligence test (W IPPSI) (Stinissen and Vander Steene 1970) was used 
in the group o f patients with a developm ental level between 4 and 7 years 
(moderately mentally retarded (IQ-level 35-40 to 50-55)). Three different tests were 
used in the group o f patients who were severely (developm ental level between 18 
months and 4 years (IQ-level 20-25 to 35-40)) or profoundly mentally retarded 
(developm ental level betw een 12 months and 18 months (IQ-level below 20-25)). 
The first test was the KID-N (Kent Infant D evelopm ent Scale) (Schneider et al 
1990), a developm ental scale between 1 and 14 months existing o f 5 sub-scales 
including cognition, m otor developm ent, language, personal autonom y and social 
skills. The second test used was the Bayley Developm ental Scale (BOS 2-30) (Van 
der M eulen and Sm rkovsky 1983) which includes a mental and a m otor scale. The 
third test was the Term an-M errill Intelligence Scale (Stinissen 1965) in which 
cognition between the ages o f 2 and 22 years can be tested. The patients were 
classified according to the criteria described in the Diagnostic and Statistic M anual 
o f M ental Disorders, 4th edition (DSM  IV) (APA 1994). Both the intellectual 
im pairm ent and the adaptive behaviour (Vineland Adaptive Behavior Scales 
(Sparrow et al 1984) and Sociale Redzaamheidsschaal voor Zwakzinnigen (SRZ) 
(Kraijer and Kem a 1972) of the individual were used to classify patients.
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2.2.2.2 C lin ical exam ination
A standard clinical exam ination was perform ed by the same clinician (Van 
Buggenhout G). The results in all patients were discussed with Hamel B (Nijmegen) 
and some o f the patients were selected for further discussion with the medical staff 
in Nijm egen and Leuven. A selected group o f patients was observed and clinically 
exam ined at the institution (Hamel B (Nijmegen) and Fryns J-P (Leuven)). 
Biom etric data on height, arm span, weight and head circumference, outer canthal 
distance (OCD), inner canthal distance (ICD), ear length, total hand length (THL) 
and palm  length (PL) and testicular volum e were recorded. Clinical exam ination 
included the general habitus o f the patient, inspection o f skin, craniofacial features, 
and exam ination o f the upper and low er extrem ities, thorax, abdomen, back and 
genitalia. A standard neurological exam ination was performed. Five standard 
clinical photographs were taken o f each patient.
2.2.2.3 C ytogenetic, m o lecu lar an d  m etabo lic  investigations
The laboratory technician o f the institution obtained blood o f the patients. 
Cytogenetic studies and DNA studies were done at the laboratories o f the 
D epartm ent o f Human Genetics, University M edical Center St Radboud Nijmegen, 
The Netherlands. M etabolic screening was perform ed at the Laboratory of 
Paediatrics and Neurology, University M edical Centre St Radboud, Nijm egen, The 
Netherlands. Cytogenetic studies were perform ed in all 471 residents on cultured 
peripheral lymphocytes, according to standard methods, and included GTG-banding 
techniques. In a selected group o f the patients DNA-studies for the FM R-1-gene 
were perform ed. In a selected group o f patients DNA studies for other diseases 
(m yotonic dystrophy, Kallm an syndrom e and Tuberous sclerosis) were performed. 
M etabolic studies were perform ed in 306 patients and included analysis o f amino 
acids, o rgan ic  acids, pu rines and p y rim id in e s , o lig o sacch arid es , 
mucopolysaccharides and neuram inic acid. Because it was impossible to obtain 24 
hours collection o f urine in mentally retarded residents, urinary m etabolic studies 
were perform ed on samples obtained in the early morning. Additional studies for 
Sm ith-Lem li-Opitz syndrom e (6 patients) and Jaeken syndrome (Congenital 
Disorders of Glycosylation; CDG syndrome) (144 patients) were perform ed in a 
selected group o f patients after the study period. Therefore, it was not possible to 
investigate m aterial o f all initially investigated patients.
2.2.2.4 A dd itional exam inations an d  investigations
Some patients required specialist exam ination, e.g. neurological, 
ophthalmologic, derm atological, or cardiological examination. In some patients
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additional technical investigations were perform ed such as cerebral M RI or 
computed tomography scan, X-rays of the skull, skeleton or hands, investigation of 
hairs by electron microscopy, audiom etric and ophthalm ologic investigations, skin 
exam ination by W oods-lam p or specialised m etabolic investigations including 
lactate, am monia or screening for urinary homocystine. These additional medical 
and technical investigations were perform ed after discussion o f the m edical data of 
each patient with the different staff members.
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Part 1 
General overview of the results o f the present study
C o n ten t P a r t  1
Clinical etiological survey of a population o f 471 mentally retarded patients living 
in an institution in the southern part o f the Netherlands. (Com munity Genet, 
accepted)
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C l in ic a l  e t io l o g ic a l  s u r v e y  o f  a  p o p u l a t io n  o f  471
MENTALLY RETARDED PATIENTS LIVING IN AN INSTITUTION IN
t h e  s o u t h e r n  p a r t  o f  t h e  N e t h e r l a n d s
G.J.C.M. Van Buggenhout,ab J.C.M . Trom m elen,0 H.G. Brunner,b B.C.J. Hamel,b 
and J.P. Frynsa
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Genetics, University Medical Center Nijmegen, The Netherlands; “Institution for Mentally 
Retarded Patients Huize Assisië, Udenhout, The Netherlands
A b st r a c t
O b j e c t i v e :  Investigation o f etiological factors in mental retardation. M e t h o d s :  
In 471 adults (mean age 46 years; 92.6% males) living in an institution for the 
mentally retarded, clinical examination, cytogenetic and molecular studies and basic 
metabolic screening were performed. R e s u l t s :  Chrom osom al abnormalities were 
found in 100 patients (21.2%). O f these, 87 were num erical autosom al 
abnormalities (all Down syndrome), 7 structural autosom al abnormalities and 6 
num erical abnormalities o f sex chromosomes.
M onogenic disorders were diagnosed in 61 patients (13%): 14 autosomal 
dominant, 25 autosom al recessive and 22 X-linked conditions. In 1.7% (n=8) o f the 
patients a central nervous system (CNS) malform ation was documented. Acquired 
CNS disorders were diagnosed in 69 patients (14.6%): a prenatal cause was found 
in 15 patients, a perinatal and postnatal cause in each o f 27. In 233 patients (49.5% 
o f the total sample; 215 males and 18 females) idiopathic mental retardation was 
present. In this group there were 2 patients with a high degree o f consanguinity 
(incest). In one third (n=73; 31.3%) o f these patients there was a fam ily history of 
mental retardation (M R in first and second-degree relatives). Pedigree data were 
m ost compatible with X-linked mental retardation in 35 males from  32 different 
families, i.e. 47.9% o f the patients with idiopathic M R and fam ily history o f MR, 
and 15% of the total group o f patients with idiopathic MR. Thus, X-linked 
inheritance was considered in a total group o f 57 males, accounting for 12.1% of 
the total population: X-linked disorders in 22 males and non-specific X-linked 
mental retardation in 35 males. M inor anom alies were present in 41 patients 
(17.6%). Their presence was significantly associated with the severity o f the MR.
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N eurological abnormalities were present in 47 patients (20.2%), with central 
nervous system dysfunction (central paresis, dyskinesia, ataxia) in 45 (19.3%). 
Seizures were present in one third o f the patients (n=78) and a statistically 
significant correlation between the level o f M R and the presence o f seizures was 
found. In the group o f males w ith idiopathic MR, the num ber o f males with the 
com bination o f m icrocephaly and m icro-orchidism  was higher than expected, but 
not statistically significant and the num ber o f males with the combination of 
m acrocephaly and m acro-orchidism  was statistically significantly increased (n=5; 
2.3%). Before systematic evaluation, only 21.8% (103/471) o f the patients had a 
known diagnosis. After this survey, 50.5% (238/471) o f the investigated patients 
had a definite diagnosis. C o n c l u s i o n :  Establishing the diagnosis in older mentally 
retarded patients is im portant in the prevention o f medical com plications and in the 
developm ent o f m anagem ent strategies o f the institution. Finally, it is the conditio 
sine qua non for genetic counseling o f the respective families.
In t r o d u c t io n
M ental retardation (MR) affects about 2 to 3% o f the population [1, 2]. The 
institution "Huize Assisië, Stichting Prisma" is located in the southern part o f the 
Netherlands. Historically, only male patients were admitted to the institute. 
Presently, 6.6% of the 591 residents are female. The institute is open to all persons 
who are not able to function independently in society because o f mental retardation. 
Some o f the patients are living outside the institute in small hom e groups integrated 
in the community.
The aim o f the study was to perform a systematic etiologic-diagnostic survey of 
all residents. It was hoped that an accurate diagnosis would allow prediction of 
prognosis and prevention o f com plications at an older age and offer the possibility 
o f genetic counselling to the respective relatives.
M a t e r ia l s  and  M eth o d s  
P a tien ts
A t the time o f the study 591 adults (552 males (93.4%) and 39 females (6.6%)) 
were living in the institution. Only 471 patients were investigated, since 4 patients 
died before the investigation was perform ed and in 116 patients no perm ission was 
obtained.
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M en ta l function ing
Educational psychologists o f the institution tested all residents to determ ine the 
level o f intellectual functioning. Several psychological tests adapted to the Dutch 
population were used. Patients with a developm ental level between 7 and 11 years 
(m ildly mentally retarded (IQ-level 50-55 to 70)) the W echsler Intelligence Scale 
for Children-Revised (W ISC-R) [3] was used. The W echsler Prim ary Pre-school 
Scale o f Intelligence test (W IPPSI) [4] was used in the group o f patients with a 
developm ental level betw een 4 and 7 years (m oderately mentally retarded (IQ-level 
35-40 to 50-55)). Three different tests were used in the group o f patients who were 
severely (developm ental level betw een 18 months and 4 years (IQ-level 20-25 to 
35-40)) or profoundly mentally retarded (developm ental level between 12 months 
and 18 months (IQ-level below 20-25)). The first test was the KID-N (Kent Infant 
D evelopm ent Scale) [5], a developm ental scale between 1 and 14 months existing 
o f 5 sub-scales including cognition, m otor developm ent, language, personal 
autonom y and social skills. The second test used was the Bayley Developm ental 
Scales (BOS 2-30) [6] and included a mental scale and m otor scale. The third test 
was the Term an-M errill [7] in which cognition betw een the ages o f 2 years and 22 
years can be tested. The patients were classified according to the criteria described 
in the Diagnostic and Statistical M anual o f M ental Disorders, 4th edition (DSM  IV) 
[8]. Both the intellectual im pairm ent and the adaptive behavior o f the individual 
were used to classify patients.
C lin ical exam ination
After perm ission was obtained, all patients were exam ined clinically according 
to a standard checklist, including also biometric values, such as length, weight, head 
circum ference, outer canthal distance, inner canthal distance, total hand length, 
finger-III-length, ear length, and testicular volume. The fam ily history was obtained 
by a questionnaire which had to be filled out by the parents or fam ily o f the patient. 
These data were completed by data present in the clinical file. The occipito-frontal 
circum ference (OFC) was defined in males with 3rd centile=53 cm and 97th 
centile=58 cm and in females 3rd centile=52 cm  and 97th centile= 56.5 cm [9, 10]. 
Bushby et al. [11] reported a correlation between height and head circum ference in 
354 healthy control individuals and stated that the P-values for the head 
circum ference should be adapted to height. The centile charts used routinely have 
data only up to age 16 years and therefore Bushby et al. [11] produced centile charts 
appropriate for use in adults. In the group o f males the OFC (after correction for 
height) was com pared with the testicular volume. M acro-orchidism  was defined as 
a testicular volume > 25 m l and m icro-orchidism  as a testicular volume < 10 ml
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[12]. M R in one or both parents, one or more sibs, or children was considered first 
degree fam ilial MR. In second degree fam ilial M R one or more uncles or aunts, 
nieces or nephews were mentally retarded. A third group com prised M R in third 
degree relatives (cousins), but this group was not taken into account for fam ilial 
MR, since detailed inform ation on these relatives was lacking. The patients were 
discussed with at least 2 experienced clinical geneticists.
C ytogenetic studies
Cytogenetic studies on cultured peripheral lym phocytes included G-banding 
techniques, according to standard procedures. In 4 patients, additional chromosomal 
studies on cultured fibroblasts were perform ed for somatic mosaicism 
(W olf-Hirschhorn syndrome and Pallister-Killian syndrome (3 patients)), or to 
confirm  Down-Turner mosaicism syndrome (1 patient).
M olecu lar studies
On the basis o f the clinical findings and pedigree data, m olecular studies were 
perform ed and included DNA screening o f the fragile X  syndrome with CGG 
expansion in the FMR1 gene in 244 patients.
M etabo lic  screening  tests
M etabolic screening tests included urine and blood screening for amino acids 
(n=306), urine for organic acids, oligosaccharides and m ucopolysaccharides, and 
purine and pyrim idine metabolism  (n=306). After this systematic screening, in 
addition 2 m etabolic disorders were investigated in a selected group o f patients, 6 
for Sm ith-Lem li-Opitz syndrome (criteria: M R and partial syndactyly o f 2nd and 
3rd toes) and 144 for congenital disorders o f glycosylation (CDG) syndrome 
(criterion: M R o f unknown origin).
N euro-im aging
It was difficult to perform  systematic neuro-technical investigations in this 
population o f older mentally retarded patients, since light anesthesia was necessary 
to obtain a good quality o f brain imaging, and because o f financial restrictions. 
Therefore, only 25 patients were selected for magnetic resonance imaging (MRI) 
(n=14) or computed tomography (CT) (n=11) o f the brain (criteria: M R of unknown 
etiology and complex neurological signs with central paresis (spastic diplegia or 
quadriplegia) or progressive neurological regression).
General Qverview Qf the results Qf the present study 39
R esu lts
P a tien ts
The m ean age o f the 471 patients was 46 years, ranging from  3 to 75 years. 
Two-thirds o f the patients were between 40 and 59 years of age (table 1).
The sex distribution was 436 males (92.6%) with a m ean age o f 47 years and 35 
females (7.4%) with a mean age o f 32 years.
Table 1. Distribution o f age and mean age of all 471 patients
Age N um ber of N um ber of Total (n) M ean age
(years) males (n) females (n) (years)
0 - 9 - 1 1 (0.2%) 3
1 0 - 1 9 6 7 13 (2.8%) 14
2 0 - 2 9 17 6 23 (4.9%) 25
3 0 - 3 9 62 14 75 (15.9%) 36
4 0 - 4 9 159 2 161 (34.2%) 45
5 0 - 5 9 153 3 156 (33.1%) 54
6 0 - 6 9 36 2 38 (8.1%) 63
7 0 - 7 9 3 - 3 (0.6%) 74
Total 436 35 471 46
(92.6%) (7.4%) (100%)
M en ta l function ing
Table 2 presents the level o f mental functioning, according to age and sex in all 
471 patients. M ore than 80% of the patients were moderately, severely or 
profoundly mentally retarded. A lm ost 50% of the females were borderline to mildly 
mentally retarded.
C lassifica tion  o f all p a tien ts  accord ing  to  d iagnosis (tab le  3)
1 .  P a t i e n t s  w i t h  c h r o m o s o m e  r e a r r a n g e m e n t s  ( n = 1 0 0  ( 2 1 . 2 % ) )
Table 4 presents an overview o f all patients with a chrom osom al abnormality. 
In 75 patients full trisomy 21 (2 fem ales and 73 males) was diagnosed. In 11 
patients trisomy 21 mosaicism was found and in one patient an autosomal reciprocal 
translocation  w as found  in the tw o eup lo id  cells: 47 ,X Y ,+ 21 / 
46,XY,t(11;17)(q13;q25) de novo. In another patient a mosaic pattern o f double 
aneuploidy was present: 45,X/46,X,+21/47,XY,+21 (79/2/19) in peripheral 
lym phocytes and a different mosaicism  45,X/47,XY,+21 (36/14) in cultured
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Table 2. Distribution o f mental level according to age and sex o f the 471 patients
Age (years) Borderline Mild Moderate Severe Profound Total (n)
0 - 9 M - - - - - -
0 - 9 F - - - - 1 1
1 0 -1 9 M - - - 4 2 6
1 0 -1 9 F - 1 - 2 4 7
2 0 -2 9 M - 1 8 8 - 17
2 0 -2 9 F - 5 1 - - 6
3 0 -3 9 M - 14 31 13 4 62
3 0 -3 9 F 2 6 5 - 1 14
4 0 -4 9 M 1 20 54 47 37 159
4 0 - 4 9 F - - 2 - - 2
5 0 -5 9 M - 19 45 48 41 153
5 0 -5 9 F - 1 2 - - 3
6 0 -6 9 M - 6 17 5 8 36
6 0 -6 9 F - 2 - - - 2
7 0 -7 9 M - 1 2 - - 3
7 0 -7 9 F - - - - - -
>= 80 M - - - - - -
>= 80 F - - - - - -
Totals M 1 (0.2%) 61 (14%) 157 (36%) 125 (28.7%) 92 (21.1%) 436 (92.6%)
Totals F 2 (5.7%) 15 (42.9%) 10 (28.6%) 2 (5.7%) 6 (17.1%) 35 (7.4%)
Total 3 (0.6%) 76 (16.1%) 167 (35.5%) 127 (27%) 98 (20.8%) 471
M: males
F: females
fibroblasts. In one patient a de novo (21;21) translocation was present.
Structural abnormalities o f the autosomes (n=7; 7%) included patients with 
well-known syndromes, 1 patient with trisom y 9p syndrome and 5 patients with a 
deletion syndrome. The patient with cri du chat syndrome (del(5)(p14.1;pter)) and 
the patient with 13q deletion syndrome (del(13)(q32.3;qter)) were diagnosed after 
G-banded chromosome studies. The three patients with m icrodeletion syndromes 
(Prader-W illi syndrome, Angelm an syndrome and Shprintzen syndrome) were 
diagnosed after FISH. The patient with a complex translocation between 
c h ro m o so m e s  1,6 and 9 (k a ry o ty p e  (F IS H ): 4 6 ,X Y ,d e r(1 )(p te r  
^q32 .1 ::q43^qter),der(6)(9q ter^9q21::1q32^1q43::6p11.1^6q11::6q22^6qter), 
der(9)(9pter^9q21::6q12?::6p11.1  ^ 6 p te r) , was a 54-year-old, profoundly mentally 
retarded m acrocephalic male with epilepsy and behavior problems.
Sex chrom osom al abnormalities included only numerical abnormalities. The 
50-years-old man with 48,XXYY karyotype was moderately mentally retarded, with 
m yopia and micro-orchidism.
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Table 3.The diagnostic classification o f the 471 patients.
N um ber of 
patients
C hrom osom al d iso rd ers
Autosom al disorders
100 (21.2%)
Numerical 87
Structural
Sex-chromosom es
7
Numerical 6
M onogenic d iso rd ers 61 (13%)
Autosomal dominant 
Autosomal recessive
14
Syndromic 9
M etabolic disorders 
X-linked disorders
16
Fragile X 16
Syndromic 2
Nonspecific 4
C e n tra l nervous system  m alfo rm ations 8 (1.7%)
A cqu ired  d iso rd e rs  (m ultifactoria l) 69 (14.6%)
Prenatal 15
Perinatal 27
Postnatal 27
Id iop a th ic  M R 233 (49.5%)
T o ta l 471 (100%)
2 .  P a t i e n t s  w i t h  m o n o g e n i c  d i s o r d e r s  ( n  =  6 1  ( 1 3 % ) )
M onogenic disorders were diagnosed in 61 patients. O f the 14 (23%) patients 
with an autosom al dom inant condition, 5 had neurocutaneous disorders: Tuberous 
sclerosis (TS) (n=4) and Sturge-W eber (n=1). Twenty-five (41%) patients had an 
autosom al recessive disorder: microcephalia vera in 6 and m etabolic disorders in 
16 patients. XLM R was diagnosed in 22 (36%) patients with FRAXA in 16 patients, 
X LM R with m arfanoid habitus syndrome in 2 and nonspecific X LM R in 4 patients 
(table 5). The 4 M RX patients included 3 brothers o f the fam ily carrying a mutation 
in the IL-1 receptor accessory protein-like gene, localized on Xp22.1-p21.3 [13] 
and one male patient m em ber o f the M RX44 fam ily [14].
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Table 4.Classification o f 100 patients with chromosomal abnormalities
C hrom osom e rea rran g em en ts n u m b er
1. A utosom es (n=94)
N u m e r i c a l  a b n o r m a l i t i e s  n  =  8 7
Down syndrom e-full trisom y 21 75
Down syndrom e-trisom y 21 mosaicism 11
Down syndrom e-de novo (21;21) translocation 1
S t r u c t u r a l  a b n o r m a l i t i e s  n  =  7
Trisom y 9p 1
Cri du chat syndrome -  46,XY,del(5p) 1
46,XY,del(13)(q32.3;qter) 1
Angelm an syndrome -  del (15q) 1
Prader-W illi syndrome -  del (15q) 1
Velo-cardio-facial syndrome -  46,XX,del (22)(q11) 1
Der(1),der(6),der(9) -  complex translocation 1
2. Sex chrom osom es (n=6)
N u m e r i c a l  a b n o r m a l i t i e s :  n  =  6
47,XXY -  Klinefelter syndrome 1
47,XYY 1
45,X/46,XY/47,XYY (6/43/1) 1
45,X/46,XY (12/88) 1
48,XXYY 1
45,X/46,XX (6/94) 1
A l l  c h r o m o s o m e  r e a r r a n g e m e n t s 100
3 .  P a t i e n t s  w i t h  c e n t r a l  n e r v o u s  s y s t e m  m a l f o r m a t i o n s  ( n = 8  ( 1 . 7 % ) )
In 7 males central nervous system malformations were present. Two patients had 
spina bifida aperta with hydrocephalus, 2 congenital hydrocephalus with cerebellar 
hem iatrophy in one, and one multicystic encephalom alacia (hydranencephaly). O f 
the 2 males with corpus callosum  agenesis, 1 had m inor anomalies with 
macrocephaly, ptosis and bifid uvula. One female had congenital hydrocephalus 
with spastic tetraparesis.
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Table 5. Classification of61 patients with monogenic disorders
M cKusick catalog number Disorder Number of 
patients
1. Autosomal dominant inheritance N= 14 (23%)
*191092 Tuberous sclerosis (BQurneville) 4
*135500 Zimmermann-Laband syndrQme 1
*160900 Dystrophia myQtQnica (Steinert disease) 1
122470 CQrnelia de Lange -  Type 1 1
122470 CQrnelia de Lange -  Type 2 (mild 
phenQtype)
1
#113650 BranchiQ-QtQ-renal syndrQme (Melnick- 
Fraser)
1
#108300 Stickler syndrQme 1
#193510 W aardenburg syndrQme type 2 1
#101200 Apert syndrQme 1
*603543 Limb-mammary syndrQme 1
185300 Sturge-W eber syndrQme 1
Autosomal recessive inheritance- 
syndromic
N= 9 (14.8%c)
229120 FQuntain syndrQme 1
*262000 Björnstad syndrQme 1
277590 W eaver syndrQme 1
*251200 M icrocephalia vera 2
M icrocephalia vera + diabetes mellitus 2
M icrocephalia vera + shQrt stature 1
M icrocephalia vera + pQlydactyly 1
Autosomal recessive inheritance- 
metabolic
N= 16 (26.2%>)
*261600 PhenylketQnuria 5
*252900 SanfilippQ A  (MPSIIIA) 1
*253220 Sly disease (MPSVII) 1
*257200 Niemann-Pick type B 1
#239500 GM1 gangliQsidQsis type III (Adult) 1
*239500 Hyperprolinaemia type 1 3
#220100 Cystinuria 1
*272300 S-sulfQcysteinuria 3
X  linked inheritance N= 22 (36%,)
309550 Fragile X  syndrQme 15
Fragile X  syndrQme + Prader-W illi-like 
phenQtype
1
*309520 Lujan-Fryns syndrQme (XLMR-marfanQid 
habitus)
2
NQnspecific XLM R 4
Total monogenic disorders N=61
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4 .  P a t i e n t s  w i t h  a c q u i r e d  a b n o r m a l i t i e s  ( n  =  6 9  ( 1 4 . 6 % ) )  ( t a b l e  6 )
Prenatal infectious agents (rubella) were present in 2 (2.9%) patients, but 
infectious agents in the postnatal period (meningitis, encephalitis and systemic 
sepsis) were the cause ofM R  in almost one third of these patients (n=22; 31.9%).
Table 6 . Distribution of 69 patients with acquired abnormalities according to
prenatal, perinatal and postnatal events
A cquired abnorm alities N um ber of patients
1 .  P r e n a t a l  c a u s e N  =  1 5 ( 2 1 .8 % > )
Congenital Rubella 2
Ecclampsia 1
Rhesus incompatibility 2
Prematurity 1
Prematurity + dysmaturity 6
Prematurity + placenta praevia 1
Dysmaturity 2
2 .  P e r i n a t a l  c a u s e N  =  2 7 ( 3 9 . 1 % )
Asphyxia/birth complication 27
3 .  P o s t n a t a l  c a u s e N  =  2 7 ( 3 9 . 1 % )
Meningitis 10
Encephalitis 11
Sepsis 1
Hemorrhagic bleeding 2
Trauma 3
T o t a l  n u m b e r N  = 6 9
5 .  P a t i e n t s  w i t h  a n  i d i o p a t h i c  t y p e  o f m e n t a l  r e t a r d a t i o n  ( n = 2 3 3  (4 9 .5 % c ) )
In the group of 233 patients (49.5%; 215 males and 18 females) without specific 
diagnosis the following parameters were analyzed: consanguinity, familial 
occurrence of MR, minor anomalies, neurological symptoms, and the 
presence/concurrence of macro- and microcephaly and macro- and 
micro-orchidism.
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A. Consanguinity
In 9 patients consanguinity was present, including 2 pairs of sibs. In 2 patients 
a high degree of consanguinity (brother and sister incest) was present.
B. Familial occurrence of MR
Table 7 presents the degree of mental retardation in the group of patients with 
idiopathic mental retardation subdivided into familial or sporadic MR. Familial MR 
(first degree (n=67), second degree (n=6 ) and third degree (n=22)) was present in 
95 patients (40.8%), sporadic MR in 129 (55.4%) and in 9 patients (3.9%) data on 
familial mental retardation could not be obtained. The group of patients with MR 
in third degree relatives (cousins) was not taken into account for familial MR.
In the 73 patients (69 males and 4 females) with familial MR, 3 affected male sib 
pairs were found, with a distinct neurological syndrome in 1 of these sib pairs. In 
29 other males pedigree data were compatible with X-linked inheritance.
Table 7. Distribution of the level of mental retardation in the group of 233 patients
with idiopathic mental retardation according to familial or sporadic MR
Level M R Qf 
Indexpatient
BQrderline 
F M
M ild
F M
MQderate 
F M
Severe 
F M
PrQfQund 
F M
TQtal 
F M
TQtal
Familial M R
1. first degree 
relatives
0 0 2 15 2 29 0 10 0 9 4 63 67
2. secQnd 
degree relatives
0 0 0 0 0 2 0 3 0 1 0 6 6
3. third degree 
relatives
0 0 0 3 0 5 0 9 0 5 0 22 22
Sporadic M R 2 0 6 22 3 31 1 35 0 29 12 117 129
No information 
on familial M R
0 0 2 0 0 3 0 1 0 3 2 7 9
Total 2 0 10 40 5 70 1 58 0 47 18 215 233
F: female
M: male
C. Minor anomalies
Minor anomalies were present in 41 patients (17.6%) (table 8). The degree of 
MR in this group was significantly more severe than in those without minor 
anomalies (Chi square = 10.33,3 degrees of freedom, p=0.016, in contingency table 
2x4). The presence of anomalies between patients with and without familial MR
46 Part 1
Table 8 . Overview of the level of mental retardation and the presence of minor
anomalies in all 233 patients with idiopathic MR
Level of mental 
retardation
Patients with minor 
anomalies 
number (%)
Patients without minor
anomalies
number (%)
Total
Borderline/
Mild
5 (12.2%) 47 (24.5%) 52 (22.3%)
Moderate 14 (34.1%) 61 (31.8%) 75 (32.2%)
Severe 7 (17.1%) 52 (27.1%) 59 (25.3%)
Profound 15 (36.6%) 32 (16.7%) 47 (20.2%)
Total 41 (100%) 192 (100%) 233 (100%)
was not statistically different (Chi square = 0.03, 1 degree of freedom, in 
contingency table 2x2, p=0.86) (table 9).
Cutis verticis gyrata in combination with mental retardation and normocephaly 
was noted in 3 patients with non-familial MR.
Table 9. Number of patients with minor anomalies in the group of patients with 
familial mental retardation (first and second degree relatives) and without 
familial mental retardation. The patients with third degree relatives (n=22) and 
the patients with no information on familial data (n=9) were not included
Familial MR No familial MR Total
Minor anomalies 12 20 32
No minor anomalies 61 109 170
Total 73 129 202
D. Neurological findings
1. Epilepsy (table 10)
78 of the 233 patients had seizures (33.5%). A statistically significant correlation 
between the degree of severity of MR and the presence of seizures was found (Chi 
square=28.85, 3 degrees of freedom, p=0.00000241, in contingency table 2x4). 
Seizures were more frequent in the group of sporadic patients (i.e. 46/129; 35.7%) 
than in the group of patients with familial MR (i.e. 19/73; 26%), but this was not 
statistically significant (Chi square=1.56, 1 degree of freedom, p=0.21).
General Qverview Qf the results Qf the present study 47
Table 10. Epileptic seizures in relation to the mental level in the group of 233
patients with idiopathic mental retardation
Level MR of 
Indexpatient
Borderline Mild Moderate Severe Profound Total General total
Familial MR
1 . first degree 
relatives
0 4(1F) 4 5 3 16 (1F) 67
2 . second 
degree relatives
0 0 1 2 0 3 6
3. third degree 
relatives
0 0 1 5 4 10 22
Sporadic MR 0 3 (1F) 12 12 19 (1F) 46 (2F) 129
No information 
on familial MR
0 0 0 1 2 3 9
Total 0 7 (2F) 18 25 28 (1F) 78 (3F)
General total 2 50 75 59 47 233
F: number of females
2. Neurological findings (table 11)
Neurological abnormalities were present in 47 of the 233 patients (20.2%) with 
central paresis and/or dyskinesia and/or ataxia in 45 patients. There were 6 males, 
including 2 sibs, with familial MR and spastic diplegia (n=1) or paraparesis of the 
lower limbs (n=5); 1 was moderately and 5 profoundly mentally retarded. Three 
also had minor anomalies and 2  were macrocephalic.
E. Biometric values
Microcephaly was present in 11 of the 215 males (5.1%). Three had both 
microcephaly and micro-orchidism (1.4%), and 1 had minor facial anomalies. The 
other 2 had small stature and spastic paraplegia and one had also minor anomalies. 
Statistical analysis showed no significant difference between the combination of 
presence of microcephaly and micro-orchidism (Analysis of a single table (2x2): 
Odds ratio=3.19; Fisher exact test: P-value (1 and 2 tailed): 0.118) although this 
combination was higher than expected (table 12). There were no males with 
microcephaly and macro-orchidism. Neurological abnormalities (spastic paraplegia) 
were present in 4 microcephalic males (1.9%) and 2 had also micro-orchidism. 
Macrocephaly was present in 8 (3.7%) males. One of these males had 
micro-orchidism, minor anomalies and diabetes mellitus. Five macrocephalic males 
had macro-orchidism (2.3%); 2 had minor anomalies and 2 had severe behavior 
problems with selfmutilation in one and autism in the other. A significant 
correlation was found between the combination of macrocephaly and
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Table 11. Overview of neurological abnormalities in 47 of the 233 patients with
idiopathic mental retardation
Number of patients 
with sporadic MR
Number of patients 
with familial MR
Total number of 
patients
CNS dysfunction 
1 . C e n t r a l p a r e s i s
Diplegia spastica 
(LL>UL) 2 1 3
Paraparesis (LL) 11 5 16
Paraparesis (UL) 0 1 1
Quadriplegia (UL=LL) 1 4 5
Hemiplegia 3 1 4
2 . D y s k in e s ia  
( E x t r a p y r a m id a l  )
Chorea 2 2 4
Athetosis 1 0 1
Dystonia 1 0 1
3 . A t a x i a 6 4 10
Basal ganglia 
abnormalities
Parkinsonism 1 1 2
Total 28 19 47
UL: upper limbs 
LL: lower limbs 
CNS:central nervous system
macro-orchidism (analysis of a single table (2x2 contingency: Odds ratio=15.30, 
Fisher exact test: P value (1 and 2 tailed): 0.00136). In all patients with 
macrocephaly and/or macro-orchidism the diagnosis of fragile X syndrome was 
excluded by molecular studies (expansion of the CGG repeat in the FMR-1 gene). 
Four macrocephalic males had neurological abnormalities, and one had also 
macro-orchidism. Micro-orchidism with normal OFC was present in 18 patients 
(8.4%), and macro-orchidism with normal OFC in 25 patients (11.6%). 
Microcephaly was present in 3 females (16.7%). One microcephalic female had also 
mild neurological problems. There were no females with macrocephaly.
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Table 12. Relation between head circumference and testis volume in the group of
males with idiopathic MR (n=215)
Micro-orchidism Macro-orchidism Normo-orchidism Total
Microcephaly 3 0 8 11
Macrocephaly 1 5 2 8
Normocephaly 18 25 153 196
Total 22 30 163 215
Discussion
In this study a systematic clinical and diagnostic evaluation was performed on 
471 mentally retarded adults. Because of the historical setting of this institution, 
most of residents were males (93%). The mean age was 46 years, ranging from 3 
to 75 years. The relatively advanced age of many patients made it difficult to obtain 
data on the pre- and perinatal period, early development and medical history. A 
number of MR syndromes are associated with reduced life expectancy and therefore 
these syndromes will be less frequently found in the elderly mentally retarded. A 
third bias was towards a more severe level of mental handicap with more than 80% 
moderately, severely or profoundly mentally retarded. Borderline or mild mental 
handicap was present in almost 50% of the females, but in only 14.2% of the male 
population. None of the patients in this study were part of previous systematical 
etiological surveys.
In previous surveys of mentally retarded patients, the frequency of chromosome 
abnormalities ranges from 1.8% to 41.6%, depending on the level of MR of the 
investigated population, and the proportion of patients with Down syndrome from 
0% to 40% (tables 13 and 14). In the present study, a cytogenetic abnormality was 
present in 100 patients (21.2%). In 87 patients the clinical diagnosis of Down 
syndrome was confirmed cytogenetically. This high proportion of Down syndrome 
patients can be expected in a population of moderately, severely and profoundly 
mentally retarded patients. However, the proportion of mosaic trisomy 21 (n=11; 
13%) was higher than expected (2.4%) and maybe due to the fact that patients with 
a milder clinical phenotype, as seen in trisomy 2 1  mosaicism, reach an older age 
(for review see [43]). Structural autosomal abnormalities were diagnosed in 7 
patients, including one patient with a partial trisomy 9p phenotype and 6 patients 
with well-known deletion syndromes. The patient with the rare complex 
chromosomal rearrangement was profoundly mentally retarded with macrocephaly 
but without minor anomalies. Sex chromosomal abnormalities included only 
numerical abnormalities. There was one patient with Klinefelter syndrome
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Table 13.0verview of previous systematic etiological studies and the present study
Study Number Level MR Unknown Chromosomal
(Down
syndrome) (1)
Czeizel et al. [15] 1364 Mild/mod/
severe
172 (12.6%) 72(5.3 %) 
(47 (3.4 %))
Thoene et al. [16] 727 Moderate/
severe
ND 72 (9.9%) 
(42 (5.8 %))
Fryns et al. [17] 173 Severe 20(11.56%) 26 (15.1%) 
(22 (12.7%))
Dereymaeker et al. [18] 158 Mod/severe 29 (18.4%) 21 (13.3%) 
(14 (8.9%))
Fryns et al. [19] 262 Moderate 80 (30.5%) 46 (17.5%) 
(43 (16.4%))
Fryns et al. [20] 114
(52F)
Mod/severe 35 (30.7%) 26 (22 .8%) 
(20 (17.5%))
Volcke et al. [21] 274
(0F)
Moderate 142 (51.8%) 9 (3.3%) 
(4(1.5%))
Haspeslagh et al. [22] 307
(0F)
Severe 180 (58%) 23 (7.4%) 
(19 (6.2%))
Volcke et al. [23] 57
(44F)
Mild/borderline 31 (54.4%) 1 (1 .8%) 
(0)
Farag et al. [24] 400 Severe (IQ<50) 40 (10%) 37 (9.25%) 
(34 (8.5%))
Temtamy et al. [25] 116 B orderline/ mild/ 
severe
32 (27.6%) 4 (3.4%) 
(3(2.6%))
Schaap et al. [26] 116 Mod/severe 59 (50.9%) 11 (9.5%) 
(7 (6%))
Claes [27] 454
(166F)
Mild/mod 318 (84%) 21 (6%)
(7 (1.5%))
Devriendt et a l. [28] 66
(19F)
Mild/mod/
severe
32 (48.5%) 22 (33%) 
(19 (29%))
Félix et al. [29] 202 Severe/mild 70 (34.65%) 69 (34.2%) 
(65 (32.15%))
Lantigua-Cruz et al. [30] 512
(206F)
Severe 66 (12.9%) 213 (41.6%) 
(205 (40%))
Present study 471
(35F)
Mild to profound 233
(49.5%)
100 (2 1 .2%) 
(87 (18.5%))
(1): Total number of patients with a chromosomal abnormality, including Down syndrome. 
(): number of patients with Down syndrome.
(2): Number of patients with idiopathic MR and with a positive family history of non­
specific MR.
(3): Number of patients with idiopathic MR and with family data compatible with X-linked 
MR.
F: number of females.
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Monogenic
disorders
MCA/MR CNS Acquired (2)Unknown MR 
/ nonspec fam 
MR
(3) Unknown 
MR / X-L fam 
MR
96 (7%) - - 396 (29%) 540 (39 .6%) ND
30 (4.1%) ND ND ND ND ND
34 (19.5%) 7 (4%) 8 (4.6%) 75 (43.4%) 9 (5 . 2%) -
36 (22.8%) 8 (5.1%) 6 (3.8%) 51 (32.3%) 7 (4 .4%) ND
44 (16.8%) 5 (1.9%) 4 (1.3%) 83 (31.7%) 24 (9 . 2%) 11 (4 . 2%)
21 (18.4%) 
3 FRAXA
4 (3.5%) 1 (0.9%) 27 (23.7%) 18 (15 . 8%) 3 (2 . 6%)
44 (16%) 5 (1.8%) 9 (3.3%) 65 (23.7%) 22 (8%) 22 (8%)
43 (13.9%) 6(1.9%) - 57 (18 .4%) 53 (17 . 3%) 13 (4 . 2%)
3 (5.3%) - - 23 (40.4%) ND 6 (10 . 5%)
137 (34.25%) 22 (5.5%) 7(1.75%) 175 (39 .25%) ND ND
13 (11.2 %) 28 (24.1%) 15 (12.9%) 6 (5 . 2%) ND ND
16 (13.8%) 4 (3.4%) - 26 (22.4%) 6 (5 . 2%) 3 (2 . 6%)
39 (10%) - - - 46 (10 .1%) 23 (5 .1%)
4 (6%)
4 FRAXA
2 (3%) 3 (4.5%) 3 (4 . 5%) 5 (7 . 6%) 2 (3%)
25 (12.37%) 8 (3.96%) 8 (3.9%) 21 (10 .39%) 8 (4%) -
28 (5.5%) ND 5 (0.9%) 200 (39%) ND ND
61 (13%) - 8 (1.7%) 69 (14 . 6%) 38 (8%) 35 (7 .4%)
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Table 14. Overview of previous systematic cytogenetic studies and the present 
study
Study Number Mental level Chromosomal 
(Down syndrome)
Remarks
Mounoud et al . 
[31]
82
(39F)
Mild/Profound 25 (30.5%) 
(18 (22%))
Speed et al . [32] 2770
(1205F)
MR 297 (10.7%) 
(250 (9%))
Sutherland, [33] 588
(258F)
Borderline/Profound 90 (15 . 3%) 
(73 (12 .4%))
Jacobs et al . [34] 475
(191F)
Borderline/Profound 57 (12%) 
(40 (8 . 4%))
Ally and Grace, 
[35]
512
(136F)
MR 57(11.1%) 
(42 (8 . 2%))
Gripenberg et al . 
[36]
1062 MR 350 (33%) 
(305 (28 .7%))
Kondo et al . [37] 449
(188F)
Mild/Profound 37 (8 .1%) 
(33 (7 . 3%))
Nelson and Smart, 
[38]
720
(?F)
MR 148 (20.5%) 
(127 (17 . 6%))
Brundum-Nielsen 
et al . [39]
476
(227F)
Mild/Profound 76 (16%)) 
(58(12.2%))
2 (0 .4%) 
FRAXA
Fryns et al . [40] 1991
(937F)
Moderate/Severe 423 (21.2%) 
(295 (14. 8%))
57 (2 .9%) 
FRAXA
Schreppers- 
Tijdink et al . [41]
1170
(449F)
Severe/Profound 258 (22.1%) 
(167 (14 . 3%))
21 (6 . 8%) 
FRAXA
English et al . [42] 512
(0F)
MR 110(21. 5%) 
(65 (12 . 7%))
30 (5 .9%) 
FRAXA
Present study 471
(35F)
Mild to profound MR 100 (2 1 . 2%) 
(87 (18 . 5%))
16 (3 .4%) 
FRAXA
F: number of females
(47,XXY) and one patient with 47,XYY syndrome. These figures are comparable 
to the incidence in the normal population and confirm that there is no relation with 
MR [44, 45]. The patient with 48,XXYY karyotype had mild dysmorphic features 
but no behavior problems. Borghgraef et al. [46] reported behavior problems in four 
48,XXYY males including personality disturbances with psychotic reactions, 
chaotic behavior, and violent and impulsive reactions.
In only 8 patients (1.7%) central nervous system malformations were diagnosed. 
Previous studies also showed between 0.9% and 12.9% of CNS malformations 
(table 13). This can be explained by the small groups of patients who received brain 
imaging, because of the technical difficulties to perform brain-imaging.
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Monogenic disorders were diagnosed in 61 patients (13%). In previous 
systematic surveys monogenic diagnoses were found in 4.1 to 34.25% and 
MCA/MR syndromes in 1.8% to 24.1% (table 13). The 5 patients (1.1 %) with 
microdeletion syndromes were classified in the group of chromosomal disorders. 
Comparison with previous studies on systematic etiological surveys is difficult, 
since other classification systems were used. The degree of MR in these populations 
was also variable and therefore not always comparable with the present population. 
Mental retardation has been well-documented in tuberosis sclerosis, 
Zimmermann-Laband syndrome, Steinert disease, Cornelia de Lange syndromes 
type 1 and type 2, Apert syndrome and Sturge-Weber syndrome. In Stickler 
syndrome and Waardenburg type 2 syndrome mental abnormality has been reported 
in individual patients [47, 48]. The patient with limb-mammary syndrome (LMS) 
(Pallister syndrome) was member of the large kindred with severe hand and foot 
anomalies and hypoplasia or aplasia of the mammary gland and nipples, and gene 
localization on 3q27 [49]. He was the only mentally retarded individual in this 
family. The LMS gene is probably the p63 gene that is involved in the EEC 
syndrome [50]. Mental retardation has been reported in the EEC syndrome [51-53]. 
The patient with the branchio-oto-renal syndrome (BOR) is candidate to perform 
microdeletion studies, since the responsible gene is thought to be located on 
chromosome 8q12.2-q21.2 [54]. Mental retardation in BOR can be explained by the 
extent of the microdeletion.
Autosomal recessive disorders were found in 25 patients. The patient with 
Fountain syndrome and the patient with Björnstad syndrome were reported 
elsewhere [55, 56]. Six patients presented with microcephalia vera without 
neurological symptoms. Diverse metabolic disorders were present in 16 patients. A 
metabolic disorders as the cause of MR was present in 10 patients (PKU (n=5), 
S-sulphocysteinuria (n=3), Sanfilippo syndrome, type A (n=1) and 
GM1-gangliosidosis type 3 (n=1)), and metabolic disorders not explaining the MR 
in 6 patients (Sly syndrome (n=1), Niemann-Pick syndrome, type B (n=1), 
cystinuria (n=1) and hyperprolinemia type 1 (n=3)) [57].
In 22 male patients the diagnosis of X-linked mental retardation was made (i.e. 
5% of the male population). In 16 (72.7%) the diagnosis of fragile X syndrome was 
confirmed (i.e. 3.7% ofthe male population). These findings are in agreement with 
the general figures for fragile X syndrome in 2 to 6 % of MR in males [58]. One of 
these patients had the Prader-Willi syndrome-like phenotype [59,60]. Two patients 
presented X-linked mental retardation in association with marfanoid habitus 
(Lujan-Fryns syndrome MIM*309520) [61,62]. In three brothers with nonspecific 
XLMR, a mutation in the ILRAPL1 gene, localized on Xp22.1-p21.3 was found
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[13]. Stevenson [58] estimated that the fragile X syndrome may account for 30 to 
40% of all XLMR and according to Claes [27] FRAXA accounts for 15% to 20% 
of the male XLMR patients. However, in the present population, more than 70% of 
the patients with XLMR have the fragile X syndrome. This finding is not surprising, 
as in more than 60% of males with XLMR clinical findings are nonspecific [58]. 
Also in the present study, a number of males with XLMR was not recognized on the 
basis of the clinical phenotype only. In the group of 233 patients with idiopathic 
type of MR, further family data were collected and showed familial MR with 
affected first and/or second degree relatives in 73 patients (69 males and 4 females). 
Among these 69 affected males there were 35 males with pedigree data compatible 
with XLMR, including 3 affected male sib pairs, with a distinct neurological 
syndrome of complicated spastic paresis in 1 of them. XLMR was thus considered 
in 57 of the 471 patients (i.e. 12.1% of the total population, and 24.1% of the males 
with idiopathic MR), including 16 fragile X males, 2 males with MRXS, 3 brothers 
with a mutation in the ILRAPL1 gene, 1 patient member of the MRX-44 family and 
35 other males with nonspecific XLMR.
In the group of 233 patients with idiopathic MR additional parameters were 
analyzed: the occurrence of minor anomalies and neurological symptoms and 
biometric data on head circumference versus testicular volumes in males.
Minor anomalies were present in 41 (17.6%) patients. This percentage is lower 
than that found by Claes [27] in another MR population (27%). In patients with 
minor anomalies, the degree of MR was significantly more severe than in patients 
without minor anomalies. Cutis verticis gyrata was present in 3 severely to 
profoundly mentally retarded patients. A cutis verticis gyrata and mental deficiency 
syndrome (MIM 219300) was described by Akesson [63, 64] in 47 mentally 
retarded patients in Sweden as a possible autosomal recessive inheritance condition.
Neurological abnormalities were noted in a large number of patients. Seizures 
were present in one third of the patients. The presence of epileptic was statistically 
significantly correlated with more severe MR. In 6 males with familial mental 
retardation, spastic paraplegia was present. Mutation analyses are planned as the 
genes for complicated spastic paraplegia 1 (MASA spectrum; L1CAM; L1 cell 
adhesion molecule; Xq28) and com plicated spastic paraplegia 2 
(Pelizaeus-Merbacher syndrome; PLP; proteolipid protein; Xq21.1) have been 
cloned.
In the 215 males the combination of microcephaly and micro-orchidism was 
higher than expected; however, no statistically significant correlation was found. 
Macrocephaly and micro-orchidism were present in only one male. The 
combination of macrocephaly and macro-orchidism was present in 5 males (2.3%)
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and this finding was statistically significant. Since we were only interested in the 
combination of microcephaly and micro-orchidism and in the combination 
macrocephaly and macro-orchidism, only these 2 correlation tests were performed. 
Even after multiplying the P-value (Fisher exact test) by 2 (two correlation tests), 
the combination of macrocephaly and macro-orchidism remained statistically 
significant. Two of these patients with macrocephaly-macro-orchidism also had 
minor anomalies and 2 had behavior problems. The study of Claes [27], showed 
macrocephaly with macro-orchidism in 3% of the males. Since several XLMR 
syndromes are described which present with the combination of micro- and 
macro-orchidism and micro- or macrocephaly further investigations, such as 
looking for point mutations in the FMR-1 gene, are necessary in these groups of 
MR patients [58, 65].
In the group of 18 females 3 (16.7%) had microcephaly. One mildly mentally 
retarded microcephalic female also had mild neurological abnormalities.
Before systematic evaluation, only 21.8% (103/471) of the patients had a known 
diagnosis. After this survey, 50.5% (238/471) of the investigated patients had a 
definite diagnosis. However, the cause and the etiology of the MR could not always 
be explained by the presence of a diagnosis [57]. The global percentage of the 
diagnoses was also biased in this institution since a large number of persons with 
the clinical diagnosis of Down syndrome was cytogenetically confirmed (n=87). 
The present study agrees with the recommendations of the American College of 
Medical Genetics concerning the evaluation of mental retardation [6 6 ]. The 
individual, his family and caregivers do benefit from a focused clinical and 
laboratory evaluation. Therefore, the evaluation should be complete and include 
anamnestic data concerning early childhood, physical and neurological examination 
and assessment of the behavioral phenotype. Technical investigations should 
include chromosomal studies, accompanied by molecular DNA studies for the 
Fragile X syndrome (expansion of the CGG repeat in the FMR-1 gene). Metabolic 
testing and neuro-imaging should be reserved for selected groups of patients [6 6 ]. 
Longitudinal evaluation may be important to find the diagnosis, and for delineation 
of the physical and behavioral phenotype [6 6 ]. Systematic studies of diagnoses in 
an older population of mentally retarded patients are helpful in recognition and 
prevention of medical complications. In contrast to persons without MR, persons 
with severe MR do have 2.7 times, and persons with mild MR 2.2 times more 
comorbidity. The estimated rates of visual and hearing problems for people with 
intellectual disability are much higher than in people without MR [67-70]. In the 
group of patients with Down syndrome these medical complications are well known 
[43, 70]. In sporadic syndromes, scarce reports on medical complications at an older
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age are found in the literature. Therefore, this study is also a first step towards 
future studies concerning medical complications in older patients.
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1.1 D o w n  s y n d r o m e
1.1.1 D o w n  s y n d r o m e  in  a  p o p u l a t io n  o f  e l d e r l y  m e n t a l l y  
r e t a r d e d  p a t ie n t s : G e n e t ic -d ia g n o s t ic  s u r v e y  a n d  
im p l ic a t io n s  f o r  m e d ic a l  c a r e
G.J.C.M. Van BuggenhQut, 12 J.C.M. Trommelen,3 A. SchQenmaker,3 C. De Bal,3 
J.J.M.C. Verbeek,3 D.F.C.M. Smeets,2 H.H. RQpers,2 K. Devriendt, 1 B.C.J. Hamel,2 
and J.P .Fryns1
'Centre for Human Genetics, Herestraat 49, B-3000 Leuven, Belgium; 2Department of 
Human Genetics, University Hospital, Nijmegen, The Netherlands; institute for Mentally 
Retarded Patients Huize Assisië, Udenhout, The Netherlands.
Abstract
Ninety-six adults with DQwn syndrQme (DS) from an institutiQnal setting Qf 591 
mentally retarded were investigated systematically with respect tQ cytQgenetic 
diagnQsis, mental functiQning and dementia, QphthalmQlQgical and audiQlQgical 
abnQrmalities, and thyroid functiQn. Seventy Qf the 96 DS patients (73%) were Qlder 
than 40 years. Only 4.2% were females. TrisQmy 21 was fQund in 8 6 % and mQsaic 
trisQmy 21 in 13%. Eighty-twQ percent Qf the patients were mQderately Qr severely 
mentally retarded, 15% were profQundly retarded and Qnly 3% mildly retarded. 
Nineteen percent Qf the patients had dementia. This number increased tQ 42% Qf the 
patients abQve the age Qf 50 years. Epileptic seizures were present in 16.7 % Qf all 
patients, and in 50% Qf the patients with dementia. Only 17% Qf the patients in the 
present study had nQrmal visual acuity, Qne third had at least mQderately reduced 
visiQn. This number increased significantly with age: in the age group 50-59 years 
almQst half Qf the patients had mQderate tQ severe visiQn Iqss. Seventy percent Qf 
the patients had mQderate, severe Qr very severe hearing Iqss, which was 
undiagnQsed befQre systematic hearing testing was perfQrmed. Increased (48%) Qr 
decreased (1%) TSH level was fQund in 49% Qf the patients examined fQr thyroid 
functiQns. We suggest a regular screening Qf all adults with DS tQ diagnQse early 
dementia, epilepsy, hypQthyroidism, and early Iqss Qf visual acuity and hearing, 
with special attentiQn tQ the group Qf patients whQ are severely tQ profQundly 
mentally retarded and thQse with advanced age. CytQgenetic studies are necessary 
tQ cQnfirm the clinical diagnQsis and are essential fQr genetic cQunseling purpQses.
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Introduction
DQwn syndrQme (DS) is the mQst frequently identified cause Qf mental retardatiQn 
with an incidence Qf 1/700 tQ 1/1000 births [Evers-KiebQQms et al., 1982; Harper,
1994]. The phenQtype is well delineated and results from the presence Qf a trisQmy 
Qf the chrQmQsQmal 21q22.1-q22.3 regiQn [Mattei et al., 1981; -Qrenberg et al., 
1990; JQnes, 1997]. The DSCR1-gene (DQwn SyndrQme Critical RegiQn 1) in the 
21q22.1-q22.2 regiQn is repQrted as a candidate gene in the pathQgenesis Qf DS, 
particularly in mental retardatiQn and heart defects, and is highly expressed in brain 
and heart [Fuentes et al., 1995]. Approximately 94% Qf DS present a classical 
trisQmy 21, while in 2.4% Qf the patients mQsaicism is fQund. In abQut 3.3% a de 
nQvQ Qr familial translQcatiQn is the cause Qf trisQmy 21 [Evers-KiebQQms et al., 
1982].
Life expectancy in DS is reduced [Thase, 1982]: the majQr cause fQr early 
mQrtality is cQngenital heart defects [JQnes, 1997]. AlthQugh the average life 
expectancy in DS has increased Qver the last years, it still remains lQwer cQmpared 
tQ the general pQpulatiQn [Thase, 1982; DupQnt et al., 1986; Buchanan, 1990; 
McGrQther and Marshall, 1990]. Susceptibility tQ infectiQns is a well-knQwn feature 
and is related tQ an abnQrmal serum IgG subclass pattern [Annerén et al., 1992]. The 
incidence Qf leukemia, variQus thyroid disQrders, such as athyreQsis, subclinical 
hypQthyrQidism and hyperthyroidism, and autQ-immune disQrders are increased 
[Buchanan, 1990; NQrman et al., 1995]. With advancing age, premature ageing is 
Qbserved, accQmpanied by several cQmplicatiQns: premature graying Qr Iqss Qf hair, 
hearing problems and presbyacusis, Iqss Qf visual acuity and cataracts, and 
Alzheimer dementia in early adulthQQd.
In the present study we systematically investigated 96 patients with DS derived 
from a pQpulatiQn Qf 591 institutiQnalized mentally retarded patients. This study 
was set up tQ inventQry impQrtant clinical cQmplicatiQns in a group Qf adult patients 
with DS.
M aterials and M ethods 
P atients
During a systematic etiQlQgical survey Qver the periQd 1991-1995 in the Institute 
Qf Mentally Retarded Patients "Huize Assisië", UdenhQut, The Netherlands, 96 
patients (92 males (95.8%) and 4 females (4.2%)) with clinical features Qf DS were 
selected Qut Qf a pQpulatiQn Qf 591 patients. HistQrically, Qnly male patients were
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living in the institute and presently Qnly 6 .6 % Qf the residents are female. Patient 
recQrds were studied and a physical examinatiQn was perfQrmed. Written 
permissiQn tQ perfQrm cytQgenetic studies was Qbtained from the legal 
representative Qf patients whQ had nQt been karyQtyped befQre.
Cytogenetic studies
GTG-banded chromQsQmes from cultured peripheral lymphQcytes were studied 
in 87 Qf the 96 patients (90.6%). In Qne patient, cultured fibroblasts were alsQ 
karyQtyped. In 9 individuals (9.4%) chrQmQsQmal investigatiQn was refused. 
HQwever, these patients were included in the present study Qn the basis Qf their 
clinical diagnQsis.
M ental functioning
All patients were tested by the educatiQnal psychQlQgists Qf the institute tQ 
determine their level Qf intellectual functiQning. Several psychQlQgical tests, 
adapted fQr the Dutch pQpulatiQn, were used, depending Qn the level Qf mental 
functiQning. In patients with a develQpmental level between 7 and 11 years (mildly 
mentally retarded (IQ-level 50-55 tQ 70)), the Wechsler Intelligence Scale fQr 
Children-Revised (WISC-R) [Van Haasen et al., 1986] was used. The Wechsler 
Primary PreschQQl Scale Qf Intelligence test (WIPPSI) [Stinissen and Vander 
Steene, 1970] was used in the group Qf patients with a develQpmental level between 
4 and 7 years (mQderately mentally retarded (IQ-level 35-40 tQ 50-55)). Three 
different tests were applied in the group Qf patients whQ were severely 
(develQpmental level between 18 mQnths and 4 years (IQ-level 20-25 tQ 35-40)) Qr 
profQundly mentally retarded (develQpmental level between 12 mQnths and 18 
mQnths (IQ-level belQw 20-25)). The first test was the KID-N (Kent Infant 
DevelQpment Scale) [Schneider et al., 1990], a develQpmental scale between 1 and 
14 mQnths cQnsisting Qf Five subscales including cQgnitiQn, mQtQr develQpment, 
language, persQnal autQnQmy and sQcial skills. The secQnd test was the Bayley 
DevelQpmental Scales (BOS 2-30) [Van der Meulen and SmrkQvsky, 1983] and 
included a mental scale and mQtQr scale. The third test was the Terman-Merrill 
intelligence scale [Stinissen, 1965] cQnstructed tQ test cQgnitiQn levels 
cQrrespQnding tQ the ages Qf 2-22 years. The mental level Qf the patients was 
classified accQrding tQ the criteria described in the DiagnQstic and Statistic Manual 
Qf Mental DisQrders, 4th editiQn (DSM IV) [APA, 1994]. BQth the intellectual 
impairment and the adaptive behaviQr Qf the individual was used tQ classify 
patients.
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D em entia
Medical and psychiatric causes leading tQ a dementia-like picture were excluded 
by the general practitiQner Qf the institute. MemQry and QrientatiQn skills were 
examined by several questiQnnaires adapted fQr the Dutch pQpulatiQn which were 
filled Qut by day care wQrkers. The scales included the DMR (the Dementia 
QuestiQnnaire fQr Mentally Retarded PersQns) [Evenhuis et al., 1992], the 
Observatielijst OuderwQrdende BewQners (ObservatiQn List fQr Ageing Residents) 
[HQefnagel, 1989], and the SQciale Redzaamheidsschaal (SRZ) (Daily Living 
Skills) [Kraijer and Kema, 1990]. Dementia assQciated with DS was cQnsidered as 
nQt attributable tQ a specific medical Qr psychiatric diagnQsis.
O phthalm ologic exam ination
In 92 Qf the 96 patients, visual acuity cQuld be tested by different tests 
depending Qn the intellectual level Qf the patients. In the group Qf patients whQ are 
mildly Qr mQderately mentally retarded the LandQlt ring chart was used and in the 
group Qf severely mentally retarded patients the Burghardt picture charts fQr distant 
visiQn. The group Qf profQundly mentally retarded cQuld nQt be tested by any 
Qbjective test. In these patients, visual acuity was estimated by QbservatiQn and 
registratiQn Qf the eye mQvements and eye cQntact. SQme patients were referred fQr 
specialist diagnQsis and treatment. A Chi-square test was used tQ determine whether 
there was a cQrrelatiQn between the level Qf mental retardatiQn and Iqss Qf visual 
acuity.
H earing exam ination
Different audiQmetric methQds were used depending Qn the level Qf mental 
retardatiQn, cQQperatiQn, and cQncentratiQn pQssibilities Qf the individual patient. 
AlthQugh some patients had already hearing aids, each patient was tested withQut 
cQrrectiQn. In the group of mildly and moderately mentally retarded patients, 
hearing on each side was tested using pure tone (play audiometry) and speech 
audiometry (speech audiometry with pictures) (Interacoustics AC 40, serial number 
0004 1.13). The mean hearing loss was calculated according to the Fletcher-high 
index (mean loss at 1,000, 2,000 and 4,000 Hz). Hearing impairment in patients 
with severe and profound mental retardation was tested by free field audiometry 
(behavior observation audiometry). In this setting hearing loss, of the best ear was 
diagnosed, and mean hearing loss was calculated according to the Fletcher-high 
index. The classification system included mild (16-30 dB), moderate (31-60 dB), 
severe (61-90 dB) and profound (>90 dB) hearing loss. Although there is a mild 
hearing loss from 16 dB on, we considered hearing loss clinically important when
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there was a mean hearing loss of > 30 dB in the best ear. The mobility of the 
tympanum was also tested by impedance tympanometry [Grason Stadler, G S I33). 
The middle ear reflex could not be tested since there was a problem of interpreting 
the ipsilateral or contralateral reflexes. According to Katz [1994], the following 
criteria were used: the ear canal volume (ECV) for adults is normal within the range 
0.65-1.75 cm3, the middle ear pressure (MEP), at or near the normal atmospheric 
pressure, is normal within the range of 0 to -100 daPa, and the static compliance 
(SC), which is determined by the impedance of tympanum and middle ear bones at 
226Hz, is normal within the range of 0.30-1.60 cm3.
T hyro id  functioning
In 90 patients serum TSH levels (Delfia hTSH assay (Pharmacia, Woerden, The 
Netherlands)) and serum T4 levels (Double Antibody Total T4 assay (Diagnostic 
Products Corporation)) were tested.
R esults
Patients
The mean age of the 96 DS patients was 44.8 years, ranging from 22-61 years. 
More than 70% of the patients were between the age of 40-49 and 50-59 years 
(Table I). During the study period, 10 patients died and 7 patients were diagnosed 
with epilepsy.
TABLE I. Classification of the population Down syndrome patients according to
age and mental level
IQ-level <29 yrs 30-39 yrs 40-49 yrs 50-59yrs >60 yrs total
mild (50-55 to 70) 1 (1 1 .1 %) 1 (5.9%) - - 1 (100%) 3 (3.1%)
moderate (35-40 
to 50-55)
5 (55.6%) 10 (58.8%) 12 (33.3%) 19 (57.6%) - 46(47.9%)
severe( 20-25 to 
35-40)
3 (33.3%) 5 (29.4%) 18 (50%) 7 (21.2%) - 33 (34.4%)
profound (<20-25) - 1 (5.9%) 6 (16.7%) 7 (21.2%) - 14 (14.6)%)
total 9 (100%) 17 (100%) 36 (100%) 33 (100%) 1 (100%) 96 (100%)
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Cytogenetic studies
Eighty-seven patients were karyotyped. In 75 patients (86.2%) full trisomy 21 
(2 females and 73 males) was diagnosed and in 11 patients (12.6%) trisomy 21 
mosaicism (Table II). In patient 10 an autosomal reciprocal translocation 
t ( 1 1 ;1 7 ) ( q 1 3 ;q 2 5 )  w as fo u n d  in  th e  tw o  e u p lo id  c e l ls :  
47,XY,+21/46,XY,t(11;17)(q13;q25) de novo. Patient 11 showed a mosaic pattern 
of double aneuploidy: 45X/46,X,+21/47,XY,+21 (79/2/19) in peripheral 
lymphocytes and a different mosaicism 45,X/47,XY,+21 (36/14) in cultured 
fibroblasts. In one patient (1.1%) a de novo (21;21) translocation was present.
TABLE II. Patients with mosaicism and cell line distribution
Patien t Sex 46,XY o r XX 
N um ber of cells
47,XY,+21 o r XX,+21 
N um ber of cells
1 M 6 44
2 M 3 27
3 M 9 6
4 M 2 48
5 M 13 19
6 M 7 23
7 M 13 37
8 F 37 13
9 F 4 29
10 M 46,XY,t(11;17)/47,XY,+21 (2/30) de novo
11 M 45,X/46,X,+21/47,XY,+21 (79/2/19)
M ental functioning
Table I shows the mental level according to age. Seventy-three percent of the 
patients with DS were older than 40 years. More than 82% of the patients were 
moderately or severely mentally retarded. However, in the age group of 40-49 
years, 6 6 % of the patients were severely or profoundly and 33% moderately 
mentally retarded (Table I).
Of the 11 patients with trisomy 21 mosaicism, one was mildly mentally retarded, 
four moderately, five severely and one profoundly (Table III). The one mildly 
mentally retarded patient with trisomy 2 1  mosaicism was a 61- year- old male who
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was able to write and read and had a mosaic pattern of double aneuploidy 
(Down-Turner patient) (Table II).
TABLE III. Relation level of mental retardation and karyotype
K aryotype Unknown Full T21 Mosaic Translocation Total
Mild MR - 2 (2.7%) 1 (9.1%) - 3 (3.1%)
Moderate
MR
6 (66.7%) 35 (46.7%) 4 (36.4%) 1 ( 10 0 %) 46 (47.9%)
Severe MR 1 ( 1 1 .1 %) 27 (36%) 5 (45.5%) - 33 (34.4%)
Profound MR 2  (2 2 .2 %) 11 (14.7%) 1 (9.1%) - 14 (14.6%)
Total 9 (100%) 75 (100%) 1 1  ( 10 0 %) 1 ( 10 0 %) 96 (100%)
MR: mental retardation
Dementia
In 18 of the 96 patients (18.8%), a diagnosis of dementia was made. The 
incidence of dementia increased significantly with age, with 4(11.1% ) patients in 
the 40-49 year group and 14 (42.4%) patients in the 50-59 year group. Most patients 
with dementia were also moderately mentally retarded (Table IV). In this last group 
6 of the 14 patients with dementia died during the period of this study and also 
suffered from epilepsy. Epileptic seizures were present in 16 of the 96 DS patients; 
nine of these patients subsequently developed dementia.
TABLE IV. Classification of Down syndrome patients with dementia according to
age and mental level
IQ-level 40-49 yrs 50-59 yrs total
Mild (50-55 to 70) - - -
Moderate (35-40 to 50-55) 1 9 10
Severe (20-25 to 35-40) 3 2 5
Profound (<20-25) - 3 3
total 4 14 18
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O phthalm ologic exam ination
In 16 of the 92 examined patients vision was normal (17.4%). However, in five 
(one patient with moderate, two with severe and two with profound mental 
retardation) vision could not be extensively tested due to lack of cooperation. As 
shown in Table V, more than 50% of the patients had a mild vision loss, which 
could be corrected in almost half of them. Moderate loss of visual acuity was 
diagnosed in 19 patients (20.7%). A severe to very severe vision loss was detected 
in eight patients (8.7%) and correction was not possible. Table VI shows the
TABLE V. Results of vision tested in 92 patients
Vision +C -C Total
Normal - 16 16
>0.30 (mild loss) 24 25 49
<0.30 (moderate loss) 13 6 19
0.02-0.05 (severe loss) - 2 2
<0.02  (severe loss/blind) - 6 6
Total 37 55 92
+C: with correction; -C: without correction
TABLE VI. Classification of the population Down syndrome patients according to
age and loss of visual acuity
Visual
acuity
Age
<29 yrs 30-39 yrs 40-49 yrs 50-59 yrs >60 yrs Total
Normal 2 (2 2 .2 %) 2 ( 1 1 .8 %) 8 (2 2 .2 %) 4(13.8% ) - 16 (17.4%)
>0.30 6 (66.7%) 12 (70.6%) 18 (50%) 12 (41.3%) 1 ( 10 0 %) 49 (53.3%)
< 0.30 1 ( 1 1 .1 %) 2 ( 1 1 .8 %) 6 (16.6%) 10 (34.5%) - 19 (20.7%)
0.02-0.05 - - 1 (2 .8 %) 1 (3.4%) - 2  (2 .2 %)
< 0.02 - 1 (5.9%) 3 (8.3%) 2 (6.9%) - 6 (6.5%)
Total 9 (100%) 17 (100%) 36 (100%) 29 (100%) 1 ( 10 0 %) 92 (100%)
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different age categories in association with loss of visual acuity. At a younger age, 
loss of visual acuity was rather mild, but with advancing age the severity of vision 
loss increased: in the age group 50-59 years almost half of the patients (13 out of 
29,44.8% ) had moderate to severe vision loss, compared to 27.8% in the age group 
40-49 years and 17.7% in the age group 30-39 years. Table VII presents an 
overview of the level of mental functioning and severity of vision loss. No 
statistically significant correlation was found between the severity of mental 
retardation and loss of visual acuity (Chi-square in contingency table (2x3); P = 
0.08; 2  degrees of freedom).
TABLE VII. Relation level of mental retardation and loss of visual acuity
Visual
acuity
Mental Retardation
Mild M oderate Severe Profound Total
Normal 1 (33.3%) 4(9.1% ) 7 (22.6%) 4 (28.6%) 16 (17.4%)
>0.30 2  (6 6 .6 %) 23 (52.3%) 19 (61.3%) 5 (35.7%) 49 (53.3%)
< 0.30 - 14 (31.8%) 3 (9.7%) 2 (14.3%) 19 (20.7%)
0.02-0.05 - 1 (2.3%) 1 (3.2%) - 2  (2 .1  %)
< 0.02 - 2 (4.5%) 1 (3.2%) 3 (21.4%) 6 (6.5%)
Total 3 (100%) 44 (100%) 31 (100%) 14 (100%) 92(100 %)
In 65 patients, a more specific ophthalmologic diagnosis was made. In 28 
(43%), two or more different eye abnormalities were present. In 26 patients 
cataracts were present, bilateral in 23. Of the seven patients with a severe form of 
cataracts, five patients received extraction of the lens (with lens reimplantation in 
two). Keratoconus was diagnosed in 11 patients, bilateral in eight. Refraction 
problems included myopia (n=16), hypermetropia (n=6 ) and astigmatism (n=9). 
Strabismus was noted in 21 patients: convergent in 12, alternans in four, divergent 
in one and amblyopia in four. In ten patients other eye problems were diagnosed: 
nystagmus (n=3), pterygium (n=2), macular degeneration (n=1), atrophia of the iris 
(n= 1 ), phtisis bulbi (n=1 ), ablatio retinae (n= 1 ) and cone and rod cell dysfunction 
(n= 1 ).
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H earing problem s
Information on hearing could be obtained from 90 of the 96 patients. Data were 
already available on ten patients and included three with normal hearing, six with 
mild hearing loss, and one with moderate hearing loss. None of these ten patients 
had hearing aids.
Table VIII presents the hearing loss in relation to age of all 90 patients. 
Sixty-five patients (72.2%) had moderate, severe or profound hearing loss. Bilateral 
hearing devices were used in31 patients. Patients with a unilateral prosthesis had 
moderate hearing loss (Table IX).
TABLE VIII. Classification of the population Down syndrome patients according
to age and hearing loss
Hearing
loss
Age
<29 yrs 30-39 yrs 40-49yrs 50-59 yrs >60 yrs Total
0-15 dB 1 ( 1 1 .1 %) - 4(11.4% ) 1 (3.4%) - 6(6.7%)
16-30 dB 4 (44.4%) 9 (56.3%) 3 (8 .6 %) 3 (10.3%) - 19(21.1%)
31-60 dB 3 (33.3%) 5 (31.3%) 20 (57.1%) 20 (69%) - 48(53.3%)
61-90 dB 1 ( 1 1 .1 %) 2 (12.5%) 6(17.1% ) 5 (17.2%) 1 ( 10 0 %) 15(16.7%)
>90 dB - - 2 (5.7%) - - 2 (2  .2 %)
Total 9 (100%) 16 ( 10 0 %) 35 (100%) 29 (100%) 1 ( 10 0 %) 90 (100%)
TABLE IX. Distribution of the patients who received hearing aids (HA)
Degree of 
hearing loss
W ithout HA With HA Total
Normal 6 - 6
Mild 19 - 19
Moderate 20 28 48
Severe 7 8 15
Profound 1 1 2
Total 53 37 90
ChromQSQmal syndromes 77
Table X presents an overview of the type of hearing loss of the best ear 
diagnosed in these 80 patients . Of one patient no information about the type of 
hearing loss could be obtained . Mixed hearing loss was diagnosed in 45%, 
perceptive hearing loss in 43 . 8 %, and conductive hearing loss in only 10% of the 
patients
TABLE X . Severity of hearing loss in relation to the type of hearing loss and
according to age (in years)
Hearing <29 yrs 30-39 yrs 40-49 yrs 50-59 yrs >60 yrs Total
loss
M P C M P c M P c M P C M
Normal 1 - - - - 1 - 1 - - 3
Mild 2 2 - - 6 2 - 1 - - - - - 13
Moderate* 3 - - 2 3 - 8 7 3 9 10  1 - 46
Severe 1 - - 1 1 - 3 1 2 3 2 - 1 15
Profound - - - - - - 2 - - - - - - 2
Total 7 2 - 3 10 2 13 9 6 12 13 1 1 79
M: mixed hearing loss 
P: perceptive hearing loss 
C: conductive hearing loss
* No specific information available on 1 patient of 43 years with a moderate hearing 
loss
Tympanometry was also performed in these 80 patients . In 45 (56.3%) patients, 
abnormalities of the mobility of the tympanum was noted: in 29 patients bilateral, 
in ten patients on the right side and in six patients on the left side . Data on reflexes 
of the bones could not be obtained .
Thyroid function
Data on serum T4 and TSH levels for 90 patients were available . The T4 level 
was normal in 87 patients (96 . 7%) and in three patients (3 . 3%) the T4 concentration 
was below 0 . 07 |J,mol/l and hypothyroidism was diagnosed . Thirteen patients were 
treated by exogenous T4 including the three patients with hypothyroidism . Table 
XI presents the distribution of the TSH levels in relation to age: no significant
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correlation between increased TSH levels and the different age groups was found 
(Chi-square in contingency table (2x3); P = 0 .17; 2 degrees of freedom) .
TABLE XI . TSH-level in relation to age
<29 yrs 30-39 yrs 40-49 yrs 50-59 yrs >60 yrs Total
Normal 4 5 18 18 1 46 (51.1%)
Increased 4 11 17 11 - 43 (47. 8 %)
Decreased - - 1 - - 1 ( 1 .1 %)
Total 8 16 36 29 1 90
Discussion
In this systematic etiQlQgical study in an institutiQnalized pQpulatiQn Qf adult 
mentally retarded individuals, we cQllected data Qn the physical and CQgnitive 
functiQning Qf the 96 trisQmy 21 patients (16.2% Qf the tQtal pQpulatiQn). MQre than 
70% Qf the patients were abQve 40 years (mean age 44.8 years). Until recently, Qnly 
male residents had been admitted tQ the institute, explaining why Qnly fQur females 
participated in this study. All patients were first selected accQrding tQ their clinical 
phenQtype. ChrQmQsQme studies cQuld be performed in 87 Qf the 96 patients, and 
the clinical diagnQsis Qf trisQmy 21 was cQnfirmed in all these patients. A full 
trisQmy 21 was fQund in 86.2% Qf the patients, in cQntrast tQ the general findings 
in the literature (94%) [Evers-KiebQQms, 1982). In the present study, 12.6% Qf the 
patients had mQsaic trisQmy 21, which is higher than the 2.4% fQund in the Qverall 
DQwn syndrQme pQpulatiQn studies. This higher percentage Qf mQsaic trisQmy 21 
in this Qlder pQpulatiQn may be due tQ the fact that patients with milder clinical 
phenQtype, as seen in trisQmy 21 mQsaicism, reach an Qlder age. In Qne mQsaic 
patient, an apparently balanced autQsQmal reciprocal translQcatiQn 
t(11;17)(q13;q25) was present in the cell line with 46 chrQmQsQmes. 
NQrmal/autQsQmal reciprocal translQcatiQn mQsaicism is rare [Fryns and 
KleczkQwska, 1986; KleczkQwska et al., 1990]. As far as we knQw, nQ Qther patient 
with trisQmy 21 mQsaicism and a de nQvQ autQsQmal reciprocal translQcatiQn in the 
nQrmal cell line has been repQrted sq far. In Qne Qther mQsaic patient, chrQmQsQmal 
analysis showed a mosaic pattern of double aneuploidy: 45X/46,X,+21/47,XY,+21 
(79/2/19) in cultured peripheral lymphocytes and a different mosaic pattern
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45,X/47,XY,+21 (36/14) in cultured fibroblasts. This patient has previously been 
reported [Van Buggenhout et al., 1994]. He presented a mixed phenotype with DS 
features (mild mental retardation, brachycephaly, upward slanting palpebral 
fissures, flat midface and short stature) as well as features of Ullrich-Turner 
syndrome (short and broad neck, low posterior hairline, wide thorax, large 
internipple distance and short stature).
M ental functioning
More than 80% of the patients were moderately or severely mentally retarded. 
In the 50-59 year age group, 60% of the patients were moderately and 40% severely 
to profoundly mentally retarded, whereas at 40-49 years, 6 6 % of the patients were 
severely and only one-third moderately mentally retarded.
Some studies indicated that patients with trisomy 21 mosaicism have better 
cognitive function [Fishler and Koch, 1991]. In the present study, this observation 
could not be confirmed since 4/11 patients were moderately and 5/11 patients 
severely mentally retarded.
D em entia
Previous studies [Warren et al., 1989; Evenhuis et al., 1991; Pueschel et al.,
1995] have extensively documented the high prevalence of dementia and 
Alzheimer's disease in DS, which affects more than 25% of individuals above the 
age of 50 years. The neuropathological findings [Norman et al., 1995] of senile 
plaques and deposition of amyloid protein in DS patients 20-30 years earlier than 
in a population without DS may be related to the increased dosage of a gene for the 
amyloid precursor protein on the proximal 21q region [Norman et al., 1995]. The 
overall percentage of trisomy 2 1  patients with dementia in the present study is high 
(18.75%) and significantly increases with age. No symptoms of dementia were 
noted in the 24 patients younger than 39 years, but symptoms were noted in 11.1% 
of the patients in the age group 40-49 years and in 42.4% of the patients in the age 
group 50-59 years. This high percentage of dementia cannot be explained by 
selective admission of DS patients with dementia. In this institute, all residents have 
been admitted as young adolescents for lifelong care. There was no correlation 
between the dementia and the level of mental retardation (Chi-square in 
contingency table (2x3); P = 0.8; 2 degrees of freedom).
During this study, ten patients died, seven had dementia, and six were in the age 
group of 50-59 years. This observation confirms that dementia is an important 
predictive factor for (limited) life prognosis in the group of adult DS patients, 
especially after the age of 50 years. However, dementia was not correlated with the
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level of mental retardation.
In DS patients, a high prevalence of seizures has been noted in the third decade 
of life [Pueschel et al., 1995] and at an older age, seizure disorders were usually 
associated with Alzheimer disease [Pueschel et al., 1995]. In the study of Evenhuis
[1990], the incidence of epileptic seizures and myoclonus increased about 8-fold in 
demented patients with DS as compared to patients with Alzheimer dementia but 
without DS. In the present study 9 of the 18 patients (50%) with dementia also 
suffered from epileptic seizures. Epileptic seizures were considered one of the first 
signs of Alzheimer dementia by the general practitioners in this institute.
O phthalm ologic problem s
Only 16 of the 92 patients (17.4%) had normal visual acuity. More than 50% 
had a mild vision loss, 20.7% had moderate loss of visual acuity, and severe to very 
severe vision loss was diagnosed in 8.7%. With advancing age (50-59 years age 
group) 44.8% of the patients had moderate to severe vision loss, compared to 27.8% 
in the age group 40-49 years and 17.7% in the age group 30-39 years. No 
correlation was found between the severity of the vision loss and the degree of 
mental handicap.
Cataracts (28.3%), strabismus (22.8%), refraction problems (33.7%) and 
keratoconus ( 1 2 %) were the main ophthalmological problems.
Warburg [1982] performed a large study in Denmark and concluded that 5% of 
the mentally retarded children had a visual acuity below 0 . 1 , as compared to 0 .0 2 % 
in the normal child population.
In the older (50-65 years) population of persons with intellectual disability, 
prevalence of visual impairment ranges from 8 to 50% [Janicki and Jacobson, 1986; 
Moss, 1991]. However, none of these authors reported any diagnostic criteria.
In apopulation of approximately 3,000 mentally handicapped individuals, Moss
[1991] observed that severe visual problems tended to be higher in the early and late 
years compared to mid-life. Also, Evenhuis [1995a] suggested a higher prevalence 
of visual impairment in the elderly population with mental retardation as compared 
to the general aging population.
Several studies were published on eye defects in developmentally handicapped 
children and a high percentage of abnormalities was present. A relationship between 
the visual problems and the developmental handicap was thus considered [Edwards 
et al., 1972; Kennerley Bankes, 1974]. Also, Warburg [1982] observed that more 
severe visual impairment is seen in more severe intellectual disability.
Several authors reported on the ocular findings in DS [Eissler and Longenecker, 
1962; Cullen and Butler, 1963; Gardiner, 1967; Walsh, 1981; Shapiro and France,
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1985; Caputo et al., 1989]. Cullen and Butler [1963] reported on a population of 
143 patients with DS, between the ages of 2-53 years, and observed ocular defects 
in 65.5%. In a study by Gardiner [1967], 70% of the 22 patients with DS had 
defective visual acuity in comparison to 30% of the 38 patients with another mental 
handicap. Aitchison [1990] reported on a large group of 367 patients with mental 
retardation, with 144 patients older than 40 years and 105 males and 262 females, 
including 31 patients with DS. In 218 patients (59%), eye abnormalities were found; 
excluding the patients with DS, this percentage was still high (54%). The most 
common eye problems included strabismus (31%), refractive error (30%), and 
cataract (11%) in this total population. In this group of patients with DS, 71% were 
older than 40 years.
Jacobson [1988] reported on a group of 228 mentally retarded patients. DS was 
present in 50 patients and in 22 of these patients visual acuity was below 0.1. In 14 
of these 2 2  patients, an acquired visual handicap was present and included presenile 
cataract, high myopia and keratoconus.
Almost one-third of the patients in our study had a moderate to severe vision 
loss, resulting in a serious limitation in functioning. In 53.3% of the patients a mild 
loss of visual acuity was diagnosed and 50% received correction. This group of 
patients with a mild loss of visual acuity should be carefully treated and regularly 
screened from the age of 35-40 years, since our data suggest that with advancing 
age more patients are found with severe loss of visual acuity. However, to confirm 
this observation follow-up studies are necessary. In keeping with the Committee 
report recommendations [Pueschel et al., 1995], we support repeated eye 
examination at least every two years in adult patients with DS to diagnose early loss 
of visual acuity and other eye problems at increasing frequency with advancing age. 
Therefore, the general practitioner should not wait for spontaneous complaints or 
observations of the care givers. A study by Kelly [1996] showed that it is possible 
for nurses to carry out a basic examination, including external inspection, lid 
eversión and pupil testing and to perform simple eye testing effectively (distance 
and near vision and peripheral vision testing).
H earing loss
Only 6.7% of the 90 participating patients in the present study had normal 
hearing. A mild hearing loss at the best ear was present in 21.1%. More than 70% 
of the patients had a moderate (53.3%), severe (16.7%) or profound (2.2%) hearing 
loss. In 41.1% hearing devices were used, and in 83.8% this was bilateral.
In 80 patients, a more extensive examination to determine the type of hearing 
loss was performed: an equal number of patients had mixed or perceptive and 1 0 %
82 Part 2 - Chapter 1
had conductive hearing loss. Conductive hearing loss was present in the age groups 
from 30-59 years. With advancing age, more patients with a moderate, severe or 
profound hearing loss were noted.
The prevalences of severe congenital perceptive hearing loss is estimated at 
1/1,000 newborns. Reviewing the literature, Trommelen and De Bal [1994] found 
the prevalence of hearing loss in persons with mental retardation to vary from 
7-52% and Mul et al., [1997] noted prevalence between 40-90% in persons with 
DS. Evenhuis [1996] reported hearing problems in 40% of DS children and noted 
that perceptive hearing loss increases from age 20 on. Buchanan [1990] estimates 
the onset of presbyacusis in patients with DS to occur 20 to 30 years earlier than in 
patients with other causes of mental retardation and 30 to 40 years earlier than in 
the normal population. Hearing loss is reported in 70% of the patients with DS 
above the age of 40 years [Evenhuis, 1991, 1992, 1995b].
Impacted cerumen in the narrow ear canals and chronic otitis media, due to 
Eustachian tube dysfunction, results in conductive hearing loss, and are the main 
causes for hearing loss in children and young adults with DS [Dahle and 
McCollister, 1986; Brown et al., 1989; Evenhuis, 1991; Crandell and Roeser, 1993; 
Maurizi et al., 1995]. Crandell and Roeser [1993] observed impacted cerumen was 
present in 28% of patients with mental retardation compared to 2 -6 % in the general 
adult population. In patients with DS older than 40 years, hearing loss is caused by 
continuous effusion of chronic otitis media and presbyacusis resulting in perceptive 
hearing loss [Evenhuis, 1991; Buchanan, 1990]. This may explain the distribution 
of perceptive (43.8%) and mixed type of hearing loss (45%) in the present group 
of older patients.
Mul et al. [1997] observed that 85% of the patients without hearing aids did not 
know that they suffered from hearing loss and for 80% of the patients, the general 
practitioner or their care givers did not know about hearing loss.
Hearing impairment in patients who were severely or profoundly mentally 
retarded could be diagnosed by behavior observation audiometry, in which the 
hearing loss of the best ear was diagnosed. Meanwhile, Verpoorten and Emmen 
[1995] developed a tactile-auditory conditioning method for difficult-to-test 
populations. The majority of patients of the present population were also examined 
for the mobility of the tympanum by impedance audiometry to diagnose middle ear 
problems. In 56.3% of the 80 patients, abnormalities of the tympanum were noted.
Depression and severe hearing loss are difficult to differentiate from dementia 
and are often present in patients with DS [Warren et al., 1989; Evenhuis et al., 1991; 
Norman et al., 1995; Pueschel et al., 1995]. Early diagnosis and treatment can 
preventmalfunctioning [Evenhuis, 1991].
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Diagnosis of middle ear infections and hearing impairment, and regular cleaning 
of the external ear canals in children and adults with mental retardation are 
important in early intervention [Evenhuis, 1995b].
The present findings reinforce the recommendations of the Committee report 
[Pueschel et al., 1995] to perform a hearing assessment in adults with DS at least 
every 2  years.
T hyro id  function
Thyroid dysfunction occurs in about 40% of adults with DS [Pueschel et al., 
1995; Dinani and Carpenter, 1990]. Thyroid antibodies are frequently present, 
suggesting a genetic predisposition to autoimmune thyroiditis. Clinical features of 
hyperthyroidism include agitation and loss of weight. Features of hypothyroidism 
are short stature, slow activity, hoarse voice and obesity [Dinani and Carpenter, 
1990].
In the present study, thyroid dysfunction with increased (n=43) or decreased 
(n=1) TSH levels was observed in 44 (48.9%) of the examined patients. 
Hyperthyroidism was diagnosed in one patient (TSH level decreased) and 
hypothyroidism in three patients, with only two patients with a primary 
hypothyroidism (TSH increased; T4 decreased) and one patient with a secondary 
hypothyroidism (TSH normal; T4 decreased). This low percentage can be explained 
because thyroid screening and treatment were performed on a regular basis before 
the beginning of the present study. Our percentages are comparable to previous 
reports [Pueschel and Pezzullo, 1985; Kinnell et al., 1987; Friedman et al., 1989; 
Dinani and Carpenter, 1990]. In an overview of the literature, Evenhuis [1991] 
reported a variation of 2.5-17% of hypothyroidism in patients with DS, with a 
prevalence below 5% under the age of 20 years.
Subclinical hypothyroidism is widely used to describe patients with increased 
TSH and normal T4, without symptoms of hypothyroidism [Anonymous, 1986]. In 
the present study, 41 patients were diagnosed with subclinical hypothyroidism and 
ten patients were treated. Smink et al. [1992] reported ten patients with DS and 
observed that TSH was increased in four patients. In a group of 105 children with 
DS between the ages of 3 months to 20 years, Alembik et al. [1996] demonstrated 
that one-half of these children had an increased TSH, which improved after 
thyroxin treatment. The main argument to support treatment of these patients is that 
it may prevent progression to hypothyroidism and that improved physical and 
mental well-being is reported [Anonymous, 1986; Cooper et al., 1984]. Therefore, 
annual screening of T4, TSH and thyroid antibodies is recommended to identify 
those who have a thyroid disorder.
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Conclusion
The findings of the present study confirm the necessity of regular screening in 
institutionalized older male adults with DS syndrome to diagnose early onset 
dementia, epilepsy, hypothyroidism and early loss of visual acuity and hearing. 
CytQgenetic studies are necessary to confirm the clinical diagnosis. Special attention 
and care should be given to the subgroups of trisomy 2 1  patients with severe to 
profound mental retardation, as these complications lead to serious additional 
limitations of functioning. Screening programs should be performed with increased 
frequency (on a yearly basis) with advancing age.
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Abstract
We present a male patient with Down-Turner m osaicism  
(45,X/46,X,+2l/47,XY,+2l) and review 27 similar cases reported so far . Clinical 
features of Down syndrome were present in all cases, whereas a combination of 
features of both Ullrich-Turner syndrome and Down syndrome was reported in 61% 
of the patients . However, one has to bear in mind that several stigmata of 
Ullrich-Turner syndrome can also be present in patients with Down syndrome and 
vice versa.
In most of the patients two different cell lines were encountered, although cases 
with one, three and even four different cell lines have been reported . Of 28 patients, 
2 1  showed female external genitalia, four were phenotypically male, and three 
showed ambiguous genitalia . Only 6 patients (21%) carried a Y chromosome, which 
is far less than expected .
Introduction
Chromosomal aneuploidy is quite frequent and may involve autosomes, as in 
Down syndrome, or sex chromosomes, as in Ullrich-Turner syndrome . In contrast, 
double aneuploidy involving both autosomal and sex chromosomes is very rare . Sex 
chromosomal aneuploidy in combination with trisomy 21 includes Down- 
Klinefelter, Down-XXX, Down-XYY, and Down-Turner syndrome (1-4) . Of these, 
Down-Turner syndrome is one of the most rare with only 27 cases being reported 
so far . We p resen t a new case o f D ow n-T urner m osaicism  
(45,X/46,X,+21/47,XY,+21), which was found during routine screening of a 59 
year old male to confirm the clinical diagnosis of Down syndrome and to rule out 
an inherited translocation . Cytogenetic and clinical features of all known cases are 
reviewed
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Case R epo rt
A 59 year old male, institutionalized from the age of 8 years, was presented for 
cytogenetic analysis to confirm the clinical diagnosis of Down syndrome and to rule 
out the presence of an inherited chromosome aberration . The proband was the 
fourth child of non-consanguineous parents . There had been one miscarriage 
between the first and second children. At birth both parents were 40 years old . 
There was no family history of either Down or Turner syndrome . When the proband 
was 7 months old, psychomotor retardation was noticed . He walked at the age of 
2 years 6 months and developed speech at 5 years . At the age of 7, he weighed 20 . 7 
kg (25th centile) with a height of 117 cm (25th centile), and features of Down 
syndrome were first noticed then . Clinical neurological investigation at the age of 
32 was normal, but a pneumoencephalogram showed periventricular atrophy . 
Substitution therapy was started for primary hypothyroidism, when he was 49 years 
old . On the Vineland Adaptive Behavior Scale his total psychological score was 4 
years 8 months at the age of 53 . However, he was able to write and read . A few 
years later a moderate bilateral perception hearing loss was diagnosed, with a loss 
of 35 dB on the left and 53 dB on the right (Fletcher Index) . He has recently 
developed diabetes mellitus type II which was treated orally .
Recent investigation showed a well nourished, short statured male with a height 
of 156 cm (<3rd centile) and a weight of 64 . 5 kg (50th centile) . He had a 
brachycephalic skull with a head circumference of 52 . 3 cm (<3rd centile) . His hair 
was sparse and there was a low posterior hairline . He had a round face with small, 
upward slanting palpebral fissures, a flat midface, and a normal tongue . His ears 
were asymmetrical and measured 7 cm on the right and 7 . 2 cm (75th to 97th centile) 
on the left (Fig . 1) . His neck was short and broad and the thorax wide with an 
internipple distance of 22 cm (97th centile) . Heart auscultation was normal and he 
had normal sized testes . The hands were broad, with a total hand length of 17 cm 
(25th centile) bilaterally, the fifth fingers were normal, and there were no simian 
creases . The foot length was 21 cm (<3rd centile) bilaterally, there was partial 
syndactyly of the second and third right toe, and there was no sandal gap .
Cytogenetic studies
Chromosome analysis was performed according to routine procedures . During 
analysis of 15 GTG banded metaphases derived from cultured peripheral 
lymphocytes, two different cell lines were found . Therefore, the study was extended 
to a total of 100 mitoses . This analysis showed a mosaic pattern of double
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Figure 1. Facies and profile of the patient .
aneuploidy : 45,X/46,X,+21/47,XY,+21 (79/2/19) . Subsequently, a skin biopsy was 
obtained from the right upper limb . Chromosome analysis of 50 cultured fibroblast 
cells after routine GTG banding also showed a mosaic pattern, but different from 
the lymphocytes in that the 46,X,+21 cell line was not found: 45,X/47,XY,+21 
(36/14) .
Discussion
Double aneuploidies involving both a sex chromosome and an autosome appear 
to be quite rare, with Down-Turner syndrome being among the most rarely reported . 
In the analysis of our patient we encountered several specific features of Down 
syndrome (mental retardation, brachycephaly, upward slanting palpebral fissures, 
a flat midface, and short stature) as well as Ullrich-Turner syndrome (short and 
broad neck, low posterior hairline, wide thorax with a large internipple distance, and 
short stature) . Mental retardation was mild as he was able to write and read and he 
was quite old for a pure trisomy 21 patient . There were no signs of dementia . 
Cytogenetic studies proved that this was because of a mosaic chromosomal pattern 
with trisomy 21 in only a minority of cells in two different tissues . The patient was 
phenotypically male although chromosome analysis showed a Y chromosome in 
only 19% and 28% of cultured peripheral lymphocytes and fibroblast cells, 
respectively
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Review of the literature
A total of 34 cases of Down-Turner syndrome have been reported so far. 
However, three of these cases apparently were diagnosed purely on clinical features 
without any cytogenetic confirmation (5, 6 ) . Since we reviewed only karyotyped 
cases, these three were not included in the table and will not be considered further . 
Another three cases of Down-Turner mosaicism in which one of the X 
chromosomes showed a deletion were not included either, as they represent a 
different genetic entity: 47,XX,+21/47,XX,p-q-,+21; 47,X,del(X)(p11),+21, and 
47,X,Xq-,+21 (7-9) . Lastly, a complex case of trisomy 21 associated with 
XO/XX/XXX, was also excluded (10) .
The clinical features and chromosomal patterns of the remaining 28 patients, 
including our own case, are summarized in table 1 .
Features of Down syndrom e against U llrich-T urner syndrom e
Eleven of the 28 patients (39%) had the typical phenotype of pure Down 
syndrome, including short stature, flat face, oblique palpebral fissures, depressed 
nasal bridge, Brushfield spots, large, protruding tongue, small ears, brachycephaly, 
short broad hands and feet, short fifth fingers, a space between the first and second 
toes, and hypotonia at birth (cases 1, 4, 5, 7, 8 , 10, 12, 13, 14, 22 and 23) . Four 
patients (14%) showed clear features of both Down and Turner syndromes (cases
3, 15, 20 and 21), while in 12 patients (43%) clear signs of Down syndrome and 
only milder features ofUllrich-Turner syndrome were reported (cases 2 ,6 ,9 , 11, 
16, 17, 18, 19, 24, 25, 27 and 28) . These less distinct features of Ullrich-Turner 
syndrome included: oedema of the hands and feet at birth, delayed sexual 
development, short stature, webbing of the neck, and ambiguous genitalia . In three 
of the 12 cases (cases 6,9 and 17) oedema of the hands and feet was reported and 
in two patients (cases 24 and 28) delayed sexual development was noted . Both 
features are quite specific for Ullrich-Turner syndrome, whereas the other signs 
may be present in Down syndrome as well . Therefore, the remaining seven patients 
could also be regarded as typical Down syndrome patients based on the published 
data . However, since all 12 patients were earlier described as showing signs of both 
Down and Ullrich-Turner syndromes we included them is this group .
In one patient only mild stigmata of both Down and Ullrich-Turner syndrome 
were described (case 26) .
Not a single patient has been reported with a pure Ullrich-Turner phenotype as 
characterized by a short stature, delayed sexual development, low posterior hairline, 
shield chest, multiple pigmented naevi, cubitus valgus and webbing of the neck .
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Table 1. Down Turner syndrome: Clinical features and cytogenetic findings in 
cultured peripheral lymphocytes of all 28 reported cases including the present one
Case Reference Chrom osom e P a tte rn
1 Baguena Candela 1966 (15) 46,X,+G
2 Townes et al .1975 (2) 45,X/46,X,+21
3 Taylor et al .1970 (16) 45,X/47,XX,+G *
4 Cohen & Davidson 1971 (1) 45,X/47,XX,+21 *
5 Barakat&DerKaloustian1973 (17) 45,X/47,XX,+G
6 Hustinx et al .1974(18) 45,X/47,XX,+21 *
7 Jansen et al .1991 (4) 45,X/47,XX,+21
8 Prieur et al . 1972 (19) 45,X/47,XY,+21 *
9 Hustinx et al. 1974 (18) 45,X/47,XY,+21
10 Baguena Candela 1965 (20) 46,X,+G/46,XX
11 Medenis et al . 1962 (21) 46,X,+G/47,XX,+G
12 Root et al . 1964 (22) 46,X,+21/47,XX,+21
13 Van Wijck et al.1964 (23) 46,X,+21/47,XX,+21
14 Pfeiffer et al . 1968 (24) 46,X,+21/47,XX,+21
15 Gatrad 1981 (3) 46,X,+21/47,XX,+21
16 MacFaul et al.1981 (25) 46,X,+21/47,XX,+21
17 MacFaul et al.1981 (25) 46,X,+21/47,X,i(Xq),+21
18 Santos Mello et al .1974 (26) 46,X,+21/47,XY,+21
19 Yeung&Yang 1976 (12) 46,X,+21/47,XY,+21
20 Villaverde&Da Silva1975 (27) 45,X/46,X,+G/47,XX,+G *
2 1 Present report 1994 45,X/46,X,+21/47,XY,+21 *
22 Grosse et al . 1971 (28) 45,X/46,XX/47,XX,+G
23 Edgren et al . 1966 (29) 45,X/46,XY/47,XY,+21 *
24 van Gelderen et al .1967 (30) 46,X,+G/46,XX/47,XX,+G
25 Singhetal. 1975 (11) 46,X,+G/46,XX/47,XX,+G
26 Feiertag-Koppen et al1966 (31) 45,X/46,X,+G/46,XX/47,XX,+G
27 Singhetal. 1975 (11) 45,X/46,X,+G/46,XX/47,XX,+G
28 Singhetal. 1975 (11) 45,X/46,X,+G/46,XX/47,XX,+G
* Cases in which a fibroblast culture also was cytogenetically analyzed:
- Cases 3,8 and 23: fibroblast cells = peripheral lymphocytes
- Cases 4 and 6 : fibroblast cells: 47,XX,+21
- Case 21 (present report): fibroblast cells: 45,X/47,XY,+21
- Case 20: the cytogenetic findings of the cultured fibroblast cells are shown . The 
47,XX,+G cell line was not found in the peripheral lymphocytes 
(45,X/46,X,+G)
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G enitalia Clinical A ppearance Age of Patient P aren ta l Age 
M other F ather
F DOWN - - -
F DOWN + turner 8y 29 -
F DOWN + TURNER 15y - -
F DOWN 6 months - -
F DOWN newborn 36 40
F DOWN + turner 9 . 5y 30 37
F DOWN 8y 24 26
M DOWN 5y - -
M DOWN + turner 15y 30 37
F DOWN - -
F DOWN + turner 9y - -
F DOWN 2  months 42 44
F DOWN 3 months 26 28
F DOWN 9y - -
F DOWN + TURNER 5y 26 28
F DOWN + turner newborn 36 65
F DOWN + turner newborn 38 -
A DOWN + turner - 18 -
A DOWN + turner 5 months 36 40
A DOWN + TURNER 25y 35 -
M DOWN + TURNER 59y 40 40
F DOWN 7y 27 28
M DOWN 25y 32 28
F DOWN + turner 2 1 y 37 -
F DOWN + turner 16 . 5y 33 -
F down + turner 16y 27 29
F DOWN + turner 17 . 5y 31 33
F DOWN + turner 13y 33 .5 31
F: female; M: male; A: ambiguous genitalia; DOWN: obvious features of Down 
syndrome; down: mild features of Down syndrome; TURNER: obvious features of 
Turner syndrome; turner: mild features of Turner syndrome
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Thus, clinical features of Down syndrome were always present, while a 
combination of Ullrich-Turner and Down syndrome features were found in 17 
patients (61%) . Apparently, phenotypic effects of even a relatively low percentage 
of trisomy 21 cells are much more prominent than those of the monosomy X cells . 
However, the proportion of trisomy 21 versus monosomy X cells does not always 
correlate with the phenotype, which can probably be explained by a different 
mosaic distribution in various somatic tissues (11) . This implies that the clinical 
diagnosis of Down-Turner syndrome based merely on the phenotype is very 
difficult to make and should be supported by cytogenetic studies in virtually all 
cases
The fact that clinical features of two syndromes may coexist shows the relative 
autonomy of these chromosomes in morphogenesis (3, 12) .
Chrom osom al mosaicism in D ow n-Turner syndrom e
Only one patient with Down-Turner syndrome has been reported who showed 
a single cell type (case 1) and is, therefore, not a true mosaic . All other cases are a 
combination of two (cases 2-19), three (cases 20-25), or even four cell lines (cases 
26-28) . Our patient (case 21) had three cell lines in cultured T lymphocytes, but 
only two in a fibroblast culture of a skin biopsy . However, since 46,X,+21 cells 
were found at a very low frequency in lymphocytes, we could easily have missed 
it if these cells had been present at a low frequency in the cells of the skin too .
K aryotype and  gender
Only four of the 6 patients with a Y chromosome were phenotypically male 
while the other two showed ambiguous genitalia . One of these two patients had a 
bifid scrotum and a penoscrotal hypospadias with a urogenital sinus . A uterus and 
bilateral testes were present (case 18) . The second patient also had a bifid scrotum, 
a perineal hypospadias and a urogenital sinus . He had bilateral small testes but no 
internal female organs (case 19) . Of the 22 patients without a Y chromosome, 21 
were phenotypically female . The remaining patient showed ambiguous genitalia, 
presenting with "hermaphroditic" external genitalia, a rudimentary uterus, and no 
ovaries or testes (case 20) . This is in accordance with the observation that patients 
with an Ullrich-Turner mosaicism are known to show a wide spectrum of different 
phenotypic expression ranging from normal females, females with mixed gonadal 
dysgenesis and male pseudohermaphroditism to almost normal males (13, 14) .
Our patient was phenotypically male although chromosome analysis showed a 
Y chromosome in only a minority of his cells . In general, the phenotypic 
appearance of the genitalia is probably a result of the chromosomal mosaicism as
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present in the various tissues, since two patients who carried a Y chromosome and 
one with an X chromosomal mosaicism had ambiguous external genitalia .
L ittle mosaicism of Y chrom osom e in D ow n-Turner syndrom e
From the 28 reported patients, only six (21%) had a Y chromosome, which is 
far less than expected . Since all described cases with Down-Turner syndrome 
showed clinical signs of Down syndrome, it seems unlikely that (male) patients with 
a Y chromosome in a certain proportion of their cells would not be traced . 
Assuming that the sex chromosomal mosaicism in the reviewed cases is probably 
caused by anaphase lagging, in XX zygotes loss of either X chromosome would be 
viable leading to a mosaic situation . However, in an XY zygote lagging of the Y 
chromosome only would lead to a mosaic fetus (45,X/46,XY), because lagging of 
the X results in a non-viable 45,Y cell . This effect considerably reduces the number 
of sex chromosome mosaics carrying a Y chromosome . Whether there are any other 
selection mechanisms reducing the number of Y chromosome mosaics in 
Down-Turner syndrome, for instance during embryogenesis, is unknown at present .
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1.2 D e s c r i p t i o n  o f  p a t i e n t s  w i t h  o t h e r  c h r o m o s o m a l  
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1.2.1 C r i  d u  c h a t  s y n d r o m e :  T h e  c h a n g in g  p h e n o t y p e  in  o l d e r  
p a t i e n t s
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and J . P . Fryns1
'Center for Human Genetics, 3000 Leuven, Belgium; 2Department of Human Genetics, 
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Abstract
The cri du chat syndrome or 5p deletion syndrome is a well-delineated clinical 
entity and has an incidence of 1/50,000 in newborn infants. A de novo deletion is 
present in 85% of the patients. Ten to 15% are familial cases with more than 90% 
due to a parental translocation and 5% due to an inversion of chromosome 5. 
Although the size of the deleted segment varies, the critical segment that is deleted 
in all patients appears to be 5p15.2. The clinical picture is well known in younger 
patients and includes the typical high-pitched cry, psychomotor retardation, 
microcephaly, growth rate failure, and craniofacial abnormalities including round 
face, hypertelorism, broad nasal bridge, downward slanting palpebral fissures, and 
micrognathia. With advancing age, the clinical picture becomes less striking. We 
present seven patients with 5p deletion syndrome, who were between age 16 and 
47 years. Comparing their phenotype at several ages, a change of their phenotype 
was noted. Some of the clinical characteristics became more evident such as long 
face, macrostomia, and scoliosis. All patients were severely or profoundly mentally 
retarded except one patient who was mildly mentally retarded. The diagnosis was 
difficult to make in some of the patients who were first seen at an older age. In 
some of them, the craniofacial appearance resembled that seen in Angelman 
syndrome. Most patients had periods of destructive behavior, self mutilation and 
aggression. The clinical diagnosis should be confirmed as soon as possible with 
cytQgenetic investigation to provide specific support, prevention, and treatment of 
complications. Therefore, it is important to perform follow-up studies in young 
children to determine their outcome after infant-stimulation programs.
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Introduction
The cri du chat syndrome, a chromosomal disorder characterized by a partial 
terminal or interstitial deletion of the short arm of chromosome 5, was first 
described by Lejeune et al. [1963]. About 85% of the patients have a de novo 
deletion. In 10- 15% there is a familial cause with a parental translocation in more 
than 90% and a familial para- or pericentric inversion of chromosome 5 in 5% 
[Chernos et al., 1992; Goodart et al., 1996; Kushnik et al., 1984]. Over 80% of the 
deletions are of paternal origin [Overhauser et al., 1990]. Niebuhr [1978a] showed 
that the typical clinical findings of the cri du chat syndrome were present when 
there was a deletion of the midportion of the 5p15 segment. Although the size of the 
critical segment varies, the critical segment that is deleted in all patients appears to 
be 5p15.2 [Niebuhr, 1978b; Chernos et al., 1992; Overhauser et al., 1994].
The incidence of the cri du chat syndrome was estimated as 1 in 50,000 
newborn infants [Niebuhr, 1978a]. There is a male to female ratio of 0.73 [Niebuhr, 
1978b; Oosterwijk et al., 1987; Wilkins et al., 1983].
Niebuhr [1978a] published an extensive review on epidemiological, cytogenetic, 
and clinical aspects in 331 patients with the cri du chat syndrome. The craniofacial 
anomalies included microcephaly, round face, downward slanting palpebral 
fissures, broad nasal bridge, cat-like cry, hypotonia, and mental deficiency. 
Although lack of speech was considered a characteristic of the syndrome, it is not 
yet known whether language comprehension is impaired to the same extent as 
language production [Cornish and Munir, 1998]. With advancing age the clinical 
picture becomes less striking, and the clinical diagnosis is difficult to make. With 
age the face lengthens and becomes “coarse” with prominent supra-orbital ridges, 
deep-set eyes, hypoplastic nasal bridge, and severe dental malocclusion, relatively 
large mouth, and full lower lip [O’Brien and Yule, 1995].
In the present study, seven patients were studied to further delineate the natural 
course of this syndrome (Table I) (Figs. 1-7).
Clinical  R eports 
P atien t 1
The patient (Fig. 1), a 47-year-old man, institutionalized since age 10 years, is 
profoundly mentally retarded. He was the first child of healthy nonconsanguineous 
parents. His father suffered from progressive hearing loss. The mother, two 
younger sisters and brother were healthy. Pregnancy was uneventful. He was born at 36
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Figure 1
Patient 1: Microcephaly, the round face and broad nasal bridge become longer 
and coarse in adulthood
weeks of gestation. Birth was difficult, and there was asphyxia. Birth weight was 
1,500g(< 3rd centile). There were feeding difficulties, and he had a weak cry. A 
few months after birth he developed seizures. When he was age 3 months, he 
underwent a bilateral mastoidectomy. Psychomotor development was severely 
delayed. He could sit at age 3 years but never learned to walk or to speak. Clinical 
investigation at age 10 years showed a small boy with a length of 114 cm (< 3rd 
centile), weight of 18 kg (< 3rd centile) and head circumference (OFC) of 44.5 cm 
(< 3rd centile). Thorax was barrel-shaped and asymmetric. There was spasticity of 
the lower limbs and scoliosis. At age 21 years there was microcephaly, small 
stature, asymmetric thorax and kyphoscoliosis and spastic and atrophic limbs with 
contractures in the knee-joints. He was afraid of noises. At age 32 years, he suffered 
from stomach ulcers and was treated with omeprazole. Periodic behavior problems, 
caused by negative stimuli, included self mutilation, head banging, and destroying
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Table I. Overview Qf the ManifestatiQns Qf the Patients
Case 1 (male) Case 2 (female) Case 3 (male)
Age 47 years 45 years 44 years
Cytogenetics del(5)(pl4.1) del(5)(p13.3) del(5)(p13.3)
History
Birth weight (g) 1,500 2,500 <3,000
Feeding difficulties + + +
Cat-like cry + + ND
Convulsions + - -
Mental retardation profound severe profound
Speech development noises a few words a few words
Voice male high-pitched hoarse, male
Neurology spasticity broad-based 
clumsy gait
ataxia-like 
broad-based gait
Childhood behavior automutilation automutilation 
destroys own things 
head banging 
scratching
automutilation
Adult behavior automutilaton disobeys handbiting
destroys own things teases jumping
afraid of noises sweet hyperactive
laughing afraid of noises 
nail biting 
hyperactive
hand-flapping
Dysmorphism
Microcephaly + (48 cm) 
brachycephaly
+ (48.8 cm) 
brachycephaly
+ (51 cm)
Face shape round-long round-long
asymmetry
long-coarse-old aspect 
asymmetry
Hair premature gray premature gray 
soft
premature gray
Eyes divergent strabismus divergent stabismus 
myopia (bilateral)
normal
Palpebral fissures upward normal normal
Hypertelorism - + +
Epicanthus - + + (R)
Nose coarse
asymmetric
coarse
hook-shaped
bulbous tip
Maxilla hypoplasia + + +
Mouth macrostomia 
macroglossia 
thin lips
dental maloccusion macrostomia 
prognathia 
thin lips
Ears simple simple thick helices
Extremities large hands 
clinodactyly V
short matacarpals 
and metatarsals
short metacarpals
Palmar creases - variant simian 
creases
bilateral simian
creases
Scoliosis severe mild -
R = right; ND = no data
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Case 4 (male) Case 5 (female) Case 6 (male) Case 7 (female)
43 years 25 years 16 years 18 years
del(5)(p13.3) del(5)(p13.3) del(5)(p13.3) del(5)(p15.31)
ND 3,350 3,100 2,050
ND + + +
ND + + +
- + - -
severe severe severe mild
a few words a few words a few words normal
male high pitched high pitched high pitched
normal spasticity ataxia-like normal
(post operative complications) broad-based gait
aggressive automutilation automutilation nervous
picking trichotillomania
biting cruel to others
scratching head banging
automutilation demands attention teases nail biting
aggressive teases impulsive
destructive disobeys
screams
teases
+ (50.8 cm) + (50.5 cm) + (50.2 cm) - (54 cm)
brachycephaly
long-coarse long long round-long
asymmetry asymmetry asymmetry
premature gray premature gray normal normal
divergent strabismus normal normal normal
normal normal normal normal
+ (mild) normal + -
+ (R) + + +
coarse coarse high nasal bridge large (profile)
+ + + +
macrostomia macrostomia macrostomia macrostomia
dental malocclusion dental malocclusion thin lips high palate
caries, full lips thin lips retrognathia
thick helices ear pit R normal normal
short metacarpals clinodactyly V clinodactyly V short IV/V
clinodactyly V metacarpals
flat feet flat feet
bilateral simian - bilateral simian siman crease R
creases creases
- severe severe -
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his own cloths.
Present investigation showed a profoundly mentally retarded male with small 
stature, weight of 48 kg (8 kg < 3rd centile), OFC of 48 cm (5 cm < 3rd centile), 
brachycephaly, gray hair, small forehead, upward slanting palpebral fissures, flat 
midface, short philtrum, macrostomia, large tongue, thin lips and simply formed 
ears. Thorax was barrel-shaped and there was severe kyphoscoliosis. Testes were 
small. Hands were large with clinodactyly o f the fifth fingers. He was not 
ambulatory due to spasticity o f lower limbs with contractures. There were clubfeet, 
and the toes were irregularly positioned with a longer fifth toe. Although contact 
was good, there was no speech and he made only sounds. Results o f screening for 
inborn errors o f metabolism were negative. Chromosomal analysis on peripheral 
blood lymphocytes showed a male karyotype with a terminal deletion o f the short 
arm of chromosome 5. His karyogram was 46,XY,del (5)(p14.1). Cytogenetic status 
of his mother was normal. Cytogenetic studies o f his father were not possible.
Patient 2
Figure 2
Patient 2: Coarsing of the typical cri du chat facies in childhood
The patient (Fig. 2) was a 45-year-old  severely m entally retarded woman. She 
was the second child o f nonconsanguineous parents. Her father was age 37 years 
and her mother age 24 years at the time o f her birth. Pregnancy was uneventful. She 
was born at 37 weeks o f gestation. Birth weight was 2,500 g (25th-50th centile). 
Cry was high pitched. There were neonatal feeding problems. Psychomotor 
development was retarded. She could walk at age 6 years. Periodic behavior 
problems were present and included self mutilation, destroying her own cloths, head
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banging, and scratching. Clinical investigation at age 30 years showed severe 
microcephaly, divergent strabismus, hypertelorism, epicanthus, bilateral severe 
myopia, hook-shaped nose, simple ears, and normal hearing. The thorax was 
asymmetric, and kyphoscoliosis was present. X-ray studies showed short metacarpal 
and metatarsal bones. Her motor development was mildly delayed, and she could 
speak a few words. An electroencephalogram was normal and cerebral computed 
tomography-scan showed dilatation o f the lateral ventricles and widened basal 
cisternae. An X-ray film of the back showed scoliosis and lumbar ribs.
Present investigation showed a severely mentally retarded female with a length 
of 148.5 cm (2.5 cm < 3rd centile), an OFC of 48.8 cm (3.2 cm < 3rd centile), round 
face, soft and premature gray hair, flat midface, hypertelorism, epicanthal folds, 
severe myopia, “coarse” nose, simple ears, dental malocclusion, and short philtrum. 
The neck was short. She had mild kyphoscoliosis and bilateral flatfeet. Walking was 
broad-based. Contact was good; she could speak a few words with a high pitched 
voice. Cytogenetic investigation of peripheral blood lymphocytes showed a female 
karyotype with a deletion o f the distal part o f chromosome 5. Her karyotype was 
46,XX,del(5)(p13.3). Cytogenetic studies o f her parents were not possible since 
they died before the diagnosis was made in their daughter. Cytogenetic findings of 
her sister were normal.
Patient 3
Figure 3
Patient 3: Note the long coarse face and premature gray hair
The patient (Fig. 3 ) ,a  44-year-old profoundly mentally retarded man, was the 
youngest o f two children o f healthy nonconsanguineous parents. His older sister
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was healthy. Birth weight was below 3,000 g. There were neonatal feeding 
problems with swallowing difficulties. He had no epileptic attacks.
Present examination showed a profoundly mentally retarded male with weight 
of 60 kg (25th centile), OFC o f 51 cm (2 cm < 3rd centile), long “coarse” face, 
facial asymmetry, flat maxilla, prognathism, gray hair, normal eyes, nose and ears. 
There were bilateral simian creases present, and the metacarpals were slightly short. 
Neurological examination showed ataxia, and walking was broad-based. He 
produced a few words with a hoarse voice. His behavior was specific withjumping 
and waving of the hands when he was happy and handbiting when he was 
frustrated. His karyotype was 46,XY,del(5)(p13.3). Cytogenetic studies o f his 
parents could not be performed because they died before the chromosomal 
diagnosis was confirmed in their son. Cytogenetic findings o f his sister were 
normal.
Patient 4
Figure 4
Patient 4: Note the long face, full lips and open mouth
The patient (Fig. 4), a 43-year-old severely mentally retarded man was the 
second child o f healthy nonconsanguineous parents. His four sibs were normal. 
Medical history showed minimal speech development. There was no epilepsy. He 
had often aggressive periods.
Present examination showed a severely mentally retarded male with length of  
170 cm (25th centile), weight of 70 kg (25th centile), OFC of 50.8 cm (2.2 cm < 3rd 
centile), long “coarse” face, flattened occiput, prematurely gray hair, epicanthus on 
the right side, divergent strabismus, thick helices o f ears, broad nasal bridge, flat
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maxilla, open mouth, and full lips. Several teeth were extracted. There was 
hyperpigmentation o f his face and left upper limb. The second finger o f his left 
hand was amputated after an accident. A simian crease was present bilaterally. The 
neck was short and the thorax was slightly barrel-shaped. Aggressive periods were 
present with yelling, beating, and destructive behavior. Although he could speak 
some words, he produced mostly sounds. His karyotype was 46,XY,del(5)(p13.3). 
Cytogenetic studies of his parents could not be performed.
Patient 5
Figure 5
Patient 5: With advancing age the phenotype becomes less typical
This 25-year-old woman (Fig. 5) was the second child of healthy 
nonconsanguineous parents. Her older brother was normal. Pregnancy and birth 
were uncomplicated. Birth weight was 3,350 g and length 50 cm. Cry was high 
pitched. She could walk at age 5 years. She suffered from febrile convulsions. She 
developed very severe scoliosis and was treated surgically at age 18 years. 
However, a severe postoperative complication lead to spasticity of the lower limbs. 
Present examination showed a 25-year-old severely mentally retarded, non­
ambulant woman. Stature was normal, weight was 60 kg (50th-75th centile) and 
OFC 50.5 cm (1.5 cm < 3rd centile). She had a long, mildly asymmetric face, flat 
midface, epicanthal folds, ear pit on the right side, coarse nose, deep philtrum, large 
mouth, dental malocclusion, and thin lips. Her hair was prematurely gray. The neck 
was short and there was bilateral clinodactyly o f the fifth fingers. Language 
comprehension was much better than language production. Her voice was high 
pitched. There were difficulties with breathing and swallowing. Although
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improving with advancing age, she had periodic behavior problems o f self 
mutilation, biting and scratching. Karyotype was 46,XX,del(5)(p13.3), de novo.
Patient 6
Figure 6
Patient 6: Microcephaly and broad nasal bridge. At older age the face becomes 
longer
This boy (Fig. 6) was the second child ofhealthy nonconsanguineous parents. 
His older sister was healthy. Pregnancy was uneventful. Birth was at term with birth 
weight o f 3,100 g (50th centile) and length o f 50 cm(50th-75th centile). Cry was 
high pitched. There were neonatal feeding problems. He could sit at age 2.5 years 
and walk at 3 years. Behavioral problems with self mutilation included 
trichotillomania, head banging, luxation o f patellae and shoulders, and biting of 
other children. He developed severe scoliosis and was successfully treated by 
surgery.
Present examination showed a 16-year-old severely mentally retarded boy with 
a length o f 160.5 cm (3rd centile), OFC o f 50.2 cm (1 cm < 3rd centile), long, 
slightly asymmetric face, flat midface, epicanthal folds, synophrys, and high nose 
bridge. The neck was long. Bilaterally, there were simian creases and clinodactyly 
of the fifth fingers. There were flat feet, and walking was broad-based and clumsy. 
His voice was high-pitched and he could speak a few words. Cytogenetic studies of 
his parents were normal. Karyotype was 46,XY,del(5)(p13.3), de novo in the 
patient.
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Patient 7
Figure 7
Patient 7: There is no microcephaly, little dysmorphism, and high pitched voice 
in a girl with small deletion o f chromosome 5p
This 18-year-old woman (Fig. 7) is mildly mentally retarded. She was the 
second-born child o f healthy nonconsanguineous parents. Her older brother was 
healthy. Pregnancy was uneventful. She was born at 38 weeks of gestation and birth 
weight was 2,050 g (< 3rd centile). Hypotonia was present at birth. Psychomotor 
development was retarded. She could walk at age 21 months. A  cerebral computed 
tomograpy-scan was performed at age 7 years and was normal. When she was 7 
years 10 months old, psychomotor examination (Termann-Merrill) showed an 
intelligence o f 6 years 2 months. In school, there were problems with calculation 
skills. At age 8 years, examination showed microcephaly, small eyelashes, 
hypertelorism, strabismus, micrognathia, and macrostomia. Ears were large with a 
simple helix and everted. The metacarpals o f the 4th and 5th fingers were relatively 
short. Speech was nasally and her voice high pitched. She had nervous behavior. 
Present examination showed a mildly mentally retarded female with a length of  
156.3 cm (10th-25th centile), weight o f 50.4 kg (1 cm > 3rd centile), OFC of 54 cm  
(1 cm > 3rd centile), a long face, flat midface, epicanthal folds, high palate and thin 
upper lip. There were bilateral simian creases and flat feet. Speech was subjectively 
interpreted as high-pitched, but expert logopedic examination showed a high­
normal tone with hypernasality and hyperresonance. Behavior problems included 
nail biting, impulsivity, and disobedience. Her karyotype was 46,XX, 
del(5)(p15.31), de novo.
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D iscussio n
Clinical
The manifestations o f the cri du chat syndrome are well known in newborn 
infants and include prenatal growth retardation, low  birth weight, microcephaly, 
hypotonia, and cat-like cry. Poor suck, vomiting, failure to thrive, respiratory 
distress, andjaundice are present in 60 to 92% o f the cases [Oosterwijk et al., 1987; 
Wilkins et al., 1983?. Several cardiac abnormalities are described and include atrial 
septal defect, ventricular septal defect, tetralogy o f Fallot, and persistent ductus 
Botalli [Oosterwijk et al., 1987; Wilkins et al., 1983?. The phenotype in infancy and 
young children include psychomotor retardation, high pitched cry, microcephaly, 
growth retardation, poor weight gain, round face, hypertelorism, broad nasal bridge, 
downward slanting palpebral fissures, and micrognathia [O’Brien and Yule, 1995?. 
Gastrointestinal abnormalities include malrotation and Hirschprung disease 
[Wilkins et al., 1983?. With advancing age the phenotype becom es less striking, 
however, marked growth retardation continues into adulthood with resulting short 
stature, poor weight gain, and significant microcephaly. The face lengthens, the 
hypertelorism and epicanthus attenuate, and the mandibular hypoplasia becomes 
less evident. Teeth are decayed and abnormally erupted. The palate is high arched 
[Niebuhr, 1978a; Wilkins et al., 1980; Breg et al., 1970; Wilkins et al., 1983; 
O ’Brien and Yule, 1995?. Hair is prematurely gray. There are short metacarpals and 
metatarsals, scoliosis, small wings o f the ilia and pes planus, clubfeet, costal and 
vertebral anomalies [Breg et al., 1970; O ’Brien and Yule, 1995?. Hypertonia o f the 
limbs with strong reflexes and spastic broad-based gait, with bent knees, appear 
[Platt and Holmes, 1971?. Coordination problems are common [Colover et al., 
1972?. Cerebral anomalies include atrophy o f the brainstem predominating at the 
pontine level, small cerebellum, atrophic middle cerebellar peduncles and cerebellar 
white matter, and hydrocephaly [Tamraz et al., 1993?. Kjaer [1998? and Kjaer and 
Niebuhr [1999? reported on abnormal profile radiographs on the skull with 
malformed dorsum sella and cerebellar hypoplasia. Optic atrophy, cataract, and 
myopia were found in older patients [Breg et al., 1970?.
During the first year o f life there is approximately 10% mortality because of 
respiratory or cardiac complications [Niebuhr, 1978a; Schinzel, 1984?. Several 
chronic complications as upper respiratory tract infections, otitis media, and severe 
constipation are present [Wilkins et al., 1983?.
Because o f the laryngeal abnormalities, retrognathia, high palatal vault, and 
hypotonia, anesthetic risks are present [Yamashita et al., 1985?.
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Our seven patients were ranged in age from 16 to 47 years and at least three of 
them had a de novo deletion (Table I). Comparing their phenotype at several ages, 
a change o f their phenotype was noted (Figs. 1-7). Birth weight was often low, and 
a high pitched cry was present. Almost all had feeding difficulties. At an older age 
these feeding difficulties were still present. A ll patients were severely to profoundly 
mentally retarded except patient 7 who was mildly mentally retarded.
Spasticity was present in two patients, however in patient 1 there was a history of 
birth asphyxia and in patient 5 spasticity occurred after surgery for severe scoliosis. 
Other patients had a clumsy, ataxia-like broad based gait. Microcephaly was present 
in all patients except patient 7. A  cerebral computed tomograpy-scan was performed 
in only two patients and showed in patient 2 dilatation o f the lateral ventricles and 
widened basal cisternae. Epileptic seizures were not present. In most patients the 
craniofacial traits changed with advancing age resulting in lengthening o f face, 
large ears, macrostomia, large mandible, and prematurely gray hair. Palpebral 
fissures were downward slanting in children but were normal in these adults. Short 
metacarpals, clinodactyly o f the fifth fingers, and simian creases were often present. 
Scoliosis was present in four patients.
There were no patients with cardiac problems, sleeping disorders, and 
constipation. Pubertal development was normal in our group o f patients, except for 
patient 6 who was now starting puberty. The three female patients had normal 
menstruation.
The diagnosis was difficult to make in some patients who were first seen at an 
older age. In some o f them, when clinically seen for the first time, the craniofacial 
appearance resembled that o f Angelman syndrome.
In the present study, all except patient 1 were able to speak a few words. In the 
females the tone o f the voice seemed high pitched, however expert logopedic 
studies in patient 7 demonstrated that the tone was high-normal but that 
hypernasality and hyperresonance were subjectively interpreted as high pitching. 
The voice in the adult males was normal, except in patient 6, who was now starting 
puberty.
In a study performed by Granoff and Preston [1971? to investigate the ‘cri’ by 
narrow-band spectrograms, they concluded that children with cytomegaly, 
hydrocephalus internus, or hyperbilirubinaemia do have a similarly high-pitched 
tone. Piérart and Remacle [1996? examined a boy o f 12 V  years with the cri du chat 
syndrome and found no phoniatric abnormalities. In contrast, Romano et al. [1991? 
described a boy and a girl whose voice was 1 and 2 octaves, respectively, above the 
normal age-matched values.
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Development and behavior
All patients included in the present study were severely to profoundly mentally 
retarded, except patient 7 who was mildly mentally retarded. All except for patient
1 were able to speak a few  words. Their personality was pleasant. They were 
interested in their environment, and they did like to have contact with others. 
However, there were periods o f destructive behavior and aggression. Most o f these 
periods were related to the inability o f expression. In childhood the problem o f self 
mutilation, head banging, scratching, biting, and cruelty to others was often severe. 
With advancing age these problems decreased, they did like teasing and were often 
hyperactive. In two patients hypersensitivity to sound was present.
Behavior problems are reported in about 30% o f the patients with hyperactivity, 
irritability, and self-stimulation [Oosterwijk et al., 1987; Wilkins et al., 1980?. 
Cornish and Pigram [1996? reported a first optimistic study on the behavior 
phenotype in the cri du chat patient and described the most striking characteristics 
including self injury, repetitive movements, obsessive attachment to objects, 
hypersensitivity to sensory stimuli, stubbornness, clumsiness, autistic disturbances, 
feeding- and sleeping problems, and mood disorders. They reported a low  incidence 
o f hyperactivity. Gross hand movements were better developed than fine hand 
movements, and speech was deficient although over 50% of the patients were able 
to use sign language. The cri du chat children who received early introduction to 
special programs were ambulatory, developed many self-care skills, and could 
communicate either verbally or through gestural language. Although these children 
did have severely compromised mental capacities, they did benefit from early, 
intensive programs o f special education [Wilkins et al., 1980?. Clarke and Boer 
[1998? reported greater problems with overactivity and restlessness in patients with 
cri du chat syndrome than found by Cornish and Pigram [1996?.
W e conclude that stimulation programs should include forms o f communication 
training to prevent self mutilation and behavior problems.
Genotype-phenotype correlation
The critical region o f typical cri du chat phenotype is caused by a deletion o f the 
band 5p15.2 [Simmons et al., 1995?. Previous reports indicated that about 80% of 
the de novo deletions are o f paternal origin [Overhauser et al., 1990?. In most o f the 
patients in the present study, except patient 7, large 5p deletions were found and all 
patients, except patient 7, were severely to profoundly mentally retarded (Fig. 8). 
In patients 2, 3, 5 and 7 further chromosome microdissection investigations were 
performed to rule out interstitial deletions and to study de novo telomere synthesis 
[Vermeesch et al., 1998?. Patients with more distal 5p(15.3) deletion are minimally
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Figure !
Chromosomal result o f each patient, except for patient 1, is compared with the 
idiogram of chromosome 5. A: Note the rather large deletions in all but patient 
7 .B : The black bar represents the location o f absence o f chromosomal material
delayed and have a much better prognosis. The proximal part of the 5p15.3 region 
seems to be associated with the cat-like cry [Overhauser et al., 1994; Gersh et al., 
1994; Gersh et al., 1995]. However, Church et al. [1995] concluded that there was 
no correlation between the size o f the deletion and the severity o f mental 
retardation. Patient 7 has a small deletion del(5)(p15.31) and has a milder 
phenotype with normal head circumference. This may indicate that the critical 
region for microcephaly, one o f the major characteristics o f the cri du chat 
syndrome, is located more proximal than 5p15.31.
Recently several genes were mapped at the cri du chat candidate interval 
[Simmons et al., 1997; Simmons et al., 1998]. The human Semaphorin F (S E M A F )  
gene is a member o f a family o f proteins that possibly play a role in axonal 
pathfinding during embryonic development and is expressed in mice on the 
ventricular zone o f the cortex and the basal ganglia. Soon after leaving the 
ventricular zone, postmitotic neurons stop expressing S E M A F . Altered neuronal 
migration could lead to severe mental retardation and microcephaly [Simmons et 
al., 1998]. Recently, Kjaer and Niebuhr [1999] studied malformations of the cranial 
base in cri du chat patients, and indicated the existence o f a developmental field  
between the rhombencephalic cranial brainstem and the laryngeal region from 
which the characteristic cry may derive. Further analysis o f the function of S E M A F  
and further molecular studies o f the 5p15 region are necessary in order to obtain a 
better delineation o f the extent o f the deletion and its phenotypic correlation.
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1 .2 .2  13q  D e l e t io n  s y n d r o m e  in  a n  a d u l t  m e n t a l l y  r e t a r d e d  
PATIENT
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A bstract
Clinical features o f the 13q deletion syndrome are difficult to define and include 
retinoblastoma, mental and growth retardation, craniofacial abnormalities, brain, 
gastrointestinal, renal and heart malformations, anal atresia, and limb and digit 
malformations. The critical region for development o f major organ systems has 
been defined in 13q32 between the proximal marker D13S132 and distal marker 
D13S147. We report a severely mentally retarded male patient with a deletion of the 
distal part o f chromosome 13 (13q32.3^qter) without major organ malformations.
Intro ductio n
Several patients with different types o f a terminal deletion o f chromosome 13
i.e. ring chromosomes, terminal and interstitial deletions have been reported (1-3, 
5 -7 ,9 ,1 1 ,1 2 ). Typical findings include mental and growth retardation, craniofacial 
dysmorphism including eye abnormalities such as microphthalmia and coloboma, 
retinoblastoma, ear abnormalities, hypoplasia or aplasia of the thumbs, heart 
defects, genital abnormalities and imperforate anus (6). Niebuhr and Ottosen (7) 
first proposed a classification in 3 groups which was later modified by Niebuhr (8) 
and Brown et al. (2). We describe an adult mentally retarded male and compare his 
findings with the published data.
Case  R eport
The patient is a 49 years-old severely mentally retarded male. He was the third 
child o f healthy non-consanguineous parents. His 6 siblings were healthy.
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Pregnancy was uneventful. He was born at term with a birth weight of 2,000 g. 
There was asphyxia. Postpartal there were feeding problems. At the age of 6 months 
psychomotor retardation was noticed. He could sit at the age of 2 years, walk at 4 
years, and at the age of 9 years he could speak only a few words. Anisocoria was 
present from the beginning. At the age of 27 years he was surgically treated because 
of severe equinovarus of the left foot. Mental retardation was not progressive.
Present examination showed a severely mentally retarded non-ambulant male 
with microcephaly (50.3 cm (< 3rd centile) and short stature of 150 cm (< 3rd 
centile). Craniofacial features were distinct and included sloping forehead, cutis 
verticis gyrata, absence of the lateral eyebrows, strabismus convergens, eccentric 
pupils with medial deviation bilaterally, large nose, small nasal bridge, flat midface, 
small mouth, small mandible, large ears (Fig. 1). The neck was short and there was 
a low posterior hairline. A mild cutaneous syndactyly of the second and third toes 
was present. Neurological examination showed hypertonia of the extremities and 
thoracic scoliosis. There was no speech. A CT-scan of the brain showed mild 
asymmetry of the ventricles. Cervical radiographs and myelography showed 
congenital fused vertebrae C3-C4 and C4-C5 and stenosis o f the cervical canal 
C4-C5-C6-C7 with bilateral radix compression C5-C7.
Figure 1
The distinct craniofacial appearance with long face, sloping forehead, absent 
lateral eyebrows, strabismus convergens, eccentric pupils, large nose, flat 
midface, small mouth, small mandible, and large ears
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Cyto genetic  Studies
Chromosomal studies on peripheral blood lymphocytes were performed 
according to standard cytogenetic techniques, and included G-banding. Cytogenetic 
analysis in all investigated metaphases revealed a deletion of the long arm of 
chromosome 13. The proband's karyotype was 46,XY,del(13)(q32.3^qter) (Fig. 2). 
Chromosomal studies of both parents were normal.
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Figure 2
ChromQSQme 13 (Qne cell; G-banding). The arrows indicate the deletiQn at band 
13q32.3, Qn the nQrmal chromQSQme 13, and Qn the schematic representatiQn Qf 
chrQmQSQme 13
D iscussio n
Several phenotypes have been associated with 13q- monosomy as a result of  
different chromosomal abnormalities varying from ring chromosomes, interstitial 
deletions and terminal deletions, often complicated by mosaicism or partial trisomy 
(8, 10). Therefore, diagnostic findings were difficult to define and include 
retinoblastoma, mental and growth retardation, craniofacial abnormalities, brain, 
gastrointestinal, renal and heart malformations, anal atresia, and limb and digit 
malformations (2). Niebuhr and Ottosen (7) were the first to propose a classification 
for patients with a 13q deletion in 3 groups, which was later revised by Niebuhr (8) 
in 4 categories on the basis o f physical and cytogenetic findings with the 
observation that those patients with distal deletions were the most severely affected 
and those with more proximal deletions tended to have fewer major anomalies,
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except for retinoblastoma. Brown et al. (2) noted that among his own patients as 
well as those in the literature, only those with deletions o f band 13q32 had severe 
malformations and proposed the following classification: group 1 comprises 
patients with a proximal deletion, usually not extending into 13q32. In this group, 
patients have mild to moderate mental retardation, variable dysmorphic features, 
and growth retardation. Retinoblastoma can be present, depending on the deleted 
segment. Group 2 include patients with a more distal deletion including at least a 
part o f 13q32, and they present major malformations including severe mental and 
growth retardation, severe microcephaly, brain malformations (posterior 
encephalocoele and holoprosencephaly), absent thumbs or other distal limb 
abnormalities, eye malformations (severe microphthalmia, retina colobomata), 
genitourinary and gastrointestinal tract malformations. Group 3 patients have distal 
deletions (13q33 or 13q34) and are severely mentally retarded, but without other 
major malformations or growth retardation.
The present patient shows a deletion o f the distal part o f chromosome 
13q32.3^qter. Therefore he fits in the second group of the proposed classification. 
He has normal limb developm ent with no absent thumbs. Turleau et al. (12) 
reported a 14 month-old boy with mild dysmorphic features, including growth 
retardation, microcephaly, brachycephaly, round and flat face, slight upward 
slanting palpebral fissures, small mouth, large ears, small penis and hypospadias 
and moderate mental retardation (IQ= 64), who has a de novo deletion of 
13q33^qter. Telfer et al. (11) reported mild dysmorphic craniofacial features 
including facial asymmetry, hypertelorism, ptosis, wide nasal bridge, protruding 
upper incisors, large ears, bilateral hearing loss, microcephaly, delayed 
psychomotor development, severe mental retardation, hypoplastic thumbs, talipes 
equinovarus, hemivertebrae at L3 and L4 and partial absence of the corpus callosum  
in an 8 years-old female with a deletion o f 13q32^qter. Rivera et al. (9) reported
2 patients with a 13q32.3^qter deletion. The first patient was a 5 months-old 
female baby with delayed development, low posterior hairline, large ears with 
overdevelopped lobules, weak cry, slender fingers, sacral dimple, muscular 
hypotonia, abnormalities o f the D3 vertebral body, and a 13q deletion as the 
unbalanced product o f a maternal translocation (8;13)(q24.3;q32.3). The second 
patient was a 2 years 7 months-old female with retarded development, 
hypertrichosis, muscular hypotonia, narrow forehead, prominent metopic suture, 
synophrys, epicanthal folds, slender fingers and broad first toes.
A critical deletion region in band 13q32 which contains one or more genes 
crucial for brain, digit and other organ development was hypothesized by Brown 
et al. (2). Brown et al. (3) proposed that the region in 13q32 in all o f the severely
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affected patients can be defined as bounded proximally by marker D13S132 and 
distally by marker D13S147, critical for development o f major organ systems. 
Recently, Guala et al. (4), described a patient with a ring chromosome 13 with loss 
o f the region D13S317-D13S285 with mental retardation and multiple congenital 
anomalies including facial abnormalities, agenesis o f the corpus callosum, heart 
defect, ambiguous genitalia and abnormalities o f the first ray o f the upper limb; his 
phenotype overlaps a previous description o f the XK aprosencephaly syndrome 
suggesting that patients with this syndrome and apparently normal cytogenetic 
findings, should be further studied at the molecular level o f the critical region 
identified by Brown et al. (3). Veugelers et al. (13) characterised the gene for a 
novel proteo-glypican (GPC5) mapping to 13q32 which is expressed in brain tissue 
o f the adult, suggesting a potential role in the control o f neurotrophic factors and 
the maintenance of neural function. Expression o f the gene in embryonic tissue 
suggests that the expression o f glypican-5 may be developmentally regulated, with 
a potentially more general role in the control o f growth and differentiation during 
mammalian development. An interesting finding is that postaxial polydactyly 
occurs almost exclusively with trisomy 13 whereas deletion 13q, with the critical 
segment in 13q31-q34, where GPC5 appears to be localised, is associated with 
oligodactyly and bony syndactyly o f thumbs and first metacarpals.
The phenomenon o f imprinting can complicate the analysis o f deletions, since 
the parental origin of the deletion could affect the observed phenotype, if  the 
deleted region is imprinted. There are several reasons for believing that 
chromosome 13 is not imprinted and that imprinting does not play a role in the 
observations made by Brown et al. (3) since patients with maternal uniparental 
disomy, and normal phenotype were reported. Furthermore, 13q deletions both of 
maternal and paternal origin have been reported in patients with absent thumbs and 
brain malformations.
In conclusion, further molecular studies to narrow the critical region within 
13q32 are needed, in order to obtain more precise data in the study o f the 
genotype/phenotype correlation o f this chromosomal region.
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A bstract
Angelman syndrome (AS) is a distinct neurogenetic disorder and the phenotype 
is well known in childhood and adolescence. However, with advancing age the 
clinical and behavioral phenotype changes. In adulthood, the phenotype can be 
rather aspecific. We report on AS in 3 severely to profoundly mentally retarded 
patients, who developed severe neurologic complications o f severe tremor, 
spasticity and coordination problems, resulting into severe loss o f function. They 
presented atypical craniofacial features, short stature, epileptic seizures, 
microcephaly, brachytelephalangy and absent speech. Two patients presented at an 
older age a change in day-night rhythm. Based on this experience, we conclude that 
all severely to profoundly mentally retarded patients with atypical phenotype, 
spasticity, absent speech, epileptic seizures and changed day-night rhythm are 
candidates for further cytogenetic and molecular investigation for AS. Clinical 
photographs o f the patient at a younger age can be helpful. The presence of the 
typical EEG pattern with frontal triphasic delta waves may direct to the diagnosis 
o fA S .
Intro ductio n
Angelman syndrome (AS) (MIM 105830) is a distinct neurological disorder, for 
the first time described in 1965 (1) in 3 non-related mentally retarded children, and 
is caused by the loss o f function o f imprinted genes in 15q11-q13 (4, 22). The 
U B E 3 A  gene has been found to be mutated in several AS patients (16, 21, 22). AS
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presents with severe mental retardation, short stature, absent speech, inappropriate 
periods o f laughter, microcephaly, macrostomia, maxillary hypoplasia, prognathia, 
ataxia, and epileptic seizures, with specific EEG pattern (26). With advancing age, 
the typical phenotype becomes less striking due to coarsening o f the face, thoracic 
scoliosis and decrease o f mobility (5 ,18). The bursts o f laughter are less frequently 
than in childhood (18). Epileptic seizures are still present in adult AS patients (18). 
Children and adults have a happy and excitable personality often with hand flapping 
movements and are attracted to and fascinated with water. With advancing age the 
hyperactivity, short attention span, and sleeping problems improve (7, 26, 28).
We report on three severely to profoundly mentally retarded patients with AS, 
confirmed by molecular studies, who presented severe neurological complications 
o f spasticity, atypical craniofacial features, changed day-night rhythm and 
brachytelephalangy.
C a se  R e p o r ts  
Patient 1 (P.H.)
The patient is a 52-year-old severely mentally retarded male. Family history 
revealed two maternal aunts with mild mental retardation and one other maternal 
aunt with epileptic seizures. His parents and brother were healthy. During 
pregnancy maternal hypertension was present. Birth was uncomplicated and 
birthweight was 3,500g. Retardation was first noticed at the age o f 1 year. He 
developed no speech. At the age o f 2 years microcephaly was noticed. He was 
institutionalized at the age o f 7 years and neurological examination revealed a slow  
and rigid boy with obsessive mimicking and poor motor development. He had no 
speech and produced only noises. Clinical examination at the age o f 15 years 
revealed slow tremor in the upper extremities, hyperreflexia in the upper and lower 
extremities and rigidity. At the age o f 27 years walking was clumsy, and tremor of 
the upper extremities and frequent bursts o f laughter were present. Epileptic 
seizures o f the grand mal type were present at the age o f 39 years. He received 
anti-epileptic drugs (carbamazepin and sodium valproate). Baclofen was given  
because o f a slow tremor o f both hands. Spasticity o f the lower extremities was 
present and clonus o f the achilles tendon. Mouth was large and palate asymmetric. 
At the age o f 51 years progressive loss o f function was noticed. Slow tremor of 
hands and arms were still present and also constant movements o f the tongue. 
Walking was slow and atactic. An EEG showed frequent paroxysms typical for 
epileptic activity. MRI o f the cerebrum showed discrete cerebellar atrophia. On the
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right occipital region an old small infarct zone was present and a gliotic zone on the 
left frontal region. Cervical spine MRI showed bulging discs on levels C3-C4, 
C4-C5 and C5-C6.
Examination at the age of 52 years showed a severely mentally retarded male 
with a height of 161 cm (1cm < 3rd centile), weight of 67.5 kg (75th centile), and 
head circumference of 51.4 cm (1.5 cm < 3rd centile). Craniofacial features 
included brachycephaly, large ears, macrostomia, narrow palate, normal teeth, and 
large mandible (Fig. 1 and 2). Scoliosis was present. He had relatively short fingers 
with flat, broad, and short distal phalanges (Fig. 3). Neurological examination 
revealed tremor of the upper extremities. He was wheel chair bound because of very 
severe clumsy walking and spasticity of the lower extremities. Speech was absent. 
At the age of 52 years, the diagnosis o f AS was confirmed by DNA studies (probe 
PW7.1B). Distinction between maternal deletion and paternal uniparental disomy 
was not made. Cytogenetic studies on peripheral lymphocytes, according to 
standard procedures, revealed a normal male karyotype 46,XY. Screening for 
inborn errors of metabolism, included amino acids, organic acids, purine and 
pyrimidine metabolism and lysosomial disorders and revealed uraciluria, 
hypoxanthinuria and xanthinuria.
Figure 1 Figure 2
Microcephaly, maxilla hypQplasia, Brachycephalic skull in patient 1
large mQuth, prQgnathia and large 
ears in patient 1
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Figure 3
Spatula-like distal phalanges o f patient 1
Patient 2 (K.S.)
This patient is a 32-years-old profoundly mentally retarded female. Family 
history was negative for mental retardation. Her parents were unrelated. During 
pregnancy there was threatened abortion. She was born at 39 weeks. Birth weight 
was 3,200 g and length 53 cm. Three weeks postpartal, she was hospitalized 
because of severe vomiting. She suffered from frequent upper respiratory tract 
infections and from otitis media. At the age of 2 years she developed epileptic 
seizures, with grand mal and petit mal. There was psychomotor retardation: she 
could sit at the age of 1 year, and at the age of 2.5 years she could speak only 2 
words. She was never ambulant. At 6 years height was 106 cm (< 3rd centile), 
weight 18 kg (10th centile) and head circumference 48 cm (< 3rd centile). 
Craniofacial features included brachycephaly, asymmetric face, large mouth, high 
palate, gingival hyperplasia. Neurological examination revealed left-sided 
hemispasticity. At the age of 13 years, length was 150 cm (10th to 25th centile), 
weigth 42.6 kg (25th to 50th centile) and head circumference 50 cm (< 3rd centile). 
There was spastic quadriplegia with contractures more severe on the left side. She 
developed dextroconvex scoliosis. Distal dystrophia and hypotrophia was present 
at the age of 17 years 7 months. At the age of 29 years a change of the sleep pattern 
was present: during the day she fell asleep, in the evening she wanted to go sleep 
early, and during the night she awakened early. An EEG, performed during a period 
of sleep, showed no specific abnormalities. Perinatal complications resulting in
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cerebral palsy were thought to be the cause o f the mental retardation and 
neurological problems in this patient.
Present examination showed a profoundly mentally retarded female with a 
height of 150 cm (< 3rd centile), weight 51 kg (25th centile), head circumference 
50.5 cm (< 3rd centile). Craniofacial features included brachycephaly, nuchal 
webbing, midfacial hypoplasia, large mouth, blond hairs, and blue eyes (Fig. 4 and
5). Thorax was asymmetric and scoliosis was present. Neurological examination 
revealed a non-ambulant female with generalized tremor, axial hypotonia, 
hyperreflexia o f the lower limbs (L>R), hypertonia (L>R) and distal hypotrophia 
of the hands and feet. The distal phalanges of both hands were short and broad (Fig.
6). Contractures of elbows, fingers, knees and feet were present. Periods of frequent
Figure 4
Maxillary hypoplasia, thin upper 
lip and poor facial expression in 
patient 2
Figure 5
Brachycephaly and prognathism in 
patient 2
Figure 6
Note the short distal phalanges in patient 2
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laughter were present. Epileptic attacks were treated by sodium valproate. Because 
of the change of day-night rhythm the diagnosis of AS was considered at the age of 
29 years, and was confirmed by DNA analysis (probe PW 7.1B), without distinction 
between maternal deletion and paternal uniparental disomy. Routine cytogenetic 
studies on peripheral lymphocytes showed a normal female karyotype, 46,XX.
Patient 3 (D.V.O.)
This patient is a 49-year-old severely mentally retarded female. Family history 
revealed no mental retardation, but 4 of her sibs died soon after birth and there were 
4 miscarriages. At 28 months, epileptic seizures were present. Speech was absent. 
At the age o f 28 years, she was institutionalized. Clinical examination showed 
height 153 cm (3rd centile), weight 48 kg (3rd to 10th centile) and head 
circumference 52 cm (3rd to 10th centile). Craniofacial features included low  
anterior hairline, macrostomia with full lower lip, small teeth and caries, and 
prognathia. Neurological examination revealed spastic paraplegia with hypotrophia 
and hyperreflexia o f the lower limbs. Coordination and vestibular function were 
poorly developed. At the age of 33 years she developed epileptic seizures and 
treatment with sodium valproate was started. An EEG showed frequent paroxysms 
of epileptic activity.
Present examination showed a severely mentally retarded female with head 
circumference of 52.3 cm (3rd to 10th centile). Craniofacial features included a flat 
occiput, light colored hairs, and macrostomia (Fig. 7 and 8). She had severe myopia.
Figure 7
Macrostomia and midfacial 
hypoplasia in patient 3
Figure 8
Prognathism and brachycephaly in 
patient 3
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Neurological examination showed a semi-ambulant female with rigidity of the 
lower limbs and spastic walking. Mild scoliosis was present. The 5th rays of the 
hands were bilaterally short. The distal phalanges o f the fingers were short and 
broad (Fig. 9). Day-night rhythm was disturbed: during the day she constantly fells 
asleep and is awakened early in the morning. She had frequent periods of 
inappropriate laughter. The diagnosis o f AS was made at the age of 49 years, 
because of the disturbed day-night rhythm and was confirmed by molecular studies 
(probe PW7.1B), without distinction between maternal deletion and paternal 
uniparental disomy.
Figure 9
Short and broad distal phalanges in patient 3
D iscussio n
AS is a distinct neurogenetic disorder caused by the loss of function of 
imprinted genes in proximal 15q11-q13 (4) and the prevalence is estimated as 1 in 
12,000 to 1 in 20,000 (8, 23).
The clinical features are well known in children and adolescents with severe 
mental retardation, severe postnatal growth deficiency, absent speech, maxillary 
hypoplasia, macrostomia, protruding tongue and widely spaced teeth, thin upper lip 
and prognathia. Ears are low-set. Strabismus, myopia and hypopigmentation of the 
fundus are frequent eye abnormalities. At birth, the head circumference is often 
within the normal range, but growth flattens and microcephaly is present in the 
postpartal period (5, 6). Neurological abnormalities include ataxia, truncal 
hypotonia with hypertonia of the limbs, laughter paroxysms and epileptic seizures
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in 80 to 90%, and 10% o f the patients are never able to walk independently (7, 15,
19, 24-28). In childhood, a diversity of seizures was observed: tonic-clonic seizures, 
atypical absence seizures, myoclonic seizures, status epilepticus and absence status, 
and myoclonic status (12, 19). CT-scan o f the brain showed diffuse brain atrophy 
and MRI indicated in 50% of cases a disturbance in the developmental process early 
in embryogenesis (2, 11, 14). The behavioral phenotype in children is a happy and 
excitable personality often with hand flapping movements, hyperactivity, without 
aggression, short attention span, sleeping problems with decreased need to sleep, 
increased sensitivity to heat, attraction to and fascination with water (7, 9, 13, 14,
26, 28).
With advancing age the clinical picture changes: in adults marked prognathism, 
macrostomia and a prominent lower lip is present. The cause o f coarsening o f the 
face is not known and is found both in patients with and without anti-epileptic drug 
therapy. Thoracic scoliosis is frequently present and mostly in females. Mobility 
decreases with advancing age, with difficulties o f walking and some patients 
become wheel chair bound. Matsumoto et al. (20), Viani et al. (25) and 
Clayton-Smith (7) report on decrease o f the epileptic seizures with advancing age 
and Clayton-Smith (7) and Boyd et al. (3) reported that the typical EEG findings in 
AS patients in childhood do not occur in adult patients. However, Laan et al. (19) 
observed that 92% o f the adult patients still experienced epileptic seizures, with 
atypical absence seizures and myoclonic seizures being the most prominent. The 
most typical EEG finding in AS, both in children and adults, was the presence of 
triphasic delta activity with a maximum over the frontal regions. The probability of 
having triphasic waves increased with age. In mentally retarded patients this EEG 
pattern can be helpful for the diagnosis o f AS and differential diagnosis includes 
hypsarrhythmia in the West syndrome or the petit mal variant pattern in 
Lennox-Gastaut. Paroxysms o f laughter are present but less frequent than in 
childhood (5, 18). The behavioral phenotype in adults includes happy disposition, 
curiosity and stubbornness, but less frequent hyperactivity, and attention span is 
longer than in childhood. Zori et al. (28) reported improvement o f sleeping 
problems with age. There is attraction to water and they like watching television and 
looking at magazines. Adults do not speak more than 6 words, and expression is 
nonverbally by using gestures (5, 18).
Neurological complications o f spasticity and tremor in patient 1 were severe and 
a progressive loss o f function was present until he became wheel chair bound. The 
cause o f his mental and neurological problems was thought in the past due to a birth 
complication. The diagnosis o f AS was made after an extensive clinical examination 
at an older age o f the patient. Uraciluria, hypoxanthinuria and xanthinuria was
Chromosomal syndromes 133
explained by anti-epileptic drug therapy.
In patient 2, the clinical diagnosis o f AS was confirmed by molecular studies at 
the age o f 29 years. In this patient perinatal complications resulting in cerebral palsy 
were considered as the cause o f the mental retardation and the severe neurological 
status o f the patient. At the age o f 29 years, a change in day-night rhythm was 
observed and this was an indication for further investigations.
Spastic paraplegia and poorly developed coordination and vestibular functions 
were present in patient 3. The etiology o f the mental retardation was unknown for 
a long time. At the age o f 49 years a disturbed day-night rhythm was present, and, 
at that time, further investigation of the patient was started. Clinical photographs of  
the patient at a younger age were helpful in making the diagnosis.
All 3 patients had rather typical short and broad distal phalanges o f both hands. 
We may conclude that the phenotype o f AS can be very difficult to diagnose in 
older patients, certainly when severe neurological complications are present and 
have affected the phenotype. Patients with severe spasticity, without speech and 
with epileptic seizures, with the diagnosis o f "birth complication" or "perinatal 
complication" need certainly cytogenetic studies completed by molecular studies 
for AS. Clinical photographs o f  the patient at a younger age and the typical EEG 
pattern can be helpful in making the diagnosis (10, 13, 17, 19).
The presence o f the atypical craniofacial features, severe neurologic 
complications, change in day-night rhythm, and brachytelephalangy was striking 
in our patients and further observations are needed to confirm these features in AS 
adults.
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Content Chapter 2
2.1 The clinical phenotype in institutionalised adult males with X-linked mental 
retardation (XLMR) (Ann Génét 44:47-55, 2001)
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A bstract
In an institutionalised population o f 471 mentally retarded adult residents (436 
males and 35 females), 22 males (i.e. 5% o f the male population) had XLMR, 
accounting for 36.1% o f the residents diagnosed with a monogenic disorder (n=61). 
Fragile X  syndrome (FRAXA) was diagnosed in 16 residents, X-linked mental 
retardation with marfanoid habitus (Lujan-Fryns syndrome) in 2, and non-specific 
X-linked mental retardation (MRX) in 4 males. The 4 MRX-patients included 3 
male sibs o f a family, carrying a mutation in the IL-1 receptor accessory 
protein-like gene, and one male patient member o f the MRX-44 family (linkage 
with LOD-score o f 2.90). In the group o f 215 males with idiopathic mental 
retardation (MR), family histories and pedigree data were compatible with XLMR  
in 35 males (35/215= 16.3%) from 32 families. O f these 35 males, 5.7% were 
microcephalic with dysmorphic features and 5.7% macrocephalic; micro-orchidism  
and macro-orchidism were each found in 11.4%. One macrocephalic male had also 
macro-orchidism and dysmorphic features. In this study, the diagnosis o f XLMR  
could thus be proposed in 57 males i.e. 13.1% o f the total male population. The 
clinical phenotype, behavioural problems, and follow-up data in these different 
subgroups of XLMR are presented.
Intro ductio n
X-linked mental retardation (XLMR) is estimated to account for 20 to 25% of 
all mentally retarded males and for 10% of mildly mentally retarded females (20, 
30,32). XLMR conditions are categorised as syndromic (MRXS) if associated with 
characteristic clinical features, or non-specific (MRX) if MR is the only symptom
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in affected individuals. The most frequent entity in the group o f syndromal XLMR  
(MRXS) is the fragile X  syndrome, occurring in approximately 1/4,000 to 1/6,000 
in males, and accounting for 15 to 20% o f XLMR in males (6, 27). The nosology 
o f non-specific X-linked mental retardation (MRX), that constitutes two thirds of 
all XLMR, is much less well defined. Recently, 8 genes involved in MRX have 
been identified, but these account each for only 0.5% to 1% o f all MRX patients (1, 
2, 4, 5, 7, 14, 15, 18, 23, 34).
An overview o f all patients with syndromal and non-specific XLMR diagnosed 
in an adult male population o f 471 institutionalised mentally retarded residents is 
presented.
M aterials  a nd  M ethods
During the systematic etiological survey in the institution for the mentally 
retarded “Huize A ssisië”, Udenhout, The Netherlands, the group o f patients with 
XLMR, with either, MRXS or MRX, was further evaluated. Patient records were 
studied and a written permission to perform a physical examination, cytogenetic and 
molecular studies, and screening for inborn errors o f metabolism was obtained from 
the legal representative o f patients who were never examined before. Family data 
and medical data were collected by a questionnaire. Mental retardation (MR) in one 
or both parents, one or more sibs, or own children was considered as first degree 
familial MR. In second degree familial MR one or more uncles or aunts, nieces or 
nephews were mentally retarded. A ll patients were psychologically tested by 
standard methods to estimate the mental level. The occipital-frontal circumference 
(OFC) was defined in males with 3rd centile = 53 cm and 97th centile = 58 cm and 
in females 3rd centile = 52 cm and 97th centile = 56.5 cm (24, 28). These figures 
were corrected for height according to Bushby et al. (3). The OFC was compared 
with the testicular volume. Macro-orchidism was defined as a testicular volume > 
25 ml and micro-orchidism as a testicular volume < 10 ml (16).
Cytogenetic studies were performed on cultured peripheral lymphocytes, 
according to standard procedures. In all clinically suspected fragile X  patients, 
GTG-banding after culturing in folic acid poor medium (22) was performed in the 
past and assessment o f the CGG expansion mutation in the FMR-1 gene was done. 
Genetic linkage studies were performed in these families with pedigree data 
suggesting X-linked mental retardation.
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R esults
Twenty-two males (5% o f the male population) were found to have XLMR, 
accounting for 36.1% o f the monogenic disorders (n=61) diagnosed in this 
institution (33). In 35 other residents with non-specific phenotype, pedigree data 
were suggestive for XLMR. Table I presents the classification o f these 57 male 
residents according to MRXS, MRX and male patients with idiopathic MR and 
pedigree data compatible with the diagnosis o f XLMR.
Table I: Classification o f all males with XLMR, and males with idiopathic MR and
familial MR
XLMR MIM number Diagnosis Number of 
patients (n)
Comment
MRXS
*309550 Fragile X syndrome 16 1 with Prader-Willi 
syndrome-like phenotype
*309520 Lujan-Fryns syndrome 2
MRX
Family with IL1RAPL 
gene mutation (locus 
Xp22.1-21.3)
3 3 sibs from 1 family
MRX44 family 
(Xp11.3-p11.21)
1
Idiopathic 
MR and 
familial MR
First degree relatives 63 Maternal MR: 32 (XLMR) 
Paternal MR: 6 
Not conclusive: 25
Second degree 
relatives
6 Maternal MR: 3 (XLMR) 
Paternal MR: 1 
Not conclusive: 2
1.Syndromic XLMR (n=18)
1. Fragile X  syndrome (n=16) (Tables I  and II)
Fragile X  syndrome (MIM *309550) was diagnosed in 16 males, including 2 
brothers (Table II). Eleven residents (68.8%) were older than 40 years o f age. Ten 
(62.5%) were moderately and 6 (37.5%) severely mentally retarded. Epileptic 
seizures were present in 5 (31%). Three patients suffered from very severe vision
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Table II: Clinical features in the patients with fragile X  syndrome
Case
(yrs)
Age at 
diagnosis
(yrs)
MR Epilepsy Clinical features Behavioural
phenotype
Vision Hearing
1 (14) 3 Moderate + SS, obesity, 
short broad 
hands and feet, 
hypogenitalism
Shy
Aggression
Difficult
N N
2(45) ! Moderate + Long face Avoids
contact
Severe loss N
3 (53) ! Severe + Long face Avoids
contact
N Moderate
loss
4(55) 47 Moderate Long face Avoids eye 
contact 
Aggression 
Destruction
N N
5(62) 62 Severe SS
Long face
Coarse
movements
Hyperactive
Difficult
Severe loss Moderate
loss
6 (58) 50 Severe - Long face 
Large mandible
Avoids eye 
contact
N N
7(31) 19 Severe + Long face 
Macrocephaly 
Flat feet
Hyperactive 
Speech delay 
Hyperactive 
Difficult 
Handbiting
N N
8 (47) 47 Moderate Macrocephaly 
Macrotestes 
Long face 
Large mandible 
Inguinal hernia
Avoids eye
contact
Hyperactive
N N
9 (48) ! Severe - N Moderate
loss
10 (39) 26 Moderate - Long face 
Large mandible
Avoids eye 
contact
N N
11 (48) 35 Moderate - Large mandible Hyperactive N N
12 (46) 33 Moderate - Long face 
Large mandible
Shy N N
13 (35) 24 Moderate - Large mandible Difficult N N
14 (61) 51 Severe - Large mandible N N
15 (69) 59 Moderate + Long face 
Large mandible
Severe loss Mild loss
16 (31) 18 Moderate Long face 
Inguinal hernia 
Neonatal 
vomiting
Hyperactive N N
N: normal; +: Present; MR: mental retardation; SS: short stature
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loss, and 3 patients had moderate hearing loss. A 45-year-old male had divergent 
strabismus and myopia with onset at the age of 20 years. A 62-years-old male had 
divergent strabismus, papillary atrophy and moderate hearing loss. A 69-year-old 
male suffered from bilateral cataract and presbyacusis. Typical clinical features i.e. 
long face, large mandible, and macro-orchidism, were present in all patients. They 
were shy and avoided eye contact, and behavioural problems included 
hyperactivity, self mutilation with hand biting and aggression. One patient showed 
Prader-Willi syndrome-like phenotypic features (Table II).
2. X-linked mental retardation with marfanoid habitus (Lujan-Fryns syndrome) 
(MIM*309520) (n=2)
Two moderately mentally retarded males presented the association of moderate 
mental retardation, ectomorphic habitus and shy behaviour (Table I). Chromosomal 
studies were normal 46,XY, and a FMR-1 expansion mutation was not found. 
Screening for inborn errors of metabolism showed no abnormalities and 
homocystinuria was excluded in both patients. Also Marfan syndrome was excluded 
since ophthalmologic and cardiac examination revealed no abnormalities.
Patient 1 (Figs. 1A and 1B)
The first patient was 43 years old. Psychomotor development was retarded and 
he could walk age 2 years. From age 12 years, walking became progressively 
difficult. Head circumference was 52.8 cm (3rd centile), height 191.5 cm (>97th 
centile) and span 189 cm. His face was long and his voice was hypernasal. There
Figure 1A and B
Note the ectomorphic habitus, long face and small feet in the moderately 
mentally retarded patient with X-linked MR and marfanoid habitus
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was pectus carinatum and spasticity o f the lower limbs. He was very shy and had 
a u tis t ic - l ik e  b eh av iou r . There w as no h istory  o f  p sy c h o s is .
Patient 2
The second patient was a 41-year-old male. There was no family history of  
mental handicap. Birth was uneventful and psychomotor development was delayed. 
During childhood he was clumsy and had co-ordination problems. Examination 
revealed head circumference o f 59.2 cm (>97th centile), height 190 cm (>97 
centile) and span of 184 cm. Craniofacial features included downward slanting 
palpebral fissures, large mandible, high palate, and myopathic face. Walking was 
ataxic and broad-based. Fingerjoints were hyperextensible. He was very shy. MRI 
of the brain showed minimal cerebellar atrophy.
2. Non-specific X-linked mental retardation (Table I) (n=4)
1. Clinical description ofthe fam ily with IL1RAPL gene mutation (IL-1 receptor 
accessory protein like)(Xp22.1-21.3)
Three mentally retarded brothers (Fig. 2) o f one family were residents in this 
institution. The 3 index-patients (II-4, II-6 and II-7) are indicated on the family 
pedigree (Fig. 3). Chromosomal studies were normal 46,XY and screening for 
FMR-1 triplet expansion was normal in all 3 patients. Parents were
Figure 2A, B & C
The non-specific phenotypic presentation of the 3 affected brothers, from the 
small MRX family with a non-sense mutation in the IL1RAPL gene
X-linked mental retardatiQn 145
nonconsanguineous and there was no family history o f MR. The oldest girl (II-1) 
had a history o f depression. A second female (II-2) was moderately mentally 
retarded but no further information was available. A male child (II-3) died at the 
age o f 9 months after complications o f encephalitis. II-5 is mentally normal and has 
one healthy daughter (III-1). There were 3 miscarriages (II-8; II-9; II-10). In the 3 
affected brothers, from this small MRX family, a non-sense mutation in the 
IL1RAPL gene resulting in a premature stop codon, was found (4).
Patient 1 (II-4) (Fig. 2A)
This male was 62 years old and moderately mentally retarded. Pregnancy was 
uneventful. He was born at term. There was periodic difficult and hot-tempered 
behaviour. Present examination showed length 173.5 cm (25-50th centile), weight 
68 kg (50-75th centile) and head circumference 55 cm (50th centile). The skin was 
soft. Craniofacial features included flat occiput, narrow eyelashes, nystagmus, and 
grooved tongue. His voice was specific with high pitch and hypernasality. The 
thorax was small and testes were normal. Neurological examination revealed 
clumsy walking and hypotrophy o f the lower legs.
Patient 2 (II-6) (Fig. 2B)
This severely mentally retarded male was 59 years old. Pregnancy was 
uneventful. He was born at term and birth weight was 4,000g. There were feeding 
difficulties with frequent vomiting in the neonatal period. At the age o f 1 year, he 
was hospitalised because o f meningitis. Behavioural problems included self 
mutilation, screaming and destroying objects. At age 55 years there was bilateral 
moderate hearing loss. Present examination showed height 162.5 cm (<3rd centile), 
w eight70.2 kg (50-75th centile) andhead circumference 55.8 cm (50-75th centile). 
Span was 173 cm. The skin was soft, with striae on the upper limbs. He could speak 
some words with a hoarse and hypernasal voice. Craniofacial features included flat 
occiput, mild facial asymmetry and grooved tongue. Testes were small. 
Neurological examination showed clumsy walking and the toes were upright. He 
was friendly and social. Language comprehension was better developed than active 
speech.
Patient 3 (II-7) (Fig. 2C)
This patient is 54 years old and moderately mentally retarded. Pregnancy was 
uneventful. He was born at term with birth weight o f 4,000g. Contact was good. He 
could walk age 18 months and developed speech at 3 years. When he became older, 
there were behavioural problems with aggression. Present examination showed
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height 175.5 cm (50th centile), weight 73.5 kg (75th to 90th centile), head 
circumference 55 cm (50th centile) and span 182 cm. The skin was very soft and 
there were striae on the upper limbs. His voice was hoarse, hypernasal and low  
pitched. Testes were normal. Stature was kyphotic.
Figure 3
The family pedigree o f the small MRX family with a non-sense mutation in the 
IL1RAPL gene. The three index patients are indiacted (II-4, II-6 and II-7)
2. Clinical description o f  thepatient o fthe MRX44 family
This mildly mentally retarded male was the youngest boy o f 5 children. He had 
an older moderately mentally retarded brother. The 2 other brothers and sister were 
normal. His mother had 2 mentally retarded brothers and her sister had 2 mentally 
retarded boys. Pregnancy was uneventful. He was born at term with birth weight 
of 3,160g. Postpartal, there were feeding problems. He could walk at age 16 
months. He was hyperactive and he walked on the tips o f his toes. Speech 
development started at age 2 years. He had severe sleeping problems and awakened 
often during the night. He had difficult behaviour with outbursts o f aggression, with 
destroying objects and self mutilation. He was aggressive to other children and 
there were even periods o f sexual aggression. Examination at the age o f 30 years 
revealed height 172 cm (25-50th centile), weight 68.5 kg (75th centile), head 
circumference 59.4 cm (> 97th centile) and span 166.5 cm. There was synophrys, 
downward slanting palpebral fissures, lateral deviation of the nose, high nasal 
bridge and high arched palate. Cytogenetic studies revealed normal chromosomes 
46,XY; no FMR1 expansion was found after molecular study, and linkage studies 
in this family showed a LOD score o f 2.90 with marker DXS1204 in the region 
Xp11.3-p11.21 (17).
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3. Non-specific familial mental retardation compatible with X linked 
inheritance (n=35)
Familial MR (first degree (n=63), second degree (n=6)) was present in 69 o f the 
215 males (32.1%) with idiopathic MR (Tables I and III). O f these 69 patients, 
pedigree data were not conclusive in 27 patients (39.1 %). Paternal familial MR was 
present in 7 patients (10.1 %). Maternal familial MR was present in 22 patients and 
13 patients were members o f affected sib pairs. X-linked inheritance was thus 
thought to be the most plausible mode of inheritance in 35 patients (50.7%) from 
32 families. Three male sib pairs were living in the institution. In one o f them
Table III Overview of the MR o f the family members and their relation to the 69 
mentally retarded males with non-specific familial MR
Number Sib pairs living in this 
institution
Not conclusive (n=27)
Both parents affected 13
Paternal familial MR (n=7)
Affected father 2
Affected father + several affected sibs 1
Paternal familial MR 3
Paternal familial MR + several affected sibs 1
Maternal familial MR (n=22)
Affected mother 5
Affected mother + 1 or more affected sibs 
(brothers)
5
Affected mother + 1 mildly affected sib (sister) 1
Affected mother + 1 affected maternal brother 1
Affected mother + 1 affected maternal sister 
and her affected child
1
Affected maternal brother 5
Affected maternal brother + 1 or more affected 
sibs (brother)
1
Maternal familial MR + 1 affected sib (brother) 3 Including 1 sib pair (with 
severe neurological 
problems)
Affected brother pairs (n=13)
1 or more affected sibs (brother) 12 Including 2 sib pairs
1 or more affected sibs (brothers) + affected 
child of sib (sister)
1
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spastic paraplegia was present in both. O f these 35 male patients 2 (5.7%) had 
microcephaly and both had dysmorphic features. Macrocephaly was present in 2 
males (5.7%) and one had also macro-orchidism and dysmorphic features. Four 
males (11.4%) had micro-orchidism and 4 (11.4%) macro-orchidism as the only 
significant clinical finding.
D iscussio n
Turner (29, 30) estimated that 20-25% o f all mentally retarded males and 
possibly 10% of mild mental retardation in females is due to X-linked genetic 
defects (29, 30, 32). In this study o f 436 adult mentally retarded males, living in a 
residential care system, we found that the proportion of males with XLMR was 
13.1% (57/436) o f the total male population or 24.1% (57/237) ofthe males without 
any other diagnosis. There were 16 males with fragile X  syndrome, 2 with XLMR  
with marfanoid habitus, 4 with non-syndromic XLMR (MRX) and 35 with 
idiopathic MR and family history suggesting XLMR.
1.Syndromic XLMR (n=18)
1. Fragile X  syndrome (n=16)
All 16 males were either moderately (62.5%) or severely (37.5%) mentally 
retarded. Clinical features in these adults were compatible with the typical 
Martin-Bell phenotype and one patient had also features o f Prader-Willi syndrome. 
In the present group one third o f the patients had epileptic seizures, which is high 
compared to the literature: seizures are observed in approximately 20% of young 
affected males, with a lower prevalence in adults, and in 5% o f the females (9). In 
infancy, connective tissue abnormalities lead to congenital hip dislocations and 
inguinal hernia, and cause in later life scoliosis, flat feet, and mitral valve prolapse. 
In the present group there were 2 males with inguinal hernia and one with flat feet. 
Gastro-oesophageal reflux and tactile defensiveness lead to failure to thrive. One 
patient had problems o f frequent vomiting in the neonatal period, although it was 
difficult to obtain reliable data o f early development o f most patients. Recurrent 
otitis media and sinusitis are present in 50% of cases and need adequate intervention 
to prevent complications. In the present group 3 had moderate hearing loss. In 30 
to 50% of cases ophthalmologic help is needed because o f strabismus (36%), 
myopia or hyperopia (22%) (9). In this group three older patients (18.8%) had 
severe loss o f visual acuity, with strabismus in two. In the ageing fragile X  patient, 
special attention should be given to detect early visual and hearing problems and 
therefore regular screening should be provided.
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In general, fragile X  patients are friendly, with attention deficit and 
hyperactivity in childhood, although some may show aggressive behaviour in 
adulthood (9). Behavioural problems in younger males include hand flapping, hand 
biting, tactile defensiveness, poor eye contact, hyperactivity, and perseverative 
speech while adults present autistic-like behaviour (10). In the present group, 
decrease o f hyperactivity was noted. Special education and training is needed and 
speech therapists and physiotherapists can offer help in language and motor 
development.
2. X-linked MR with marfanoid habitus (MIM *309520) (n=2)
X-linked MR with marfanoid habitus was present in 2 moderately mentally 
retarded sporadic patients with ectomorphic habitus, triangular face, narrow palate, 
and hypernasal voice. Homocystinuria was excluded biochemically. Also Marfan 
syndrome was excluded since cardiac and ophthalmologic examinations were 
normal.
Several reports have been published on “X-linked mental retardation-marfanoid 
habitus syndrome” (11, 19, 25), including mild to moderate mental retardation, 
emotional instability, shyness, psychotic behaviour, marfanoid habitus with long 
hyperextensible fingers and toes, short halluces and long second toes (12). The 
marfanoid habitus becomes evident after puberty (13). Psychiatric problems include 
psychotic disturbances with hallucinatory visions and sounds (20), and 
schizophrenia (8, 26). However, the genetic defect remains to be discovered (21). 
The 2 present cases did not have a psychiatric history, only the first patient 
presented some autistic-like behaviour such as talking to himself, but both were 
very shy.
2. Non-specific X-linked mental retardation (MRX) (n=4)
Non-specific XLMR includes only mental retardation in affected persons 
without other dysmorphic features, neuromuscular symptoms, genital abnormalities, 
overgrowth, micro- or macrocephaly. Until recently, only the FMR2 gene, adjacent 
to the Fragile X-E (FRAXE) site on Xq28 has been identified as the cause of 
XLMR. Additional genes OPHN1 (oligophrenin 1) gene, PAK3 (p21 activating 
kinase), GDI1 gene, TM4SF2 gene, ARHGEF6 gene and RPS6KA3 gene have only 
recently been identified. A new gene, highly expressed in the brain, was isolated in 
the critical region Xp22.1-21.3 (4). A point mutation producing premature 
termination o f the coding sequence was found in a small family with 3 sibs in this 
institution. The IL1RAPL1 gene encodes a 696 amino acid protein that has 
homology to IL-1 receptor accessory proteins and may be involved in memory
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development and learning abilities. Non-overlapping deletions and a non-sense 
mutation in this gene were identified in patients with cognitive impairment only. 
The three brothers presented non-specific mental retardation without specific 
dysmorphic features. Speech was peculiar with hypernasality. Behavioural problems 
included self-mutilation and aggression.
The patient member o f the MRX44 family, with normal clinical phenotype, 
presented periods o f behavioural problems with self mutilation, aggression, 
destroying objects, and sexual aggression.
3. Patients with idiopathic MR and family history positive for XLMR (n=35)
In this group o f 215 males with an idiopathic type o f MR, non-specific familial 
MR (first and second relatives) was present in 32.1% (n=69). The presence of 
familial MR was three times increased in the maternal families (n=22) in contrast 
to the presence o f MR in the paternal family (n=7). Also 13 patients were members 
o f sib pairs. X-linked inheritance was thus considered in 35 males. In this group of 
35 males, from 32 families, 5.7% were microcephalic with dysmorphic features and 
5.7% were macrocephalic. Micro-orchidism and macro-orchidism were each 
present in 11.4%. Macrocephaly in association with macro-orchidism is an 
important finding in several X-linked mental retardation syndromes, including 
FRAXA (MIM* 309550), XLMR-macrocephaly-macro-orchidism (MIM 309530), 
XLMR-macrocephaly, Atkin-Flaitz syndrome, Clark-Baraitzer syndrome, 
Lujan-Fryns syndrome (MIM* 309520) and PPMX (Psychosis-Pyramidal 
signs-Macro-orchidism Syndrome (MIM 300055)) (27). In the present group, only 
one patient had this association o f macrocephaly and macro-orchidism together with 
dysmorphic features.
In general, the higher recurrence risk in brothers than in sisters strongly suggests 
that genes on the X  chromosome are important contributing factors to the 
recurrence risk in undiagnosed mental retardation (31). X-linked inheritance was 
thus diagnosed in this institution in a group o f 57 patients, accounting for 13.1% of  
the total male population (57/436), while in the group o f males without any other 
diagnosis, this percentage was 24.1% (57/237). Regarding the general figure of 
XLMR in males (20 to 25%) a higher figure in this group o f 436 mentally retarded 
males was expected. This indicates that also in the present survey several members 
o f MRX families are currently not discovered. Since this is a population o f older 
mentally retarded patients, family data are not always accurate and genetic 
counselling is not requested anymore. The influence o f ageing and drug therapy, i.e. 
anti-epileptic drugs, may coarsen the face and hide the clinical diagnosis. In
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addition, with advancing age, the natural history and medical complications are 
unknown.
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M e t a b o l ic  d is o r d e r s
Content Chapter 3
3.1 Metabolic studies in older mentally retarded patients: significance o f metabolic 
testing and correlation with the clinical phenotype (Genet Couns 12:1-21, 
2001)
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A bstract
In 471 adult mentally retarded adult patients (mean age 46 years; 92.6% males) 
living in an institution for the mentally retarded, a clinical examination, cytogenetic 
and molecular studies were done. 306 patients were screened for metabolic 
disorders. In 7 additional patients a metabolic disorder (phenylketonuria (n=5), 
mucopolysaccharidosis type III (Sanfilippo syndrome, type A) (n=1) and 
mucopolysaccharidosis type VII (Sly syndrome) (n=1)) was diagnosed in the past. 
The abnormal metabolic findings in this group o f 313 patients were classified in 
three categories and the clinical findings are reported: 1. metabolic disorders as the 
cause o f mental retardation (MR), 2. metabolic disorders not explaining the MR, 
and 3. metabolic abnormalities o f unknown significance. The first two groups 
included 16 patients, i.e. 26.2% o f the group o f monogenic disorders and 3.4% of 
the total population: phenylketonuria (PKU) (n=5), S-sulfocysteinuria (n=3), 
mucopolysaccharidosis type III (Sanfilippo syndrome, type A) (n=1) and 
GM 1-gangliosidosis type 3 (n=1) (first group), and mucopolysaccharidosis type VII 
(Sly syndrome) (n=1), Niemann-Pick syndrome, type B (n=1), cystinuria (n=1) and 
hyperprolinemia type 1 (n=3) (second group). The third group included patients 
with citrullinemia (n=2), methionine sulphoxide reductase deficiency (n=1), 
ornithinemia (n=1), glycinuria (n=20), neuraminaciduria (n=8), uraciluria (n=6) and 
diabetes mellitus (n=2). Screening for Congenital Disorders o f Glycosylation 
(CDG) in 144 patients and for Smith-Lemli-Opitz syndrome (SLO) in a selected 
group o f 6 patients was normal. O f the total group o f 306 patients screened for 
inborn errors o f metabolism, only 5 (1.6%) were found with a 'true' metabolic 
disorder. These 5 patients presented clinical symptoms, neurodegenerative or
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behavioural problems, indicating further metabolic screening. The present study 
illustrates that a selected group of patients with mental retardation o f unknown 
origin are candidates for metabolic screening, especially if  aberrant behaviour, 
neurodegenerative problems or dysmorphic features are present.
Intro ductio n
Few reports have been published on large-scale studies o f inherited metabolic 
disorders. Yadav and Reavey (50) reported on 35 patients with aminoacidopathies 
in a group o f 800 patients in Kuwait. Thirty-three o f these 35 patients were the 
offspring o f first-cousin consanguineous marriages. Carroll et al. (8) reported on 
sialic acid screening in neurologic disorders and Aula et al. (1) diagnosed 26 
patients with aspartylglucosaminuria and 24 patients with Salla disease by screening 
urinary oligosaccharides in 1058 mentally retarded patients in Finland.
M aterials  and  M ethods
During the systematic etiological survey in the institution o f mentally retarded 
patients "Huize Assisie", Udenhout, The Netherlands, 471 patients (mean age 46 
years; 92.6% males) were investigated and in 306 patients metabolic screening tests 
were performed. In 7 patients a metabolic disorder was diagnosed in the past and 
the clinical data o f these patients were also included in the present study.
Patient records were studied and a written permission to perform a physical 
examination, to collect blood and urine for chromosomal studies on peripheral 
lymphocytes, and screening for inborn errors o f metabolism, was obtained from the 
legal representatives. Molecular studies for the FMR-1 gene were done on specific 
indication. Family history and medical data were collected by questionnaire. All 
patients were tested by standard psychological methods to estimate their mental 
level. Urine and serum were obtained from these 306 patients. Because 24-hour 
urine collection is difficult to organise in mentally retarded patients, single urine 
and blood samples were obtained early in the morning. The blood sample was 
centrifuged at the institution and serum was transported to the Laboratory of 
Paediatrics and Neurology, University Medical Centre Nijmegen, The Netherlands. 
Screening on these samples was performed according to standard procedures, and 
included analysis o f amino acids, organic acids, purines and pyrimidines, 
oligosaccharides, mucopolysaccharides and neuraminic acid. Six patients showed
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MR, partial syndactyly o f 2nd and 3rd ray o f the feet and hypospadias, and they 
were screened for Smith-Lemli-Opitz syndrome (SLO) by measuring 
7-dehydrocholesterol and cholesterol in serum. In 144 patients with idiopathic MR 
metabolic studies for Jaeken syndrome (Carbohydrate deficient glycoprotein or 
Congenital disorders o f glycosylation (CDG syndrome)) were done by means of 
iso-electric focusing o f plasma transferrin.
R esults
After a systematic etiological screening in 471 mentally retarded patients o f this 
institution, 238 patients (238/471=50.5% ) were found with an etiological diagnosis, 
including 61 with a monogenic disorder (44). Metabolic disorders were diagnosed 
in 16 patients i.e. 26.2% o f the group o f monogenic disorders and 3.4% o f the total 
population. There was no consanguinity in the parents o f these 16 patients.
In 7 patients a metabolic disorder was diagnosed in the past: PKU (n=5), 
Sanfilippo syndrome, type A (n=1), Sly syndrome (MPS type VII) (n=1). O f the 
306 patients, screened for inborn errors o f metabolism, 9 additional patients were 
diagnosed: an aminoacidopathy (Cystinuria (n=1), Hyperprolinemia (n=3), 
S-sulphocysteinuria (n=3)) was present in 7 patients and a lysosomal storage 
disorder in 2 patients (Niemann-Pick syndrome, type B (n=1), GM1 gangliosidosis 
type 3 (n=1)).
The clinical description and metabolic abnormalities in this group o f patients are 
presented in tables I to VI, figures 1 and 2, and addendum 1.
Cholesterol and 7-dehydrocholesterol levels o f the 6 patients screened for SLO 
syndrome, were in the normal range. In all 144 patients examined for CDG 
syndrome, normal plasma transferrin (iso-electric focusing of plasma transferrin) 
was found. Diabetes mellitus was diagnosed in 2 patients.
D iscussio n
This study was an etiological study focused to detect the cause o f the MR in this 
group o f older mentally retarded patients. Therefore, the abnormal metabolic 
findings in this group o f  306 screened and 7 previously diagnosed additional 
patients were further sub-classified in three categories: 1. metabolic disorders as the 
cause o f mental retardation (MR), 2. metabolic disorders not explaining the MR, 
and 3. metabolic abnormalities o f unknown significance.
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Table I: Classification o f all patients with metabolic disorders and metabolic
abnormalities
Classification Number of 
patients (n)
1. Metabolic disorders as the cause of MR
Phenylketonuria (PKU) (M IM *261600) 5
S-sulphocysteinuria (M IM *272300) 3
Mucopolysaccharidosis type III (Sanfilippo syndrome, type A) 
(M IM *252900)
1
GM1 gangliosidosis type 3 (MIM #230650) 1
2. Metabolic disorders not explaining the MR
Cystinuria (M IM #220100) 1
Hyperprolinemia type 1 (M IM *239500) 3
Mucopolysaccharidosis type VII (Sly syndrome) 
(M IM *253220)
1
Niemann-Pick syndrome, type B (MIM *257200) 1
3. Metabolic abnormalities of unknown significance
Citrullinemia 2
Ornithinemia 1
Methionine-sulphoxide reductase deficiency 1
Glycinuria 20
Neuraminaciduria 8
Abnormal metabolites o f lysosomal metabolism 4
Uraciluria 6
4. Diabetes mellitus 2
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Figure 1
Cystine crystals in the urinary sediment Qf the prQfQundly mentally retarded 
male with cystinuria
Figure 2
Patient with GM1 gangliQsidQsis. NQte the facial grimacing
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Table II: AminQ-acid metabQlic disQrders: clinical features Qf the patients with 
phenylketQnuria, S-sulphQcysteinuria, cystinuria and hyperprolinemia
Patient Family MR Epilepsy Neurology Dysmorphism
Phenylketonuria
(n=5)
AA-1 Fam MR Moderate + - Light coloured hairs
AA-2 Fam MR Profound - Motor problems 
turricephaly
Light coloured hairs 
Blue eyes
AA-3 Fam MR Profound + - -
AA-4 Fam MR Profound - Motor problems Coarse
AA-5 Fam MR Profound + Microcephaly -
S-sulphocysteinuria
(n=3)
AA-10 RFW (5-6) Profound + Leucotomy
Behaviour
problems
Macrostomia,
synophrys
AA-11 RFW (6) Profound + Leucotomy
Behaviour
problems
Microcephaly
Macrostomia 
Facial asymmetry
AA-12 Profound + Spastic
tetraplegia
Microcephaly
Macrostomia,
Synophrys,
Scoliosis
Moderate vision loss
Cystinuria
(n=l)
AA-6 Fam MR Profound + Self mutilation -
Hyperprolinemia type 
l  (n=3)
AA-7 RFW Mild + Aggressive
Autistic-like
-
AA-8 RFW Moderate - Microcephaly SS
AA-9 RFW Profound + Microcephaly SS
RFW: recurrent fetal wastage (> 3 miscarriages); MR: mental retardation; SS: short stature; 
N: normal; R: right; +: present
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Hearing loss Biochemical Results
-
moderate
severe
-
moderate
Urinary S- 
sulphocysteine 
concentration 
(normal value: <20 
|imol/mmol creat)
R ear: perforation 5 2 - 2 0 -  35
Severe 34
Severe 2 9 -1 8
Urinary cystine 
(normal value: 6- 
34p,mol/mmol creat)
Urinary lysine 
(normal value:7-58 
|imol/mmol creat)
Urinary ornithine 
(normal value: 0-5 
|imol/mmol creat)
Urinary arginine 
(normal value: 0-5 
|imol/mmol creat)
- 390 -339 787 - 764 335 -323 235 - 230
Urinary proline (0- 
9p.mol/l)
Serum proline (83- 
391^mol/l)
- 17 -1 551 -4 7 8 -4 6 2
moderate 2 524 - 546
moderate 1 545 - 425
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Table III: LysQSQmal metabQlic disQrders: clinical features
Patient Diagnosis MR Epilepsy Dysmorphism Hearing loss Neurology
LD-1 Sanfilippo 
syndrome, 
type A
Profound + Coarse face
Hepatospleno-
megaly
Severe Progressive loss 
of motor function 
Behavioural 
problems
LD-2 GM1- 
ganglio­
sidosis 
type 3
Mild Long face, large 
ears, pectus 
excavatum
Mild Progressive 
Hypotonia arms 
Hypertonia legs 
Facial dystonia
LD-3 Niemann­
Pick
syndrome, 
type B
Severe Left-sided iris
coloboma
Left-sided
haemangioma
upper eye-lid
Thin lips
Splenomegaly
N Dysarthric speech
LD-4 MPS type 
VII (Sly 
syndrome)
Moderate + SS N Normal 
Behavioural 
problems as child
+: present
1. Metabolic disorders as the cause of the MR
A.Aminoacidopathies
The 5 patients, members o f 4 families, with PKU (Phenylketonuria (PKU) 
(MIM *261600)) were diagnosed after a systematic screening in 1967. In 2 families, 
there were other sibs with PKU and MR. The parents o f the 2 brothers were 
borderline intelligent. V ogel (47, 48) observed an increased incidence o f familial 
MR in PKU heterozygotes.
There were 3 patients with S-sulphocysteinuria (M IM *272300) and isolated 
sulphite oxidase deficiency (ISOD) was most likely (normal urinary xanthine and 
hypoxanthine, and uric acid levels). However, enzyme assay studies could not be 
performed. They had severe and difficult to treat epileptic seizures. There was 
recurrent fetal wastage with 5 to 6 miscarriages respectively in the parents o f 2 
patients. In ISOD, at the molybdenum cofactor centre, located in the intermembrane 
space o f the mitochondrion, sulphite accumulates and sulphate production is 
decreased (5). S-sulphocysteine is formed by direct reaction o f sulphite with 
cysteine and results in an increased urinary excretion o f sulphite, thiosulphate,
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Table IV: Clinical presentatiQn Qf the patients with glycinuria
Patient MR E Therapy Clinical features Familial Hearing Vision Glycinuria
(43-173
^mol/mmol
creat)
Gly-1 Severe + Sodium
valproate
Meningitis
(meningococ)
3 RFW Deaf N 397 - 443
Gly-2 Severe + Carbamazepine 
Valproic acid 
Phenobarbital
Tremor
Coordination abn 
Cerebellar abn 
Pyramidal abn
N Mild 293 - 264
Gly-3 Moderate + Sodium
valproate
Carbamazepine
Oxazepam
Fam MR Mild N 434 - 489
Gly-4 Severe + Sodium
valproate
Carbamazepine
Phenobarbital
Asphyxia 
Microcephaly 
Dysmorphism 
Coarse face
Moderate Mild 7 9 4 -8 1 3
Gly-5 Severe + Carbamazepine
Phenobarbital
Arachnoid cyst 
Microcephaly 
Dysmorphism 
Tetraplegia
N Mild 500 - 367
Gly-6 Profound + Sodium
valproate
Carbamazepine
Luminal
Tremor
Ataxia
Fam MR Mild Mild 522 - 397
Gly-7 Mild + Sodium
valproate
- - N Moderate 296 - 235
Gly-8 Mild + Sodium
valproate
BW:6,200g Fam MR N N 5 9 2 -4 0 9
Gly-9 Severe + Sodium
valproate
Carbamazepine
Macrocephaly
Trichotillomania
Moderate Blind 572 -274
Gly-10 Profound + Sodium
valproate
Carbamazepine
Microcephaly 4 RFW 3 1 7 -3 8 9
Gly-11 Severe + Carbamazepine - - Moderate N 217 -2 2 1
Gly-12 Moderate + Sodium
valproate
Macrocephaly - N N Increased - 
286
Gly-13 Moderate Carbamazepine Asphyxia 
Turricephaly 
Pyramidal abn 
Cardial abn
Moderate N 4 1 8 -3 3 8
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Table IV continued
Patient MR E Therapy Clinical features Familial Hearing Vision Glycinuria
(43-173
^mol/mmol
creat)
Gly-14 Moderate - - SS Consan­
guinity
N N 265-1336
Gly-15 Mild - - Progressive 
neurological abn
Fam MR N N 2 1 1 -2 4 1
Gly-16 Profound Ranitidin Asphyxia 
Pedes cavi 
Neurological abn 
No speech
Fam MR Severe N Increased - 
276
Gly-17 Moderate - - Asphyxia 
Behavioural probl
- N Mild 292 - 576
Gly-18 Severe - Periciazine - Fam MR N N 316-266
Gly-19 Severe - Carbamazepine
Dipiperon
Speech
retardation
- Mild N 233 - 608
Gly-20 Moderate Asphyxia 
Spasticity legs 
Pyramidal abn
Moderate Mild 285 - 229
E: epilepsy; +: present; RFW: recurrent fetal wastage; N: normal; abn: abnormality; MR: 
mental retardation; BW: birth weight; SS: short stature; probl: problems
taurine and S-sulphocysteine. The severe neurological abnormalities, with poor 
prognosis, are a consequence of the neurotoxicity of sulphite accumulation or as a 
deficit in sulphate concentration. Barbot et al. (2) and van der Klei-van Moorsel et 
al. (45) described a mild type of ISOD with normal concentration of sulphate in 
urine, despite the complete absence of sulphite oxidase activity in fibroblasts. 
Probably, there is a relationship between the clinically milder form and the normal 
urinary concentration of sulphate. Garrett et al. (15) described a mutation in the 
sulphite oxidase gene in a 5 year-old girl with ISOD, who exhibited developmental 
delay, hypotonia, bilateral dislocation of the lenses and progressive neurologic 
abnormalities. An ophthalmological examination showed no lens dislocation in the 
third patient, but he had moderate loss of visual acuity. He had also severe 
non-progressive spastic paraplegia.
B. Disorders oflysosom al metabolism
The patient with Sanfilippo syndrome, type A (Mucopolysaccharidosis type III; 
MPSIIIA) was diagnosed at age 10 months because of psychomotor retardation and 
hepatosplenomegaly. At age 10 years, he had severe behavioural problems with self
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Table V: Clinical presentatiQn Qf the patients with neuraminaciduria
Patient Neuraminaciduria 
Biochemical 
results (5-65 
|imol/mmol creat)
Medication MR Epilepsy Neurology Dysmorphism Hearing loss
NA-1 85 Mild Autistic-like
psychotic
behaviour
Macrocephaly
Normal
phenotype
N
NA-2 79 Carbamazepine
Phenobarbital
Profound +(severe) Frontal
leucotomia
Pica
Coarse N
NA-3 87 Severe + Bil pes
cavus
Autistic
Normal
phenotype
N
NA-4 73 Cisordinol
Akineton
Severe + Self
mutilation
Microcephaly
Microphtalmia
Severe
NA-5 71 Carbamazepine
Lioresal
Melleril
Severe + Myopathy Mild
NA-6 75 - Moderate - Motor
irritability
Microcephaly
SS
Severe
NA-7 88 Carbamazepine Severe + Frontal
leucotomia
Aggressive
Normal
phenotype
Mild
NA-8
=Gly-4
140 Sodium
valproate
Carbamazepine
Phenobarbital
Severe + Microcephaly
Coarse: large
mandible,
hypertelorism
Myopia
Barrel-shaped
chest
Moderate
MR: mental retardatiQn; +: present
mutilation and sleep difficulties. The clinical features in MPSIIIA include severe 
central nervous system degeneration with delayed development, coarse hair, 
hirsutism, diarrhoea, mild skeletal abnormalities, joint stiffness, and 
hepatosplenomegaly in older patients. Behavioural problems with destructive 
tendencies and hyperactivity are frequent presenting symptoms (32).
The patient diagnosed with GM1 gangliosidosis type 3 (beta-galactosidase 
deficiency) presented since the age of 7 years progressive neurologic deterioration 
with dysarthria, progressive gait disturbance, and dystonia in the neck and 
extremities. Brain imaging showed only periventricular atrophy. Uyama et al. (42)
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Table VI: Clinical presentation of the patients with uraciluria
Patient
(years)
MR E Medication Neurology Dysmorphism Biochemistry uraciluria 
( 0 - 5  mmol/mol creat)
U-1
(48 y)
Profound + Carbamazepine
Dipiperon
Polyneuropathy Coarse: synophrys, 
deep-set eyes, broad 
nasal tip 
Coarse ears 
SS
3 0 .9 -3 6
U-2 
(51 y)
Severe - - Self mutilation Microcephaly 
Low frontal hairline
1 6 -2 2
U-3 
(18 y)
Severe Neuleptil Pica
Self mutilation 
Autistic
Progressive loss 
of speech
Synophrys, flat midface 
Scoliosis
24 .7 -2 3 .9
U-4 
(26 y)
Severe Anxious
Irritability
Down slanting palpebral 
fissures, synophrys
5 7 .4 -3 9 .2
U-5 
(62 y)
Moderate + Dystonia 
Dysarthria 
Spasticity 
Atrophia m 
deltoideus
Severe perceptive 
hearing loss
30.9 -  increased
U-6 
(50 y)
Severe + Phenobarbital Moderate hearing loss 5 3 -3 0 .3
E: epilepsy; +: present; SS: shQrt stature; m: musculus
reported MRI lesions in the putamen and nucleus caudatus, which may be 
responsible for the symptomatic dystonia which is characteristic of this disorder. 
Age of onset of the first neurological symptoms may be variable (4 to 30 years) (39, 
49, 41). Additional symptoms are mild mental retardation, epileptic seizures, 
angiokeratomas of the skin, and mild spondylodysplasia with flattened vertebral 
bodies, but organomegaly and cherry red spots are no typical findings (40).
2. Metabolic disorders not explaining the MR
A.Aminoacidopathies
In one profoundly mentally retarded male, cystinuria (MIM#220100) was 
present. Cystine, lysine, ornithine and arginine levels were all highly increased. He 
was considered as a type 1 cystinuria patient, although it was not possible to 
determine the carrier status of the family members. Two profoundly mentally 
retarded brothers died at early age. In cystinuria there are 3 clinical types and the
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genetic defect (2p16.3 (SLC3A1 gene)) results in a defective heavy subunit of the 
renal aminoacid transporter (rBAT), with defective cystine transport in the brush 
border of the proximal renal tubule and the intestinal epithelium. This results in 
defective reabsorption of cystine and dibasic aminoacids, most probably by means 
of a heteroexchange diffusion mechanism of transport with neutral aminoacids (7, 
28,29, 34). Interestingly, Scriver et al. (33) observed a 10 fold increased incidence 
of cystinuria in mentally retarded patients. However, the possibility of a contiguous 
gene syndrome exists. Also 'hidden' consanguinity may be an explanation of this 
increased incidence of MR.
There were 3 patients with hyperprolinemia type 1 (MIM*239500). One was 
mildly, one moderately, and one profoundly mentally retarded. In addition, 2 of the 
3 patients had short stature, microcephaly, and moderate hearing loss, and 2 of the
3 had epileptic seizures. In the 3 families there was recurrent fetal wastage. 
Hyperprolinemia type 1 is a very rare disorder and is generally considered as a 
benign condition, although EEG abnormalities, photogenic epilepsy, nerve 
deafness, and mental retardation have been reported. The defect involves the 
enzyme proline oxidase in the degradation pathway of proline, a non-essential 
amino acid important in connective tissue collagen and in the brain as a precursor 
of the GABA neurotransmitter (26, 27).
B. Disorders oflysosom al metabolism
The patient with MPS Type VII (Sly) presented moderate mental retardation, 
severe epileptic seizures, short stature and behavioural problems. The diagnosis was 
also confirmed (beta-glucuronidase deficiency) in 2  other institutionalised mentally 
retarded sisters. The clinical presentation of Sly syndrome is heterogeneous and 
clinical features include coarse face, corneal opacities, hearing loss, 
hepatosplenomegaly, pectus carinatum, skeletal defects with abnormalities of the 
vertebral bodies (35). Lee et al. (23) differentiated a severe early-onset type and a 
mild late-onset type. Urinary MPS (chondroitin sulphate) excretion, variable with 
age, was observed by Lee et al. (23) in one patient. Intelligence is normal or may 
be impaired (11, 38).
The patient with Niemann-Pick syndrome, type B presented a normal phenotype 
but splenomegaly was found after abdominal ultrasound investigation. He had 
left-sided iris coloboma. In Niemann-Pick syndrome sphingomyelinase deficiency 
(11p15.4-p15.1) results in storage of sphingomyelin in reticuloendothelial cells and 
ganglion cells. Several subtypes are described. However, only type A (classic type) 
and B (visceral type) are caused by sphingomyelinase deficiency. Type B manifests
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with organomegaly without neurological abnormalities. Type B patients express an 
enzyme with sufficient residual activity to prevent neurologic manifestations. 
Splenomegaly may not be noted until adulthood (3,24, 31). Intelligence is normal. 
However, Sogawa et al. (37) reported 2 males with mental retardation and 
hepatosplenomegaly.
3. Metabolic abnormalities of unknown significance
In 42 patients biochemical disturbances of unknown significance or secondary 
to drug therapy were found. Of these patients, 24 had abnormal values of urinary 
and/or serum amino acids.
Citrullinemia was present in 2 patients. Both patients had behavioural problems 
with self mutilation. One patient had familial MR and parents were consanguineous 
(second cousins). MR was present from early childhood. In adult-onset 
citrullinemia (type II citrullinemia) (CTLN2) (7q21.3) (MIM#603471), mental 
retardation, bizar behaviour, sleep reversal, echolalia, tremor, convulsions, 
psychosis, manic periods and hallucinations are present (6 , 21, 22, 30). In the urea 
cycle argininosuccinate synthetase (ASS), catalyzes the formation of 
argininosuccinate from citrulline and aspartate (30). It was difficult to conclude 
whether the repeatedly abnormal findings in the present two patients with aberrant 
behaviour indicated a metabolic disorder or were caused by exogenous food 
suppletion.
An increased serum level of ornithine was found in one patient. Two inherited 
disorders result in hyperornithinemia. Gyrate atrophy of the choroid and retina, 
with symptoms limited mainly to the eye is caused by a deficiency of the 
mitochondrial matrix enzyme ornithine aminotransferase (OAT) (MIM*258870). 
Hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome, with 
symptoms resulting from ammonia accumulation and protein aversion, results from 
a defect in the transporter that mediates ornithine entry into mitochondria 
(MIM#238970) (43). A disorder of the urea cycle was excluded in the present 
patient.
The clinical significance of methionine-sulphoxide reductase deficiency in the 
patient with 45,X/46,XY/47,XYY mosaicism and testis tumor was not clear. 
Methionine levels in this patient were normal. Whether the increased plasma and 
urinary methionine-sulphoxide levels were caused by the presence of the testis 
tumor or whether this patient presented a new metabolic disorder could not be 
resolved, because he died before additional studies were performed. Metabolic 
studies in patients with a similar gonadal tumor type were started. Recently, Huang 
et al. (20) reported on changes in methionine adenosyltransferase deficiency (MAT) 
which seem to be important in the pathogenesis of hepatocarcinogenesis.
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Methionine and methionine-sulphoxide are increased in hepatic MAT deficiency 
(MIM*250850), which is usually considered a clinically benign condition which 
may present clinically with breath odor (12, 13, 16, 19, 25).
Glycinuria was present in 20 patients, and in 19 patients glycine concentration 
in serum was normal. Treatment with anti-epileptics, especially depakine, is an 
explanation for the increased urinary glycine in 14 patients. Two patients were 
treated with neuroleptic drugs. In 4 other patients it was difficult to explain the 
glycinuria. Until the age of 6  months physiological iminoglycinuria is a common 
finding. Persistent glycinuria has been reported in association with aminoaciduria 
in hyperprolinemia and hydroxyprolinemia, in Fanconi syndrome and in renal 
glycinuria as a specific error of membrane transport of aminoacids. Renal 
glycinuria should be differentiated from dominantly inherited renalhyperglycinuria, 
autosomal dominant glucoglycinuria, and X-linked hypophosphatemia with 
glucoglycinuria. Familial iminoglycinuria is a benign condition involving 
nonessential amino acids, and no therapy is indicated. (9, 17). In conclusion, 
glycinuria without hyperglycinaemia is probably a benign condition without clinical 
symptoms.
Abnormal results of lysosomal metabolism were found in 12 patients. 
Neuraminaciduria was present in 8 patients, including 6  with severe behavioural 
problems. The family of the sialic acids is derived from neuraminic acid and the 
predominant sialic acid in humans is N-acetylneuraminic acid (sialic acid). 
Although intralysosomal accumulation of free sialic acid has been documented in 
several organs, its role is unknown (14). Salla disease and infantile free sialic acid 
storage disease (ISSD) are probably allelic mutations of a gene coding for a 
lysosome membrane transport protein (36). The clinical findings in Salla disease 
include hypotonia, ataxia, nystagmus, spasticity, delayed psychomotor 
development, and impaired speech development, EEG abnormalities, and coarse 
face. In ISSD failure to thrive, visceromegaly, edema and early death are 
characteristic findings (14). In sialuria, with accumulation of free sialic acid in 
cytosol and not in the intralysosomal fraction, developmental delay, 
hepatosplenomegaly and coarse facial features are the clinical findings. However, 
definite conclusions concerning the diagnosis of a metabolic disorder could not be 
made in these 8 patients.
In 4 patients, abnormalities of metabolites of the lysosomal metabolism were 
present and the significance of these abnormal levels was not clear. In one patient 
this was probably due to medication.
Biochemical abnormalities in the purine and pyrimidine metabolism were found 
in 6  patients with uraciluria, but no clear diagnosis could be made and the 
significance was not known. Pyrimidines play an important role in the regulation
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of the central nervous system and metabolic changes affecting the levels of 
pyrimidines may lead to abnormal neurological activity. Dihydropyrimidine 
dehydrogenase (DPD) is the initial and rate-limiting enzyme in the degradation of 
the pyrimidine bases. DPD deficiency is often accompanied by a neurological 
disorder with a wide variety in clinical presentation (46). Large concentrations of 
thymine and uracil are detected in urine, blood and cerebrospinal fluid. Uraciluria 
may indicate the presence of hyperammonemia. In 2 patients postprandial ammonia 
was measured and was normal.
C o n c l u sio n
Bradley (4) suggested screening on amino acids, mucopolysaccharides and 
mellituria in every infant with failure to thrive, mental retardation or neurological 
defect. Guidelines to perform metabolic screening, concerning mitochondrial 
cytopathies, peroxisomopathies, and inborn errors of neurotransmission, were 
reported by Haan (18). Recently, Curry et al. (10) published recommendations on 
evaluation of mental retardation, and concluded that metabolic testing should be 
selective and targeted at patients with symptoms suggesting this category of 
disorders and that unselected metabolic screening should not be routinely 
performed in patients with MR. In the present study, only 5 additional patients were 
found with a metabolic disorder and 4 patients with a metabolic disorder without 
clear relation with mental handicap. The diagnosis of other metabolic disorders 
besides PKU (systematic screening of newborns) and the clinically recognisable 
lysosomal storage disorders remains low in institutionalised mentally retarded 
persons. Screening for the CDG syndrome was done for the first time on a large 
scale of patients since the biochemical procedure became available for routine 
procedures. However, no patient was diagnosed with CDG syndrome. In 6  selected 
patients, based on the presence of MR, partial syndactyly of the 2nd and 3rd toes 
and hypospadias, cholesterol and 7-dehydrocholesterol were measured, but the 
diagnosis of SLO was not confirmed. These data suggest that the number of 
patients with these syndromes among institutionalised mentally retarded may be not 
as high as previously thought. Therefore, we agree with Curry et al. (10) to perform 
only basic metabolic screening in a selected group of mentally retarded patients in 
whom chromosomal studies, microdeletion studies and DNA studies appeared 
normal. Patients with the diagnosis of "birth complication" and the presence of 
behavioural abnormalities, neurodegenerative problems or dysmorphic features are 
the first candidates for selective metabolic screening.
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A ddendum  1: M e ta b o l ic  a b n o r m a l i t i e s  o f  u n k n o w n  s ig n if ic a n c e :
PATIENT data AND CLINICAL DESCRIPTION
1. Biochemical abnormalities in amino acid metabolism (n=24)
1. Citrullinemia (n=2)
Two patients were found with increased serum citrulline. The first patient was 
a 61 years old moderately mentally retarded male and family history revealed 2 
miscarriages. Behaviour was bizar and autistic-like and there was aggression, self 
mutilation, echolalia and echopraxia, stereotypias, facial dystonia. Renal function 
was normal. There was partial syndactyly of the second and third toes. 
Citrullinemia was present: 73 and 74 ^m ol/l (normal value: 23-49 ^.m ol/l).
The second patient was a 69 years old profoundly mentally retarded male. 
Parents were consanguineous. He had one profoundly mentally retarded brother, 
who had normal biochemical levels of citrulline. Craniofacial features included 
brachycephaly, coarse face with hypertelorism, large mouth, high arched palate and 
there was deafness. There was self mutilation and he was very anxious. Renal 
function was normal. Citrullinemia was present: 79 and 72 ^mol/l.
2. Ornithinemia (n=1)
A 59 years-old severely mentally retarded patient had an increased serum 
ornithine level (141 and 142^mol/l (normal value: 29-103^mol/l). He had one 
mentally retarded sister. There were no dysmorphic features, he had only 
strabismus convergens. There was no speech and behaviour was normal. To 
exclude a disorder of the urea-cycle, serum ammonia was measured after 
protein-rich diet and was found to be normal.
3. Methionine-sulphoxide reductase deficiency (n=1)
Basic metabolic studies in a 55 years old moderately mentally retarded male 
revealed an increased plasma and urinary methionine-sulphoxide level. The 
patient's karyotype was 45,X/46,XY/47,XYY (6/43/1). There was no familial 
history of mental retardation. Psychomotor development was delayed. Span was 10 
cm above height and OFC was on the 3rd centile. He had no dysmorphic features. 
There was a partial cutaneous syndactyly of the second and third toes. 
Methionine-sulphoxide was repeatedly increased in plasma (91 and 308 ^mol/l) 
and urine (40 and 60 |j,mol/mmol creatinine). Unfortunately, before complementary 
studies could start, the patient died, because of complications of status epilepticus 
and respiratory insufficiency after metastatic testis cancer. Postmortem studies 
revealed a malignant gonadal stromal tumor.
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4. Glycinuria (n=20)
In 20 patients (Table IV) an increased value was found of the urinary glycine 
excretion and varied between the level of 211 and 1336 ^mol/mmol creatinin 
(normal value: 43-173 ^mol/mmol creatinin). Fourteen patients received 
anti-epileptic therapy. One patient received periciazine (Neuleptil) and one patient 
ranitidine. There was no oral therapy in 4 patients. Patient Gly-15 had also 
increased serum glycine of 501 and 443 ^m ol/l (normal value: 154-358 ^mol/l). 
Cerebrospinal fluid was not investigated. He suffered from an unknown progressive 
neurologic disorder. He had 2 mentally retarded children. Patient Gly-14 had first 
degree consanguineous parents.
2. Biochemical abnormalities in lysosomal metabolism (n=12)
1. Neuraminaciduria (Table V) (n=8)
Eight patients presented an increased level of urinary neuraminic acid. Six of 
these 8 patients showed severe behavioural problems and 2  of them were surgically 
treated in the past with a frontal leucotomy.
2. Other unknown abnormalities oflysosom al metabolism (n=4)
Screening for lysosomal disorders was also disturbed in 1 profoundly mentally 
retarded patient (Patient AA-11)(Table II). Epileptic seizures, microcephaly, mild 
craniofacial dysmorphism, deafness, loss of visual acuity were present. 
Psychomotor development was retarded and he was surgically treated because of 
severe behavioural problems of self mutilation. Amino acid screening showed an 
increased value of glycine and S-sulfocysteine. However, enzyme assay studies on 
mucopolysaccharidoses in leucocytes were normal.
Screening for lysosomal disorders in another profoundly mentally retarded 
patient showed an unknown urinary metabolite. Contractures, epileptic seizures, 
hypertelorism, large ears, high palate and pectus excavatum were present. Visual 
acuity was severely decreased. Cytogenetic studies and DNA investigation for the 
FMR-1 gene were norm al. Enzym atic studies in leucocytes on 
mucopolysaccharidoses revealed no abnormalities.
In 1 patient heparansulfate was increased, but enzyme studies on 
mucopolysaccharidoses showed normal values. He was profoundly mentally 
retarded, epileptic seizures and progressive neurologic deterioration was present. 
There was macrocephaly, coarse face, palatoschizis and he was blind. There was 
severe hearing loss. A cerebral CT-scan showed a large right sided parieto-occipital 
porencephalic cyste. A definite metabolic diagnosis could not be made.
In 1 mildly mentally retarded patient disturbances of oligosaccharide excretion
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was present probably due to medication treatment of his psychotic behaviour 
(Fluanxol, Nozinan and Orpenadrine).
3. Biochemical abnormalities of purine and pyrimidine metabolism (n=6)
Uraciluria was present in 6  patients (Table VI). Postprandial ammonia was 
measured in the patients U-2 and U-3 and was normal. Patient U-1 was mentally 
retarded and presented dysmorphic features. Patient U-4 presented dysmorphic 
features of mild Cornelia de Lange syndrome and patient U-5 had distinct 
neurological symptoms with atrophy of shoulder muscles and facial dystonia.
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C h a p t e r  4
D y s m o r p h o l o g y  a n d  m e n t a l  r e t a r d a t io n
Content Chapter 4
4.1 Description of patients with dysmorphic syndromes
4.1.1 Zimmermann-Laband syndrome in a patient with severe mental 
retardation (Genet Couns 6:321-327, 1995)
4.1.2 Fountain syndrome: Further delineation of the clinical syndrome and 
follow-up data (Genet Couns 7:177-186, 1996)
4.1.3 Björnstadt syndrome in a patient with mental retardation. (Genet Couns 
9:201-204, 1998)
4.2 Molecular cytogenetic studies in dysmorphic mentally retarded patients
4.2.1 Dysmorphology and mental retardation: molecular cytogenetic studies
in dysmorphic mentally retarded patients. (Ann Génét, accepted)
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4.1 D e s c r ip t io n  o f  P a t ie n t s  w it h  D y s m o r p h ic  S y n d r o m e s
4.1 .1  Z im m e r m a n n -l a b a n d  S y n d r o m e  in  a  P a t ie n t  w it h  S e v e r e  
M e n t a l  R e t a r d a t io n
G.J.C.M. Van Buggenhout1, H.G. Brunner1, J.C.M. Trommelen2 and B.C.J. Hamel1
department of Human Genetics, University Hospital Nijmegen, The Netherlands; 
institution for Mentally Retarded Patients, Huize Assisië, Udenhout, The Netherlands.
A b s t r a c t
The Zimmermann-Laband syndrome (ZLS) is a rare autosomal dominant 
disorder characterized by gingival hyperplasia or fibromatosis, various skeletal 
anomalies including dysplasia of the distal phalanges of thumbs and halluces, 
vertebral defects, and hepatosplenomegaly. Thus far, 23 cases, including 11 patients 
from 2 families, have been reported. Most cases of ZLS have a normal intelligence 
although some cases are mildly retarded. Differential diagnosis includes other 
causes of gingival hyperplasia.
We report on a patient with ZLS and severe mental retardation and review the 
literature.
We conclude that severe mental retardation is a feature of the syndrome. 
In t r o d u c t io n
The Zimmermann-Laband syndrome is a rare autosomal dominant disorder 
characterized by gingival hyperplasia or fibromatosis, various skeletal anomalies 
including dysplasia of the distal phalanges of the halluces and thumbs, vertebral 
defects, and hepatosplenomegaly. The first two patients were described by 
Zimmermann (15). Most patients reported have a normal intelligence. There are a 
few patients with a borderline intelligence and one patient with severe mental 
retardation. We report on another patient with severe mental retardation and review 
the literature.
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C a s e  R e p o r t
The proband, a 54 year-old male, was severely mentally retarded. He was the 
fourth child of healthy non-consanguineous parents. He had 3 healthy siblings. At 
birth, his father was 38 years old and his mother 36 years old. There was no family 
history of either mental retardation or ZLS. Birth weight was 4.5 kg (>97th centile). 
The absence of thumb- and halluxnails was noticed. He showed mental retardation 
at the age of 2 years. Because of seizures anti-epileptic therapy with phenobarbital 
and diphantoin was started at age 7 years. Multiple root remnants and fibromata of 
the upperjaw  were surgically removed at age 53 years.
Clinical examination showed a wheel-chair bound male with a heigth of 165 cm 
(3rd-10th centile) and a weight of 51 kg (3rd centile). Head circumference was 57 
cm (50th-97th centile). Craniofacial features included a coarse face with poor 
expression, a full fleshy nose, hypoplasia of zygoma and maxilla, downslanting 
palpebral fissures, ptosis (L>R), strabismus divergens, retrognathia, a flat philtrum, 
a high narrow palate, absence of teeth and gingiva hyperplasia (Fig. 1 ,2 ). Hair 
implantation on the skull was thin with bushy eyebrows, but hair structure and 
distribution on the rest of the body were normal. Because of tonic-clonic seizures, 
carbamazepine was prescribed. Hearing was normal. Truncal obesity was present; 
there was no hepatosplenomegaly. He had scoliosis and paresis of both legs with 
contractures of the hips and right knee. Thumbnails were absent but the other 
fingernails were normal (Fig. 3). Phalangealjoints were hyperextensible. Feet were 
short with absent halluxnails and hypoplastic toenails (Fig. 4). The Vineland 
Adaptive Behavior Scale showed severe psychomotor retardation.
Figures 1&  2
Facial appearance and profile Qf the patient
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Figure 3
Left hand, nQt the absent thumbnail.
Technical  Investigations
Figure 4
HypQplatic tQenails and absent hallux­
nails
Radiologic investigation of hands and feet showed subluxation of both thumbs 
with short, broad distal phalanges. Distal phalanges of second and fifth fingers of 
both hands were hypoplastic (Fig. 5). Halluces were short, broad and hypoplastic 
and distal phalanges of the other toes were also hypoplastic (Fig. 6 ).
Cytogenetic investigation showed a normal male karyogram: 46,XY (Fragile X 
negative). Screening for inborn errors of metabolism was normal.
Figure 5
X-ray Qf the right hand, nQte 
subluxatiQn Qf the thumb and the shQrt, 
brQad distal phalanges and the 
hypQplastic distal phalanges Qf the 
secQnd and fifth fingers
Figure 6
X-ray Qf the right fQQt, nQte the 
shQrt, brQad and hypQplastic hallux 
and the hypQplastic distal phalanges 
Qf the Qther tQes
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D isc u ssio n
The diagnosis of ZLS in our patient was based on the typical clinical findings: 
coarse face with full fleshy nose, high narrow palate, gingival hyperplasia, scoliosis, 
dysplasia of the distal phalanges of thumbs and halluces with absent thumbnails and 
halluxnails and hypoplastic toenails.
Differential diagnosis includes other causes of gingival hyperplasia which are 
shown in Table I and the DOOR syndrome (deafness-onycho-osteo- 
dystrophy-retardation) (5,6,14). Although anti-epileptic therapy can cause gingival
Table I: Differential diagnosis of gingival hyperplasia (GH)
A. With other abnormalities
Name Birth defects 
MIM
Major manifestations Inheritance
Cowden Syndrome 0412
*158350
GH-hypertrichosis 
fibroadenomas of breasts
AD
GH-hypertrichosis 0410
135400
GH+hypertrichosis AD
Jones Syndrome 2315
*135550
GH-sensorineural hearing 
loss
AD
Rutherfurd Syndrome 0408
*180900
GH-corneal dystrophy AD
Zimmermann-Laband 0409
*135500
GH-digital anomalies AD
Cross Syndrome 0413
*257800
GH-athetosis-
depigmentation
microphtalmia
AR
Puretic Syndrome 0411
*228600
GH-multiple hyaline 
fibromas
Murray syndrome
AR
Ramon Syndrome 2610
266270
GH-cherubism-seizures
hypertrichosis
AR
B. Without other abnormalities
Autosomal dominant 
Autosomal recessive
Exogenous (drugs eg. phenytoin, cyclosporin A) 
Unknown
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hyperplasia, it does not explain the other features in our patient. Unfortunately, we 
do not know whether gingival hyperplasia was present before anti-epileptic therapy 
was started. Mental retardation and epilepsy are common components of syndromes 
associated with gingival fibromatosis. These other syndromes are clearly different 
from the patient reported here. The diagnosis of DOOR syndrome was rejected 
because of the absence of sensorineural hearing loss and characteristic facial 
dysmorphism in our patient.
Twenty-three cases of Zimmermann-Laband syndrome (10 males and 13 
females) have been reported. In Table II, the main clinical features of ZLS are 
summarized. Of 3 patients, only data on the presence of gingival hyperplasia and 
aplasia of the nails were available (cases 15, 16 and 17). Included are 2 families 
with autosomal dominant inheritance. In one family, a mother, her 2 sons and 3 
daughters were affected (11). In the second family, a mother, her 3 sons and 1 
grandson had ZLS (1). The 12 other patients were sporadic cases and were probably 
a result of a new mutation. Of the 23 cases with ZLS, 5 patients were mildly 
mentally retarded (cases 2, 4, 18, 21 and 22) and 1 patient had a mildly delayed 
motor development (case 23). Chodirker et al. (7), described one patient with "ZLS 
and profound mental retardation" (case 19). This patient was also the only other 
patient with epilepsy and anti-epileptic therapy. To our knowledge, our patient is 
the second case of ZLS with severe mental retardation. We conclude that severe 
mental retardation is a feature of the syndrome. Although the two patients with 
severe mental retardation were sporadic cases, more cases should be reported to 
evaluate the relevance of this finding for genetic counseling of patients and families 
with ZLS. Heterogeneity in an autosomal recessive syndrome or variable expression 
may be possible explanations but the most probable explanation, however, is a 
contiguous gene syndrome in ZLS.
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Table II: Zimmermann-Laband: Main clinical features
Case Reference Sex Age Mental
Retardation
GH Facial
features*
HepaVo-
spleno­
megaly
Nails1 Hands2 Feet3 Vertebral
defects
1 Zimmermann
(15)
M 16y - + 5 - + + + + (spina 
bif.occ.)
2 Zimmermann
(15)
F 10y mild + 1;3;4 - + ND ND -
3 Jacoby et al. 
(10)
F 2,5y - + 2 - + + +4 + (spina 
bif. occ.)
4 Laband et al. 
(11)
F 38y low level + 1;2 + - + - -
5 Laband et al. 
(11)
M 14y - + 1;2 + + + - -
6 Laband et al. 
(11)
F 13y - + 1;2 +
hepaVom.
+ + - -
7 Laband et al. 
(11)
M 12y - + 1;2 +
splenom.
+ + - +
kyphosis
8 Laband et al. 
(11)
F 8y - + 1;2 + + + - -
9 Laband et al. 
(11)
F 5y - + 1;2 - + + - -
10 Alavandar (1) F 59y - + 1;2 - + + + -
11 Alavandar (1) M 29y - + 1;2 - - + + -
12 Alavandar (1) M 23y - + 1;2 + - + + -
13 Alavandar (1) M 16y - + 1;2 +
hepaVom.
- + + -
14 Alavandar (1) M 9
mth
- +5 - - - + + -
15 Atanasov et
al. (2)
F? 16y ND + ND ND + ND ND ND
16 Atanasov et
al. (2)
M? 23y ND + ND ND + ND ND ND
17 Atanasov et
al. (2)
M? 65y ND + ND ND + ND ND ND
18 Oikawa et al.
(13)
F ND mild + 1;2;4;5 +
hepaVom.
+ + + +
kyphosis
19 Chodirker et 
al. (7)
M 30y profound + 1;2;3;4 - + - -4 +
scoliosis
20 Beemer (4) F 20y - + 1;3;4 - + + + -
Dysmorpholosy and mental retardatiQn 191
Table II continued
Case Reference Sex Age Mental
RetardatiQn
GH Facial
features*
HepatQ-
splenQ-
megaly
Nails1 Hands2 Feet3 Vertebral
defects
21 de PinQ 
NetQ et al. 
(8)
F 8[ mild + 1;2;3 + + -6 +4
22 BaZQpQulQU 
et al. (3)
F 8[ mild + 1;3;5 - + + + -
23 LacQmbe et 
al. (12)
F 8
mth
mild?7 + 1;2;4;5 +
hepatQm.
+ + + ND
24 Present
repQrt
M 54y severe + 1;2;5 - + +6 +4 +
scQliQsis
*Facial features: 1: bulbous soft nose; 2: thick floppy ears; 3: large tongue; 4: thick lips; 5: 
full eyebrows
'Nails: aplasia or dysplasia; 2Hands: distal phalanges absent or dysplastic; 3Feet: distal 
phalanges absent or dysplastic; 4abnormal shape distal phalanx of the hallux; 5thickened 
epithelium on the alveolus; ^abnormal shape distal phalanx of the thumb; 7motor 
development was mildly delayed
ND: No Data; - : not present; + : present; GH: Gingival hyperplasia; Hepatom.: 
Hepatomegaly; Splenom.: Splenomegaly; Spina bif. occ.: Spina bifida occulta
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Abstract
We present five patients with the clinical diagnosis of Fountain's syndrome, an 
autosomal recessive entity with mental retardation, deafness, skeletal abnormalities 
and coarse face with full lips as cardinal features and review all cases reported so 
far. We report two new isolated cases, and present follow-up data on three 
previously reported patients. The clinical features of all these patients are presented 
to further delineate the clinical picture and the natural course of this rare syndrome. 
We propose that epilepsy, short stature, large head circumference, broad, plump 
hands and the remarkable behavior are important accessory findings of this 
syndrome. The clinical features of this syndrome become more evident with 
advancing age.
Introduction
Fountain (1) described in 1974 a family with four members with a specific 
clinical picture including mental retardation, deafness, skin granulomata, and bone 
abnormalities. Fryns et al. (2,3) reported 3 moderately to severely mentally retarded 
males (2  brothers and 1 sporadic male patient) with congenital deafness due to an 
inner ear anomaly, facial plethorism and skeletal anomalies. We describe two new 
isolated patients and present follow up studies of the three patients described by 
Fryns et al. (3) to delineate the clinical picture and the natural course of this 
syndrome.
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C a s e  R e p o r t s  
Patient 1
The patient, (AA), now 50-years-old and institutionalized from the age of 10 
years, was a moderately mentally retarded male. He was the first child of healthy, 
non-consanguineous parents. The second pregnancy ended in a stillborn girl. His 
only brother was healthy but had severe perceptive hearing loss. Pregnancy was 
uneventful. He was born at term. Birth weight was 3,250 g (25th centile). 
Psychomotor development was delayed. He could sit at the age of 3 years, walked 
at 4 years and developed speech at 5 years (Figure 1A). At age 10 years, he weighed 
26 kg (10th-25th centile) with height of 118 cm (7 cm < 3rd centile) and head 
circumference of 52 cm (25th centile). Clinical investigation showed abdominal 
obesity, lumbosacral lordosis, thick skin, undescended right testis, hypotonia of the 
upper and lower extremities, and a large, curved tongue. His total psychological 
score was 4 years 5 months. At age 19 years, severe vision loss due to high grade 
myopia was diagnosed and corrected with vision aids. When he was 27 years, he 
weighed 53 kg (1 kg < 10th centile) with height of 158 cm (4 cm < 3rd centile) and 
headcircumference of 58 cm (97th centile). He had severe vision problems, high 
and small palate, absent right testis, and weak motor development of both legs. Age 
36, severe bilateral hearing loss was confirmed with a loss of 50 to 70 dB on the 
right and 65 to 80 dB on the left ear. He suffered since one year from chronic otitis 
media. Two years later, myopia gravis was found at the left eye with an ulcer of the 
cornea and glaucoma of the right eye for which he was treated with laser therapy. 
At age 44 he was helped with a hearing device at the left ear. Recently, he became 
totally blind. He suffered from chronic infections of the upper respiratory tract.
Present investigation showed a very friendly, well nourished, short statured male 
with a height of 159 cm (3 cm < 3rd centile) and weight of 67.5 kg (50th-75th 
centile). He had a turricephalic skull with a head circumference of 59.5 cm (0.5 cm 
> 97th centile) and sparse hair implantation. He had a coarse face with thick 
eyebrows, downward slanting palpebral fissures, blindness and a chronic 
conjunctivitis of the left eye (Figure 1B). His ears were asymmetrical, with a rather 
simple structure and hair on the helices, and measured 7 cm (75th to 97th centile) 
(right ear) and 7.5 cm (97th centile) (left ear). He had a flat midface, large mandible 
and large open mouth with thick full lips and high palate. The skin of the cheeks 
was very soft. There was truncal obesity, hypotonia of the abdominal muscles, and 
small testes. Bilateral cubitus valgus was noticed. The hands were broad and large 
with a total hand length of 20 cm (>97th centile) and relatively short fingers. On the 
right hand there was a simian crease. X-rays of hands, skull and spine showed
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Figure 1A & B
AggravatiQn Qf the facial cQaseness and full lips in patient 1
general osteoporosis, plump aspect of the hands with tufting of the distal phalanges, 
and sclerosis of the skull base and plathyspondyly. Chromosomal analysis on a 
peripheral blood lymphocyte culture showed a normal 46,XY male karyotype. DNA 
studies were performed to exclude the fragile-X syndrome. The result of an 
extensive screening for inborn errors of metabolism was normal and excluded 
mannosidosis and aspartylglycosaminuria.
Patient 2
This boy, R.d.J., was the second child born to healthy, nonconsanguineous 
parents. The family history was negative for mental retardation. His mother was 22 
and his father 25-years-old at the time of his birth. He was born after an uneventful 
pregnancy and delivery at gestational age of 40 weeks, with a birth weight of 
3,100g (10th-25th centile). An omphalocoele was detected at birth and surgically 
corrected on the first postnatal day. The neonatal period was complicated by a 
sepsis and bacterial arthritis of the left hip resulting in necrosis of the femur head. 
There were neonatal feeding problems and recurrent infections. The boy was able 
to walk with support at age 18 months and without support at age two and a half 
years (Figure 2A). There was an extreme delay in language development and 
deafness was suspected. At age 4 years sensorineural deafness was confirmed by 
electrocochleography: no response was detectable below 2 kHz. At age 5 years 
nocturnal epileptic attacks developed, that worsened with advancing age (Figure 
2B). Seizures were of generalized tonic-clonic type. Interictal EEG's were normal 
until age 16 years. After that age a slowing of the background activity appeared to 
correlate with mental regression and increase of seizures during the day. Cerebral 
CT scans at age 13 and 16 years were normal. At age 11 years bilateral
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orchidopexia was performed.
Physical examination at age 17 years showed a moderately mentally retarded 
boy with length of 175 cm (25th centile) and head circumference of 55.5 cm (50th 
centile). He had an extremely friendly and optimistic behavior. There was 
brachycephaly with broad forehead. Mild hypertelorism, with ICD of 3,5 cm (75th 
to 97th centile) and OCD of 10,2 cm (97th centile), and ptosis of the eyelids were 
seen (Figure 2C). The ears were slightly posteriorly rotated and ear pits were 
bilaterally present. The nose was large with bulbous tip (septum and alae nasi). The 
mouth was large with full lower lip. The palate was extremely high and narrow with 
hyperplasia of the gums. There was no oligodontia. Retrognathia and broad neck 
were noticed. There was acne. Scoliosis was present and was ascribed to a 
post-infectious shortening of the left femur. Hand length was 18 cm (50th centile), 
the palms of the hands were short with palm length of 9,5 cm (10th centile), and the 
fingers were stubby.
Figure 2A, B & C
AggravatiQn Qf the facial cQarseness and full lips patient 2
Chromosomal and ophthalmological investigations revealed no abnormalities. 
Screening for inborn errors of metabolism was normal and excluded mannosidosis 
and glycosaminuria. In the cerebrospinal fluid (CSF) there was a slight increase of 
neuron specific enolase (15.7^g/l; Normal: 1.6-14.5 |ig/l) and of S-100 (7;1 |ig/l; 
Normal 0.9-5.5 |ig/l) compatible respectively with neuronal and glial damage. No 
HbH bodies were detectable in peripheral blood. Cerebral MRI scan at the age of 
17 years showed T2W signal increase in semi-ovale centers bilaterally and normal 
subcortical U-fiber myelinisation. An X-ray of the skull showed sclerosis of the
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basis of the skull. X-rays of the hands confirmed the plump aspect of the hands, 
tufting was within the normal ranges. The skeletal age was 15 years at chronological 
age o f17  years.
Patient 3
The patient, PV, now 43-years-old, was the first child of healthy unrelated 
parents. His sister was normal and had two normal boys. His brother (patient 4) was 
mentally retarded and deaf. These two brothers were reported by Fryns et al. in 
1987 (3). PV was born after an uneventful pregnancy at term with birth weight of 
4,150 g (90th centile). At age 3 months, he developed hypsarrhythmia with seizures 
which were difficult to control despite ACTH therapy. Later he developed grand 
mal epilepsy and focal seizures of the left arm. Deafness was noted at age 15 
months. Clinical investigation at age 29 years showed a mildly retarded male with 
height of 170 cm (25th centile), weight of 62 kg (25th-50th centile) and a head 
circumference of 55 cm (25th-50th centile). He had a peculiar round and coarse face 
and with mild swellings of the subcutaneous tissue of the lips and cheeks. His hands 
and feet were short and broad with short and broad terminal phalanges. 
Ophthalmological, biochemical and metabolic investigations were normal. 
Cytogenetic investigation, including G- and R-banding, showed normal male 
karyotype 46,XY. Profound sensorineural hearing loss with rudimentary hearing at 
the lowest frequencies was noted on audiometry; the vestibular function of the ear 
was normal. The pars petrosa of the temporal bones showed anomalies on the 
cochlea on X-ray tomography. X-ray of the skull showed thickness of the calvaria 
and X-rays of the hands and feet confirmed the broad and plump aspect of the hands 
and feet. Since a few years he worked in a sheltered workshop, before he worked 
as a butcher. At age 42 years he was hospitalized several times because of severe 
epileptic attacks.
Present investigation showed a mildly mentally retarded male in good general 
condition. His length was 170 cm (25th-50th centile), weight of 65 kg (50th-75th 
centile) and head circumference of 58.6 cm (97th centile). He had severe hearing 
loss and there was no speech, but he could communicate by using hand movements. 
He had a very friendly personality. He had long and coarse face, with high forehead 
and flat midface. There was synophrys and OCD was 10.5 cm (>97th centile) and 
ICD 3.3 cm (75th-97th centile). Lips were full and everted, the skin of the cheeks 
was soft with loose subcutaneous tissue (Figure 3A). Hands were broad and plump 
with total hand length of 19.5 cm (97th centile) and palm length of 11.5 cm (75th- 
97th centile).
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Patient 4
This patient, LV, was the younger brother of patient 3. He was a 36 years old 
and severely mentally retarded. Pregnancy was uneventful. Birth weight was 3,900 
g (75th-90th centile). At age 3 months he developed infantile spasms which later 
resulted in generalized convulsions. Psychomotor development was moderately to 
severely retarded. He could walk at 18 months of age. Profound hearing loss was 
diagnosed at that time. Since the age of 5 years he was institutionalized. At age 18 
years, he showed mental regression. Physical investigation at 26 years showed a 
severely mentally retarded male with height of 172 cm (25th-50th centile), weight 
of 65.5 kg (50th-75th centile) and head circumference of 55.5 cm (50th centile). He 
had long coarse face with open mouth and full everted lips, high palate, small teeth, 
and mandibular prognatism. The swelling of the subcutaneous facial tissues, 
especially of the lower lip, became more evident between 13-26 years of age. He 
had generalized hypotonia and thoracolumbar scoliosis. Hands and feet were broad 
and plump. Screening for inborn errors of metabolism was negative. Chromosomal 
investigation showed normal male 46,XY karyotype. Audiometry showed severe 
sensorineural hearing loss with normal vestibular function. X-ray investigation of 
hands and feet showed thickened corticalis without ossification anomalies. X-ray 
of the skull showed marked thickness of calvaria. Tomography of the pars petrosa 
of the left temporal bone showed a congenital anomaly of the left inner ear. The 
cochlea was replaced by a simple cavity. Ophthalmological investigation was 
normal.
Figure 3A & B
Facial appearance Qf the 2 brothers at the present age Qf 43 years in patient 3 (A) 
and 36 years in patient 4 (B)
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Present investigation showed a severely mentally retarded male with height of 
172 cm (25th-50th centile) and weight of 65.5 kg (50th-75th centile). He had no 
speech, but he could communicate by using simple hand movements. He had an 
extreme friendly behavior. He looked microcephalic, although his head 
circumference was 55.5 cm (50th centile). His face was long and coarse, with flat 
midface and long forehead. There was pro-optosis with OCD of 11.5 cm (>97th 
centile) and ICD of 2.8 cm (25th-50th centile). He had extreme full everted lips, 
high palate, and coarse nose (Figure 3B). Pectus excavatum, lumbar scoliosis, and 
hypotonia of the abdominal muscles were noted. Hands were broad with lower 
implantation of the thumbs, and he had flatfeet.
Patient 5
The patient, W.V.L., a 26-year-old severely mentally retarded male, was the 
second born of three children. His two sisters were normal. There was no 
consanguinity and both parents were in good health. Pregnancy was uneventful. 
Birth weight was 2,750 g (25th-50th centile) at 36 weeks. Psychomotor 
development was severely delayed. When he was 2 years old, a round, plethoric 
face and short stubby hands and feet were noted. At age 4 years, he was severely 
retarded and could not walk or speak. His height was 93 cm (3rd centile), weight
15.2 kg (25th centile) and head circumference 51.5 cm (50th-75th centile). The 
diagnosis of complete bilateral sensorineural deafness was made at this age. He was 
institutionalized at age 6  years. Physical investigation at 17 years of age (see Fryns 
et al. (3)) revealed severe mental retardation, deafness, edemateous coarse face with 
thick everted lips, full cheeks, and depressed nasal bridge. Hands and feet were 
short and plump and X-ray confirmed the presence of broad, heavy phalanges and 
metacarpals with thick cortices but whithout ossification defect. Length was 143.5 
cm (<3rd centile). He had severe motor impairment and could hardly walk without 
support. Screening for inborn errors of metabolism was normal and chromosomal 
investigation showed normal male karyotype: 46,XY.
Present investigation showed a severely mentally retarded male with height 163 
cm (1cm > 3rd centile), weight 67.5 kg (50th-75th centile) and head circumference 
58.5 cm (97th centile). The span was 167.5 cm. His behavior was very friendly. 
There was no speech. He had coarse face with normal midface and large mandible. 
There was acne. He had small eyelashes with epicanthus (Figure 4A). He had full 
lips and the lower lip was everted. Hairline was low and the nose was very coarse 
(Figure 4B). Thorax was barrelshaped and there was abdominal obesity. There was 
bilateral camptodactyly of 5th fingers. He walked atactic and the musles of the 
lower extremities were hypoplastic.
200 Part 2 - Chapter 4
Figure 4A & B
Facial appearance Qf patient 5 at the age Qf 26 years
D isc u s s io n
Mental retardation, deaf mutism and skeletal abnormalities were first reported 
by Fountain in 1974 (1), in a family with 4 affected sibs. The two oldest children, 
a girl and a boy, had also gross papular swelling of the skin of the cheeks, upper lip 
and chin. The fourth child died and had spina bifida. X-rays of the skull of the 3 
oldest children showed thickened calvarium. The mental retardation and deafness 
became more clear at age 2-3 years.
Patients 3,4 and 5 of this report were first published by Fryns et al. in 1987 (3). 
Follow-up data of these three patients are presented in this report. The abnormal 
facial appearance in all three patients became more evident. Patient 3 suffered from 
severe epileptic attacks, for which hospitalisation was neccesary during the last 
years. Due to change in therapy his clinical condition improved. His brother (patient 
4) and patient 5 did well and had no specific health problems.
Of the two new patients with Fountain syndrome, described in the present 
report, patient 1 was a moderately mentally retarded patient and he was the only 
patient in his family. However, his brother had a severe hearing loss and was helped 
with hearing aids but he was not mentally retarded and had a normal phenotype. 
Patient 2 had delayed psychomotor development and he had severe epileptic insults. 
He was also the only patient in his family. Table I gives an overview of all reported 
and present cases.
Of the five present patients there were three patients with epilepsy (cases 2, 3 
and 4), three with rather large headcircumference (cases 1, 3 and 5), two with
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thoracal abnormalities (cases 4 and 5) and two with scoliosis (cases 2 and 4). All 
patients had coarse face, mental retardation, deafness and broad plump hands. Small 
stature is noticed in two patients (cases 1 and 5) and was also noted in the first 
patient of Fountain (girl) (1). Patient 1 had also severe myopia leading to blindness. 
An omphalocoele, which was corrected the first postnatal day was noted in patient
2. Noteworthy is the remarkable behavior of all patients who were extremely 
friendly.
Differential diagnosis includes Coffin-Lowry syndrome, alpha-thallassemia 
syndrome and Melkersson-Rosenthal syndrome. Coffin-Lowry syndrome is 
characterized by hypoplastic appearance of the distal phalanges and dysplasia of the 
vertebral bodies. In alpha-thalassemia syndrome, hearing is normal and inclusions 
of hemoglobin in red blood cells are observed. Melkersson-Rosenthal syndrome is 
an autosomal dominant disorder without mental retardation and without deafness; 
and swellings of the gums, cheeks, and lips can be seen. Fountain (1) wrote in a 
subscript of his publication that "a substance, probably aspartylglycosaminuria, has 
now been isolated", but further data were lacking. In our patients 
aspartylglycosaminuria was excluded.
Considering all the patients that have been reported up to now, we conclude that 
the mode of inheritance in Fountain syndrome is most likely autosomal recessive. 
Follow-up studies showed that the parents of the sibs, reported by Fountain, came 
from the same part of London (1). In the two brothers, reported by Fryns et al. (2, 
3), X-linked inheritance is possible, although there were no other patients in their 
family. The other three patients were sporadic cases.
The clinical signs in the two new described patients matched well with the 
previous reported ones (2). We propose that epilepsy, short stature, large head 
circumference, broad and plump hands and the friendly behavior are accessory 
features of this syndrome. Follow-up data suggest that the clinical picture becomes 
more clear with advancing age with extreme coarsening of the face and severe 
hearing impairment. The follow-up data of cases 2 and 4 suggest possible slow 
decline in mental functioning, which is associated in patient 2 with CSF changes 
compatible with cerebral degeneration. Follow-up in patient 3 showed an evolution 
to difficult to treat epilepsy.
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Table I: Features in the Fountain syndrome : review
Reference Fountain (1) Fountain (1) Fountain (1) Fountain (1) Present case 1
Age (yrs) 22 24 21 ND 50
Sex F M M ND M
MR + + (IQ75) + + moderate
Epilepsy ND ND ND ND -
Deafness + + + ND +
OFC ND ND ND ND 59.5cm (>P97)
Face coarse coarse ND ND coarse
Midface ND ND ND ND flat
Eyes ND ND ND ND blind/thick
eyebrows
Lip/cheek full/swelling full/swelling normal ND full/swelling
Length 150cm
(lcm<P3)
ND ND ND 159cm (3cm<P3)
Thorax normal ND ND ND normal
Hands ND ND ND ND broad/relative short 
fingers
Feet ND ND ND ND normal
Behavior ND ND ND ND friendly
X-ray skull thickening
calvarium
thickening
calvarium
thickening
calvarium
ND ND
Other gingival
hypertrophia
spina bifida high palate
ND = no data, M = Male, F = Female, MR = Mental retardation, + = feature is present, 
- = feature is not present, P = centile
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Present case 2 Present case 3 
(Fryns et al. (3))
Present case 4 
(Fryns et al. (3))
Present case 5 
(Fryns et al. (3))
17 43 36 26
M M M M
moderate mild moderate severe
+ + + -
+ +
sensorineural
+
sensorineural
+
55.5cm (P50) 58.6cm (P97) 55.5cm (P50) 58.5cm (P97)
coarse coarse/long coarse/long coarse
normal flat flat normal
ptosis/hypertelorism synophrys pro-optosis small eyelashes/ 
epicanthus
full full/swelling full/swelling full/swelling
175cm (P25) 170cm (P25-P50) 172cm (P25-P50) 163cm (P3)
normal normal pectus excavatum barrel shaped
stubby/short hands broad/short terminal phalanges broad/plump short/plump
normal normal normal short
friendly friendly friendly friendly
normal
MRI: increased 
signal
thickening
calvarium
thickening
calvarium
ND
ear pits 
large nose 
hyperplasia gums 
scoliosis 
omphalocoele
coarse nose 
scoliosis
coarse nose, 
large mandible 
atactic walk
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A b s t r a c t
Pili torti or twisted hair can appear as an isolated defect, in association with 
other ectodermal defects, in association with other clinical features or can be 
acquired. Björnstad syndrome is a rare condition with apparent autosomal recessive 
inheritance, characterized by hearing loss and twisted hairs (pili torti). All patients 
with Björnstad syndrome reported thusfar have normal intelligence. We report on 
a patient with severe mental retardation and review the literature.
Introduction
Anomalies of the hair are a main feature in several developmental defects. Pili 
torti or twisted hair can appear as an isolated defect, in association with other 
ectodermal defects, in association with other clinical features or can be acquired.
Björnstad syndrome is a rare condition characterized by sensorineural hearing 
loss and twisted hairs (pili torti) (1). Additional reports have been published (2, 
6-10). All patients with Björnstad syndrome reported thusfar have normal 
intelligence. We report on a patient with pili torti, hearing loss and severe mental 
retardation and review the literature.
C a s e  R e p o r t
The index patient of this report is a 57-years-old severely mentally retarded 
male. He was the 6 th child of healthy non-consanguineous parents. His 8 brothers 
and sisters are healthy and also their children. Pregnancy and birth were uneventful.
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Psychomotor development was retarded from the beginning. There was no speech 
development. At the age of 7 years he was hospitalized because of a disorder 
affecting the skin of the skull. No further information was available about this 
disorder, except that he received radiation therapy only. At the age of 52 years, 
severe sensorineural hearing loss of 70 dB on the left side and of 50 dB on the right 
side was diagnosed. He learned some signs of non-verbal communication. He had 
visual agnosia and therefore he suffered from apraxia.
Present investigation showed a severely mentally retarded male, with a length 
of 175.5 cm (50th centile), weight of 60.1 kg (25th to 50th centile) and head 
circumference of 58.1 cm (97th centile). He had a long face. The posterior hairline 
was high (Fig. 1). The hair of the skull was sparse and brittle. The eyebrows and 
eyelashes were sparse. The skin, nails and teeth were normal. There was thoracic 
hyperkyphosis. Speech was absent and communication was poor. He had a bilateral 
pes cavus deformity. Walking was clumsy. He showed a normal behaviour, 
although he was anxious during the examination.
Figure 1
NQte the brittle hair and the high pQsteriQr hairline
T e c h n ic a l  In v e st ig a t io n s
Cytogenetic investigation showed a 46,XY normal male karyotype and 
molecular study of the FMR-1 gene was normal. Screening for inborn errors of 
metabolism was normal. Scanning electron microscopy of the hairs of the skull 
revealed severely abnormal hairs with flattening, grooving, twisting, pili torti, and 
sometimes with the aspect of a pilum triangulatum (Figs. 2 and 3).
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Figure 2
Scanning electron micrQscQpy shQws twisting and flattening Qf the hairs
Figure 3
GrQQving Qf the hairs Qf the skull
D isc u s s io n
The diagnosis of Björnstad syndrome in our patient was based on the association 
of severe hearing loss and the abnormalities of the hair. There were no other clinical 
features of ectodermal dysplasia. A cause for his severe mental retardation could not 
be found. Speech was absent, probably as a consequence of his hearing deficit, 
diagnosed at the age of 52 years only.
Pili torti can appear as an isolated defect or can be found in association with
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other ectodermal abnormalities (9). Acquired pili torti after trauma was excluded 
in our patient, because there was no history of self mutilation. Differential diagnosis 
included other syndromes with pili torti. In Menkes kinky hair syndrome, an 
X-linked disorder, affected males show growth retardation, cerebral and cerebellar 
degeneration, hair abnormalities with trichorrhexis nodosa and have low copper and 
ceruloplasmin serum levels (5). M onilethrix, pseudomonilethrix and 
argininosuccinic aciduria were also excluded in our patient, as none of these 
syndromes is associated with hearing loss (4, 9). Also the syndrome of 
hyperkeratosis palmoplantaris striata - pili torti - hypodontia - sensorineural hearing 
loss described by Egelund and Frentz in a 14 years old female is a different clinical 
condition (3).
In Björnstad syndrome, the main clinical features are sensorineural hearing loss 
in association with pili torti: Björnstad (1965) (1) reported on eight individuals with 
pili torti and five had also sensorineural hearing loss. Two of these five patients had 
affected siblings and one an affected aunt; the two other patients were isolated 
cases. The patients with the most pronounced hair anomalies had the most severe 
hearing problems. The scalp hair, eyebrows and eyelashes were affected (1). Reed 
et al. (1967) (7) reported on 4 additional patients: 3 siblings and one patient whose 
mother was probably affected, but who was not examined. He equally noted that the 
patients with the most severe hair problems also showed severe hearing loss (7, 8 ). 
Voigtländer (1979) (10) reported one family with 2 affected siblings and concluded 
that the syndrome is probably inherited as an autosomal recessive condition. 
Robinson and Johnson (1967) described a female with severe hearing loss and pili 
torti (8 ). Two new families and a restudy of a third family were presented by 
Cremers and Geerts (1979) (2). These authors hypothesized that pili torti is an 
autosomal dominant disorder with low penetrance of a pleiotropic manifestation of 
hearing loss. Two non-related children with pili torti were reported by Scott et al. 
(1983) (9). One of them had sensorineural hearing loss. Their family history was 
negative for hair abnormalities. Petit et al. (1993) (6 ) reported on 3 patients in 1 
family, a mother with two affected children, and equally suggested an autosomal 
dominant inheritance.
In conclusion, the main clinical feature in all patients with Björnstad syndrome 
is pili torti of the hairs of the skull. Eyelashes and eyebrows are not always affected. 
Also, sensorineural hearing loss is not seen in all patients. Therefore, hearing should 
be tested in patients with pili torti in order to offer early treatment and hearing 
devices, certainly in young children with developmental delay.
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A b s t r a c t
In an institutionalised population of 471 mentally retarded adult residents (436 
males and 35 females), 18 patients (16 males and 2 females) with dysmorphic 
features were selected to perform FISH studies by using subtelomeric probes to 
discover cryptic terminal deletions or duplications, undetectable with standard 
banding techniques. In the 13 investigated patients, no abnormalities were found 
with a selected battery of subtelomeric probes. The results of cryptic chromosomal 
rearrangement studies are variable but the frequency of positive diagnostic findings 
seems to be lower than previously expected.
In t r o d u c t io n
Until recently, chromosomal studies were performed according to standard 
procedures and included analysis of 15-20 GTG banded metaphases on peripheral 
blood lymphocyte cultures (18). At present, new molecular cytogenetic techniques 
are available (fluorescence in situ hybridisation techniques (FISH)) (6 ) and are used 
to confirm the clinical diagnosis of a number of well known contiguous gene 
syndromes such as Shprintzen syndrome (velo-cardio-facial syndrome (22q11 
deletion syndrome), Williams-Beuren syndrome (7q11 deletion syndrome; elastin 
gene), Miller-Dieker syndrome (17p13.3); Wolf-Hirschhorn syndrome (4p deletion 
syndrome) and Cri du chat syndrome (5p deletion syndrome). In addition, small
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deletions/duplications, which are not detectable with standard cytogenetic 
techniques, can be discovered by using this method. Also small (familial) 
translocation rearrangements (cryptic translocations) can be found in families with 
apparently normal chromosomes (11, 14).
M e t h o d  o f  t h e  S t u d y
In the present study, out of 471 mentally retarded residents (mean age: 46 years; 
436 males and 35 females) of the Institution for the mentally retarded Huize Assisië, 
Udenhout, The Netherlands, 18 patients with dysmorphic features, without clear 
diagnosis, or with a clinical diagnosis were selected. After an extensive study of 
their clinical file accomplished with a clinical examination and routine 
chromosomal investigation, DNA-studies to exclude the FMR-1 gene mutation 
and/or Angelman syndrome, and screening for metabolic disorders, FISH studies 
were done, by using subtelomeric probes to discover cryptic terminal deletions or 
duplications, undetectable with standard banding techniques. A selected battery of 
subtelomeric probes was used, according to the clinical features in each patient 
(Nijmegen checklist: unpublished data). Table I gives an overview of mental level, 
clinical features and selected panel of subtelomeric probes in each patient. The 
subtelomeric probes used in this study have been described previously (10, 11, 13).
R e s u l t s
In 2 patients (patients 2 and 8) a syndrome diagnosis was made based on the 
clinical features of the patients. Only 13 patients could be investigated, since 3 
patients moved to another institution, one patient died and one patient was not 
investigated (Table I). Until now, no abnormalities were found in this selected 
group of patients (Table I).
D isc u ssio n
In the present study of 13 mentally retarded adults, selected on the basis of their 
clinical phenotype and fam ily h istories, no cryptic chromosomal 
deletions/duplications were detected with a selected battery of subtelomeric probes, 
up to 7 individually adapted probes per case. The patients were selected by the
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Table I: Summary Qf the clinical features and selected panel Qf subtelQmeric probes 
in each patient
Number
Sex
Age
(years)
Pedigree data Mental level Dysmorphic features Selected panel of 
subtelomeric probes
1. Female 33 No familial 
MR
Borderline Cleft palate-divergent 
strabism-sacral dimple
2q,4q,8p,10p,13q,
18p
2. Male 50 No familial 
MR
Mild Weaver syndrome- 
macrocephaly- 
hypertelorism-small mouth- 
small genitalia
1p,5q,8p,11q,16p,
22q
3. Male 46 No familial 
MR
Moderate flat occiput-epicanthal 
folds-hypertelorism-large 
ears-prenatal growth 
retardation
1p,8p,11q,22q
4. Male 46 No familial 
MR
Moderate long face- frontal upsweep- 
hypertelorism-large ears- 
pedes cavi-hearing problems
1p,8q,10q,18q,22q
5. Male 47 Familial MR: 
both parents 
and other sibs
Moderate macrocephaly-frontal 
bossing-downward slanting 
palpebral fissures- 
hypertelorism-hearing loss- 
epicanthal folds-strabismus- 
high palate-bifid uvula­
small genitalia-nystagmus
1q,6q,7p,9q,16q,22q
6. Male 24 Familial MR: 
paternal sibs
Severe macrocephaly-downward 
slanting palpebral fissures- 
hypertelorism-epicanthal 
folds-ptosis-bifid uvula­
hearing loss-corpus 
callosum agenesis- 
cryptorchidism
1p,6p,7p,9q,10p,22q
7. Male 43 No familial 
MR
Severe Clinical features of 
Angelman syndrome­
strabismus
1p,1q,6p,7p,18q,22q
8. Male 50 Familial MR: 3 
sibs (2 
females) and 
maternal 
family
Severe Mild Cornelia de Lange- 
prenatal growth retardation- 
large hypoplastic ears
1p,7p,16p,18q,22q
9. Female 13 No familial 
MR
Severe cleft palate-facial 
asymmetry- broad helices- 
hypertelorism-SS-scoliosis- 
spasticity
1p,6p,7p,10p,18q,
21q,22q
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Table I cQntinued
10. Male 50 No familial 
MR
Profound E-coarse face-synophrys- 
strabismus-hypertelorism- 
large ears-SS- 
macroorchidism
1p,6p,7p,10q,18q,
22q
11. Male 49 No familial 
MR
Profound Macrocephaly-strabismus- 
large mandible-downward 
slanting palpebral fissures- 
pectus excavatum- 
microorchidism
1p,7p,9q,22q
12. Male 36 Familial MR: 
son of maternal 
sister
Profound Clinical features of 
Angelman syndrome- 
microcephaly-prenatal 
growth retardation
1p,1q,7p,10p,10q,
22q
13. Male 51 No familial 
MR
Profound hair abnormalities-facial 
dysmorphism-cutis verticis 
gyrata-thick helices
1p,5q,16q,18p,22q
MR: mental retardation 
SS: short stature 
E: epileptic seizures
clinical geneticists of the Department of Human Genetics, University Medical 
Centre St Radboud, Nijmegen, The Netherlands. A panel of subtelomeric probes 
was selected according to the Nijmegen checklist (unpublished data). Prenatal 
growth retardation and a positive familial history for mental retardation, in addition 
to phenotypic features suggesting a chromosomal abnormality may indicate the 
presence of subtelomeric rearrangements (4). Knight and Flint (9) observed facial 
dysmorphism, minor physical abnormalities of the hands and feet, small stature, and 
microcephaly as consistent findings in patients with moderate or severe mental 
handicap, in combination with a small chromosomal anomaly.
Table II presents an overview of the results of previous studies of subtelomeric 
chromosomal rearrangements in selected groups of patients with idiopathic mental 
retardation or non-specific MR/MCA syndromes.
Slavotinek et al. (14) reported on 27 patients with MR/MCA and there were 2 
patients in whom a small subtelomeric deletion was discovered. Knight et al. (11) 
reported their search for submicroscopic subtelomeric rearrangements and deletions 
in a population of 466 children (284 children with moderate to severe mental 
retardation and 182 children with mild mental retardation) with idiopathic mental 
retardation. Subtle rearrangements were found in 7.4% of moderately to severely 
mentally retarded patients and in 0.5% of the children with mild mental retardation. 
Half of these rearrangements were familial cases with cryptic balanced reciprocal
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translocations resulting in unbalanced derivate chromosomes in the affected family 
members. In these affected individuals no consistent phenotype was present and 
often the diagnosis of "birth injury" was made in the past. Furthermore, they 
concluded that cryptic chromosomal rearrangements are the most frequent 
chromosomal disorder after Down syndrome, and they advised use of subtelomeric 
probes to screen all individuals with unexplained moderate to severe mental 
retardation. Joyce et al. (8 ) (2 abnormal findings in 93 patients) and Lamb et al. (12) 
(1 abnormal finding in 43 patients) found much lower frequencies (2.2%-2.3%). 
Finally, Turner and Partington (15) tested 20 patients with idiopathic mental 
retardation with an incomplete battery of subtelomeric probes, but they found no 
positive cases, as was also experienced in the present study. In the Leuven 
experience, only 1 patient out of 60 ( 1 .6 %), selected on familial mental retardation 
or mental retardation with dysmorphic features, was detected with a cryptic 
chromosomal rearrangement (unpublished data).
Table II: Overview of previous studies on subtelomeric rearrangements
Study Total 
number of 
patients
Frequency
(%)
Clinical information
Flint et al. (6 ) 99 6 % Idiopathic MR
Giraudeau et al. (7) 99 7.4% Idiopathic MR
Slavotinek et al. (14) 27 7.5% Moderate to severe idiopathic MR
Knight et al. (11) 284 7.4% Moderate to severe idiopathic MR
Knight et al. (11) 182 0.5% Mild idiopathic MR
Vorsanova et al. (17) 209 3.8% Mild and severe MR-congenital 
malformations
Viot et al. (16) 17 23% Major criteria: MR, dysmorphic features 
Minor criteria: family history, 
convulsive and behavioural disorders
Anderlid et al. (1) 44 13% Severe MR (n=27), dysmorphic features 
(n=31), family history (n=14)
Joyce et al. (8) 93 2 .2 % Idiopathic MR
Lamb et al. (12) 43 2.3% MR and dysmorphic features
Turner and Partington 
(15)
20 0 % Idiopathic MR
Ballif et al. (3) 154 2 .6 % ND
MR: mental retardation
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With the available experience, the results of cryptic chromosomal rearrangement 
studies are variable but the frequency of positive diagnostic findings apparently 
depend very much on selection criteria of the patients, screening method, and 
number of screened subtelomeric regions.
As these molecular techniques (FISH) for testing subtelomeric rearrangements 
are time consuming and expensive, an alternative approach may be a new technique 
of multiplex amplifiable probe hybridisation (MAPH). Short probes, each 
recognising a unique region of genome DNA, can be recovered and amplified 
quantitatively following hybridisation to genomic DNA. The amount of each probe 
will be proportional to the copy number of the corresponding sequence in the test 
DNA (2). Comparative genomic hybridization (CGH) allows the genome-scale 
detection of complete and partial chromosome gains and losses, and might be a 
powerful tool in the search for small gendose changes in the total genome (5).
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1 I n t r o d u c t io n
Most Dutch mentally retarded adults are residents of institutions for the mentally 
handicapped. Presently, the large majority of these adults have no etiologic 
diagnosis. We expected that systematic etiologic screening of such an institution 
(Huize Assisië - Stichting Prisma) would increase the number of diagnoses. Further, 
we wondered about the changing phenotypes in ageing mentally retarded patients, 
not only the change in physical appearance, but also diagnosis-related medical 
comorbidity and behavioural problems that occur with age. Better knowledge of 
medical and behavioural problems in older mentally retarded patients can be used 
to improve prevention and care. Preventive management offers an important 
opportunity to minimise complications in children and adults with special health 
care needs, and the key to preventive management is a specific diagnosis and 
approach (Wilson and Cooley 2000).
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2 D ia g n o s t ic  in v e s t ig a t io n s  in  m e n t a l l y  r e t a r d e d  a d u l t s
In the present study, the diagnostic approach was initially different for 2 groups 
of residents. In residents with Down syndrome (n=87), a clinical examination and 
routine cytogenetic studies on cultured peripheral lymphocytes were done to 
confirm trisomy 21 .In  the second group, residents were clinically and technically 
extensively investigated. Before systematic evaluation only 21.8% (103/471) of all 
patients had a known diagnosis. After this survey, 47.6% (224/471) of the 
investigated patients had a definite diagnosis explaining the MR (See table 1). Since 
this population consisted mainly of older mentally retarded males, data on early 
childhood, developmental milestones, childhood behaviour and medical history 
were not always complete.
For specific syndromes clinical features and behavioural phenotype are usually 
well known only in childhood. Better insight into the change with age of clinical 
features and behavioural phenotype may be of help for future clinical diagnosis in 
adults with MR. The effect of advancing age on dysmorphic features and the use 
of medication such as anti-epileptics, which lead to coarsening of the face, often 
render the diagnostic process difficult. The presence of severe spasticity, 
contractures and deformities also often preclude instant recognition of a genetic 
syndrome. A specific behavioural phenotype may be of help in making a diagnosis. 
Conversely, the recognition of a specific syndrome may help to predict (and 
sometimes prevent) aberrant behaviour. With advancing age behavioural problems 
may change e.g. decrease because of inactivity (as in Angelman syndrome), or 
increase when undiagnosed sensory problems are present as occurs frequently in 
Down syndrome. Speech problems may lead to behavioural problems as we 
observed in Cri du chat syndrome adults.
Technical investigations in the present study included standard cytogenetic 
investigation (GTG banding) on cultured peripheral lymphocytes. In a selected 
group of patients fluorescence in situ hybridisation studies (FISH) were performed, 
based on the presence of specific clinical features. Recently, Knight et al (1999) 
reported a frequency of 7.4% of subtle telomeric chromosome rearrangements in 
children with moderate to severe mental retardation. In the present study 
subtelomeric microdeletion studies were reserved for a selected group of 13 
patients, with normal results.
Fragile X syndrome (expansion of the CGG repeat in the FMR-1 gene) was 
investigated in the presence of a positive family history (maternal MR) and/or the 
presence of clinical features of the syndrome.
Metabolic investigation was systematically done in 306 of the 471 investigated
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mentally retarded patients. Practical problems were often present, since collection 
of 24-hours urine is difficult to organise in institutionalised MR adults because of 
incontinence or inability to co-operate with the technique of urine collection. In a 
small group of patients (n=15) it was not possible to obtain a urine sample for 
metabolic screening. Patients with Down syndrome (n=87) or with a diagnosis 
made in the past (n=63) were not investigated for metabolic disturbances. There 
were 7 patients with a previous diagnosis of a metabolic disorder, namely 
phenylketonuria (n= 5), mucopolysaccharidosis type III (Sanfilippo syndrome, type 
A) (n=1) and mucopolysaccharidosis type VII (Sly syndrome) (n=1). Of the total 
group of 306 patients screened for inborn errors of metabolism, only 5 (5/306; 1.6 
%) were diagnosed with a "true" metabolic disease. In 4 patients this diagnosis 
explained the MR, namely GM1-gangliosidosis type 3 (n=1) and S-sulfocysteinuria 
(n=3). These patients all presented specific clinical symptoms that suggested the 
presence of a metabolic disease, as well as neurodegenerative behavioural problems. 
In 5 cases, a metabolic disorder was diagnosed that did not explain the MR. One 
patient was diagnosed with Niemann-Pick syndrome type B. Three had 
hyperprolinemia type 1, and one had cystinuria. Screening for Jaeken syndrome 
(Congenital Disorders of Glycosylation; CDG syndrome) was done for the first time 
on a large scale (n=144), but no patient was diagnosed. The number of patients with 
this syndrome among institutionalised mentally retarded may not be as high as 
previously thought. In a small number of patients (n=6 ) a clinically suspected 
diagnosis of Smith-Lemli-Opitz syndrome was not confirmed. The yield of 
screening for metabolic diseases apart from those which had already been 
previously diagnosed, was thus low in this cohort of institutionalised mentally 
retarded adults. In 24 patients we observed repeatedly abnormal values of certain 
metabolites without known significance.
Based on the experience in the present institution, screening of metabolic 
disorders in older institutionalised mentally retarded adults can be restricted to those 
patients with neurodegenerative features or behavioural problems (Van Buggenhout 
et al 2 0 0 1 ).
In the present institution, only a small number of patients was selected for 
magnetic resonance imaging (MRI) (n=14) or computed tomography (CT) (n=11) 
of the brain (criteria: MR and neurological problems), due to budget restrictions. 
Even in this highly selected group few abnormalities were found and none of these 
were diagnostic. The American College of Medical Genetics recommends 
neuro-imaging in patients without a known diagnosis especially in the presence of 
neurological symptoms, macrocephaly, microcephaly or cranial contour 
abnormalities. In most situations MRI is the testing modality of choice (Curry et al
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1997). Brain imaging is especially difficult in severely and profoundly mentally 
retarded patients, since this investigation has to be performed in hospitals and light 
anaesthesia is required to obtain good qualitative results. Often, there is no 
evolutionary comparison possible, since brain CT or MRI was never performed 
before. Follow-up brain imaging studies can be ofhelp  for making diagnosis at an 
older age, for further delineation of the natural history of syndromes and for early 
prevention of syndrome related complications (Curry et al 1997).
A large number of patients (n=69) was diagnosed with an acquired disorder, and 
in almost one third of these patients infectious agents in the postnatal period (i.e. 
meningitis, encephalitis and systemic sepsis) were the cause of the MR. The 
diagnosis of these acquired disorders was important for genetic counselling 
purposes. For several patients with a previous diagnosis of birth complication or 
perinatal asphyxia, this diagnosis was not convincing (not well documented) and 
such patients were included in the study. In some cases a genetic diagnosis was 
subsequently made (i.e. Angelman syndrome and Cri du chat syndrome).
Genetic counselling of the families was provided. Long-term follow-up of the 
patients and re-evaluation to obtain an accurate diagnosis should be included in the 
diagnostic process.
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Table 1: The presence of a (re-evaluated) diagnosis before and after the systematic 
survey of the 471 investigated patients present institution. In 224 patients the 
diagnosis explained the mental retardation. In 14 more patients, the diagnosis 
did not explain the mental retardation: five had a numerical chromosomal 
disorder, four an autosomal dominant disorder and five a metabolic disorder
Number of patients with a Number of patients with a
diagnosis before the diagnosis after the systematic
systematic investigation investigation of 471 patients
(n=103) (n=224)
Chromosomal disorders
Autosomal disorders
Numerical 40 (Down syndrome) 87 (Down syndrome)
Structural 2 7
Sex-chromosomes
Numerical - 1 (and in 5 not explaining the
MR)
M onogenic disorders
A u to s o m a l  d o m in a n t 7 10 (and in 4 no clear relation
with MR)
Autosomal recessive
Syndromic 2 9
Metabolic disorders 7 11 (and in 5 not explaining
the MR)
X-linked disorders
Fragile-X 14 16
Syndromic - 2
Nonspecific - 4
Central nervous system 8 8
malformations
Acquired disorders
Prenatal 3 15
Perinatal 6 27
Postnatal 14 27
Total 103 224
Note: Only patients in whom a genetic defect was documented at the molecular 
level were diagnosed as having definite X-linked non-syndromic mental retardation 
(XLMR). The number of patients with non-specific XLMR may well be much 
higher since 35 males (from 32 families) with idiopathic MR had a family history 
and pedigree data compatible with XLMR.
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3 I m p l ic a t io n s  o f  s y s t e m a t ic  s c r e e n in g  o f  m e n t a l l y  
RETARDED INSTITUTIONALISED ADULTS
3.1 E d u c a t io n a l  a n d  s o c io -e c o n o m ic  im p l ic a t io n s
Children with mild mental retardation attend schools for children with learning 
difficulties. As adults, they will be employed in sheltered working places and live 
independently or in sheltered homes. Moderately mentally retarded children will 
attend special schools, and as adults they are in sheltered working places and 
become institutionalised at some point in their lives, depending on their home 
situations. Patients with severe and profound MR will need as much as possible 
individual speech training and motor skill training, but they will be dependent on 
either home care or institutionalised care.
Traditionally, attention was focused on MR children, adolescents and young adults, 
while the characteristics and needs of middle and old aged MR adults are still 
poorly documented and understood (Seltzer and Kraus 1987; Florez 1989; Evenhuis 
and Nagtzaam 1999).
3 .2  M e d ic a l  a n d  b e h a v io u r a l  p r o b l e m s
3.2 .1  M ed ica l p rob lem s com m on  to  a ll m en ta lly  retard ed  ad u lts
Comorbidity denotes a situation where a person has more than one disease or 
medical condition at the same time. Congenital disorders are rarely found as a single 
condition and most often involve multiple organ systems. The normal ageing 
process adds to these congenital disorders. Moreover, the pathogenic factors that 
lead to the MR, may add new features to the ageing individual in the brain or in 
other organs.
In the general population, the most frequent problems associated with age are 
cardiovascular problems, hypertension, cancer, diabetes, urinary tract infections and 
dementia. In mentally retarded residents specific problems besides these general 
problems appear with ageing, and these are related with the etiological diagnosis.
In most individuals with mental retardation their cognitive level does not seem 
to decline with advancing age, except for Down syndrome, where a decline in 
cognitive capacities is frequent (Silverstein et al 1988).
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Problems that are more frequently reported among the elderly mentally retarded 
are visual and hearing loss, mobility problems with progressive motor impairment, 
epilepsy, language difficulties, emotional and/or psychiatric problems (Seltzer and 
Krauss 1987).
Cardiovascular, digestive, musculoskeletal, hearing and vision loss, respiratory 
and neoplastic problems are found in all levels of MR, with a roughly similar 
frequency. An exception may be that a significant higher incidence of 
musculoskeletal problems was apparent in one study of severely and profoundly 
retarded patients, aged 45-64 years (Janicki and Jacobson 1986). The risk of 
fractures and other musculoskeletal trauma has received special attention because 
fractures are a common medical problem in the mentally retarded, and certainly in 
the group of females (Tannenbaum et al 1989). They often result in considerable 
discomfort, loss of independent function and complications related to inactivity. In 
the age groups of 45 to 64 years, this risk was increased. A high morbidity and 
mortality of 12 to 20% is associated with hip fractures. The presence of seizures did 
not seem to result in an increased risk of fractures. However, the use of drug therapy 
carbamazepine, valproic acid and phenobarbital was associated with higher fracture 
risk (Tannenbaum et al 1989). Gastrointestinal problems are often present in 
bedridden patients, notably reflux, stomach ulceration and constipation.
Ophthalmological and hearing problems are frequently present. The diagnosis 
of these problems is difficult in severely and profoundly mentally retarded. In 
patients with mild or moderate mental retardation standardised screening methods 
for hearing such as play audiometry, speech audiometry or whisper test can be used 
and vision can be tested by using the Landolt ring chart. In the groups of patients 
with more severe level of mental retardation, hearing impairment can be tested by 
free field audiometry and distant vision with Burghardt picture charts (Van 
Buggenhout et al 1999).
Persons with more serious levels of MR are at a higher risk for health problems. 
It has been estimated that severely mentally retarded persons have 2.7 times, and 
mildly mentally retarded persons 2.2 times the number of health problems that 
persons without MR have (van Schrojenstein Lantman-de Valk et al 1997). In 
mildly mentally retarded persons a higher prevalence of deafness, obesity, fractures, 
skin problems and hemorrhoids was found. Severely mentally retarded persons have 
so many other problems that some of the minor health problems found in the mildly 
mentally retarded persons, are not recognised (van Schrojenstein Lantman-de Valk
1998).
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In this study, we evaluated neurological abnormalities in patients with idiopathic 
MR (n=233; 215 males and 18 females). Neurological findings were present in 47 
patients with in 45 central paresis and/or dyskinesia and/or ataxia. Seizures were 
present in one third of the patients (n=77) and this correlated with a more severe 
level ofM R. Patients with severe MR had more neurological problems.
3.2.2 Behavioural problems common to all mentally retarded adults
In the group of profoundly and severely mentally retarded persons, the presence 
of congenital disorders, major central nervous system disorders, sensory handicaps 
such as blindness, strabismus and deafness, severe motor disabilities such as 
cerebral palsy, and seizures, will obviously limit social contacts. When such persons 
cannot express themselves, this lack of active communication may provoke 
aggressive behaviour and self mutilation (Menolascino et al 1986).
Although moderately mentally retarded patients possess some degree of 
receptive and expressive language, self-care and daily living skills, they are at high 
risk ofbehavioural problems. In times of stress, they often react with maladaptive 
behaviour, such as excessive sadness, withdrawal or avoidance. Without adequate 
support they are likely to develop depression (Menolascino et al 1986).
Severe behavioural problems or psychiatric illness are twice as frequent as in 
those without mental retardation. The frequency of dementia in the group of 
patients without Down syndrome is probably comparable with the frequency in the 
general population (Visser 1999). Depression and severe hearing loss are difficult 
to differentiate from dementia, especially in persons with poor verbal capacities. 
Tuinier and Verhoeven (1992) concluded that diagnosing depression in persons 
with poor verbal capacities is very difficult and often impossible.
More knowledge regarding comorbidity would help to improve treatment for 
mentally retarded persons who often have problems in verbalising symptoms and 
signs (Day and Jancar 1994). It would be interesting to learn in prospective 
randomised studies whether educational programs for mentally retarded adults 
really improve behaviour. Overmedication because ofbehavioural problems should 
be avoided in older patients since the sensitivity to the drug and the 
pharmacokinetic profile may be altered.
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3.2.3 Diagnosis-related specific medical and behavioural problems
Persons with Down syndrome are at higher risk for a number of specific 
conditions. However, comorbidity is not well described for other genetic syndromes 
(Evenhuis and Nagtzaam 1999). The present study intended to collect more 
information on comorbidity in Down syndrome and other genetic syndromes.
3.2.3.1 Down syndrome
Disorders due to a chromosomal imbalance often result in a more rapid 
deterioration and frequently there is a shorter life span. This is clearly the case for 
Down syndrome (DS) where specific brain changes are induced by imbalance of the 
genetic material of chromosome 21. Comorbidity is well described in DS and 
includes congenital malformations (notably cardiac and gastro-intestinal 
malformations), immunologic problems, leukemia, hepatitis, hypo- and 
hyperthyroidism, sensory impairments with visual and hearing impairment, 
Alzheimer dementia, psychiatric disorders, atlanto-axial dislocation, obesity, 
cardiovascular disorders, epilepsy, and dental problems. A decline with age in some 
of the cognitive capacities is observed frequently (Silverstein et al 1988). Guidelines 
for optimal medical care were described by a group of international experts 
(Pueschel et al 1995). Borstlap et al 2000 described recently guidelines for children 
with DS. Mitral valve prolapse and aortic regurgitation have been found to be more 
prevalent in adults with Down syndrome, and the clinical diagnosis may be 
confirmed by echocardiographic examination (Pueschel et al 1995). Behavioural 
and psychiatric disorders are frequently present in the group of patients with DS and 
to such patients, specific psychotherapy and medication should be offered (Pueschel 
et al 1995; Van Allen et al 1999).
In our group of DS patients (n=96) dementia was present in almost 20% of the 
patients, increasing to more than 40% of those above the age of 50 years. Epileptic 
seizures were present in 50% of the patients with dementia. Vision loss was present 
in 83% of the patients and in one-third this vision loss was at least moderate. With 
age this percentage increased significantly. Moderate or severe hearing loss was 
present in 70%. Thyroid function was abnormal in almost 50% of the investigated 
patients. These findings confirm the necessity of the implementation of a yearly 
screening in residential DS adults. Such a formal screening program does not yet 
exist in most institutions. The yearly physical examination by the general 
practitioner of the institution should include heart auscultation, screening for thyroid 
dysfunction, for early loss of visual acuity and hearing, and should exclude medical 
or psychiatric causes leading to a dementia-like picture. These recommendations are
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comparable with the Guidelines for optimal medical care (Pueschel et al 1995). 
Objective evaluation of cognitive functioning to diagnose early onset dementia can 
be done by using one of the following questionnaires such as "Sociale 
Redzaamheidsschaal" (SRZ) (Daily living skills) (Kraijer and Kema 1990), "DMR" 
(the Dementia Questionnaire for Mentally Retarded Persons) (DVZ; Dementie 
Vragenlijst voor Verstandelijk Gehandicapten) (Evenhuis et al 1991) and the 
"Observatielijst Ouderwordende Bewoners (OOB) (Observation List for Ageing 
Residents) (Hoefnagel 1989).
3.2.3.2 Cri du chat syndrome.
In the Cri du chat syndrome (deletion of the terminal short arm of chromosome 
5) the dysmorphic features become less striking with advancing age. However, 
marked growth retardation continues into adulthood and results in short stature, 
poor weight gain and microcephaly. The face lengthens and teeth are abnormally 
erupted (Niebuhr 1978). Scoliosis is often present in older patients and is severe in 
half of the cases (O'Brien and Yule 1995).
The findings in our group of patients (n=7) included a history of feeding 
difficulties with poor sucking, chewing and swallowing in almost all patients, and 
these problems were still present at an older age. Four patients developed scoliosis. 
In childhood the problems of self mutilation, head banging, scratching, biting, and 
cruelty to others were often severe. With advancing age these problems decreased. 
They did like teasing, and were often hyperactive. Although their personality was 
generally pleasant, periods of destructive behaviour and aggression were present. 
Most of these periods ofbehavioural problems were related to the inability of verbal 
and/or non-verbal communication.
Stimulation and revalidation of sucking, chewing and swallowing functions by 
occupational therapists and speech therapists may lead to improvement of feeding. 
Offering skills for the use of non-verbal communication from an early age, may be 
of help to prevent behavioural problems.
3.2.3.3 Angelman syndrome
In Angelman syndrome the clinical and behavioural features change with age 
and the phenotype can be rather non-specific. In adult patients there is coarsening 
of the face. Thoracic scoliosis is frequently present, mostly in females. Mobility 
decreases with advancing age, with difficulties of walking and some patients 
becoming wheelchair bound (Buntinx et al 1995). Stimulation and physiotherapy 
may be of help to prevent other complications related to the inactivity. Epileptic 
seizures are still present in adulthood (Laan et al 1997).
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The findings in our patients (n=3) showed severe neurological complications of 
tremor, spasticity and coordination problems, resulting in severe loss of function. 
Craniofacial features were atypical. They had short stature, epileptic seizures, 
microcephaly, brachytelephalangy and absent speech. Two patients presented at an 
older age a change in day-night rhythm. More stimulation of the patients during the 
day was helpful and led to improved sleep at night. This phenomenon of a disturbed 
circadian rhythm warrants further investigation. At a young age Angelman 
syndrome patients are physically hyperactive (actors). With ageing, patients become 
passive, but seek variation by watching other persons (people-watchers). We 
hypothesize that absence of variation makes them uncomfortable and leads to 
behavioural problems. At all ages patients are more interested in persons than in 
objects. Increasing social activities during the day might thus improve both 
behavioural problems and sleeping at night (Van Buggenhout et al, 2000).
3.2.3.4 Fragile X syndrome
In the fragile X syndrome seizures are observed in approximately 20% of young 
affected males, with a lower prevalence in adult males and females (5%). Recurrent 
otitis media and sinusitis are present in 50% of cases and need adequate intervention 
to prevent complications. In 30 to 50% of cases ophthalmologic help is needed 
because of strabismus, myopia and hyperopia. Attention deficit disorder and 
hyperactivity are present in childhood. In adulthood some individuals may show 
aggressive behaviour (De Vries et al 1998).
Major medical complications in the present group of patients (n=16) with the 
fragile X syndrome included epileptic seizures (n=5), moderate hearing loss (n=3) 
and severe loss of visual acuity (n=3). One patient with severe loss of visual acuity, 
had divergent strabismus and myopia. The second patient had divergent strabismus 
and papillary atrophy. The third patient had bilateral cataracts. Behavioural 
problems (n=8) included hyperactivity, self-mutilation with hand biting, and 
aggression. In the ageing fragile X patient, special attention should be given to 
detect early visual and hearing problems and therefore regular screening should be 
provided. Speech therapists and physiotherapists can ameliorate language and motor 
problems.
3.2.3.5 X-linked mental retardation-marfanoid habitus syndrome
In X-linked mental retardation-marfanoid habitus syndrome (Lujan-Fryns 
syndrome) major clinical criteria include mild to moderate mental retardation, 
emotional instability, shyness, psychotic behaviour, marfanoid habitus with long 
hyperextensible fingers and toes, short halluces and long second toes (Fryns and
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Buttiens 1987).
In the 2 moderately mentally retarded adults of the present institution with 
ectomorphic habitus, triangular face, narrow palate and hypernasal voice, no 
psychiatric problems were observed. The first patient presented some autistic-like 
behaviour and both males were very shy.
3.2.3.6 IL1RAPL gene mutation family
In the family with the mutation in the IL1RAPL gene non-specific mental 
retardation was present and the natural history and medical complications are 
unknown. Speech was peculiar and their voice was hypernasal. Behavioural 
problems included self mutilation and aggression.
3.2.3.7 Metabolic disorders
Those metabolic disorders that cannot be controlled therapeutically will cause 
a decline in the function of several organs, including the brain, thereby resulting in 
a more rapid deterioration. The exact pathogenesis of metabolic disorders is not 
always known and the variability in appearance and rate of expression of the 
individual lipid and protein components suggests that there are wide differences in 
vulnerable periods in specific pathways of myelinisation of the white matter 
(Kinney et al (1994)).
The four adults in this study, diagnosed with a metabolic disease, explaining the 
MR, all presented specific clinical symptoms and neurodegenerative or behavioural 
problems. In 5 other patients, a newly diagnosed metabolic disorder could not 
explain the etiology of MR.
3.2.3.8 Fountain syndrome
Fountain syndrome was first reported in 1974 in a family with 4 affected sibs 
who had mental retardation, deafness and skeletal abnormalities (Fountain 1974). 
In our study the clinical picture becomes more clear with advancing age, with 
extreme coarsening of the face, severe hearing impairment and slow decline in 
mental functioning.
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3.3 E a r l y  d ia g n o s is  a n d  t r e a t m e n t  o f  c o m o r b id it y  a c q u ir e d  l a t e r  in  l ife
3.3 .1  A im
The United States Healthy People 2000 program (U.S. Public Health Service, 
1991) set forth 3 goals: 1. Increase the span of healthy life, 2. Reduce health 
disparities among individuals and, 3. Improve access to preventive services (Wilson 
and Cooley 2000). The main goal is the improvement in quality of life.
Preventive management of genetic disorders can be defined as the avoidance or 
amelioration of complications in the patient with a genetic disease. These 
complications, depending on the level of MR, include chronic diseases and physical 
problems (e.g. sensory problems, gastro-intestinal problems, neurological 
disorders), psychiatric problems (e.g. dementia) and behavioural and 
communication problems (e.g. inappropriate behaviour, changing behaviour). 
Medication should be limited and overmedication elimited.
3 .3 .2  M ed ica l care p lan
There is a need to design a preventive care plan, including daily activities and 
therapies, for adults. However, each individual patient has specific problems which 
are compounded by differences in mental level and in motor capacities, and 
therefore it is not possible to create one "golden standard" care plan. A personal 
caregiver or parent, who best knows the mentally retarded individual, is of great 
value, since they may recognise problems in an early stage.
Follow-up and regular screening on a yearly basis by the general practitioner of 
the institution of vision, hearing, thyroid function, dental status, psychiatric 
problems and behavioural problems should be included in the preventive medical 
program for all mentally retarded adults. Changes in levels of general functioning 
can be measured year by year. In addition, prevention of specific complications 
known to occur with genetic syndromes is warranted. Since for many syndromes 
the natural history is poorly defined, long-term follow-up is needed.
Wilson and Cooley (2000) described preventive management of children with 
30 rare congenital anomalies and syndromes. Medical checklists were developed 
for 2 anomalies (spina bifida and cerebral palsy), 2 associations and 26 syndromes, 
including 16 related with mental retardation. Of these extensively described MR 
conditions, Down syndrome, Prader-Willi syndrome, Shprintzen syndrome 
(Velo-cardio-facial syndrome), Fragile-X syndrome, tuberous sclerosis
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(Bourneville), Brachmann- de Lange syndrome, mucopolysaccharidoses, cerebral 
palsy and spina bifida were all found in Huize Assisië-Stichting Prisma. Other 
syndromes that we found in this institution, such as the Cri du chat syndrome and 
Angelman syndrome, were discussed only briefly. However, with the present data 
and future research, it will be possible to construct similar checklists for these and 
other more rare syndromes.
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4 R e c o m m e n d a t io n s
1. Based on the results of this pilot study, nation-wide systematic 
etiologic-diagnostic screening is recommended. Every mentally retarded patient 
has the right to a diagnosis because of implications for himself, his family and 
the management of the institution.
2. Guidelines for systematic etiological surveys of institutions are proposed (see 
Addendum). Data collection on family history and perinatal and childhood 
medical data in adult mentally retarded patients is frequently very difficult. It is 
recommended that institutions keep all familial and medical data life-long and, 
preferably, indefinitely, to allow accurate genetic counselling in current or 
future family members at any time. Financial means have to become available 
to allow at least one MRI or CT of the brain for each mentally retarded patient 
without a known diagnosis in the presence of neurological symptoms, 
microcephaly, macrocephaly or cranial contour abnormalities.
3. This study stresses the importance of life-long follow-up of mentally retarded 
patients, especially of those with an etiologic diagnosis to learn more about the 
evolution of genetic syndromes and the occurrence of comorbidity in adulthood. 
Based upon these findings, diagnostic and therapeutic guidelines for the 
institution physicians will be continuously refined. Large-scale studies on 
comorbidity have only just started (Evenhuis and Nagtzaam 1999). After the 
etiological screening of large institutions more adult patients with rare 
syndromes will be diagnosed. This may in the end allow meaningful conclusions 
and recommendations concerning comorbidity and behavioural problems.
4. The present study shows that the recognition, follow-up and treatment of a 
diagnosis-related behavioural phenotype, is an integral part of the care for 
mentally retarded adults such as in Cri du chat syndrome and Angelman 
syndrome.
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5 F u t u r e  s t u d y  a im s
1. In the present study, we mainly focused on the systematic etiologic-diagnostic 
process, but we also came across medical and behavioural problems. Further 
evaluation of the persistent feeding problems at an older age in the Cri du chat 
syndrome, the change in day-night rhythm in Angelman syndrome and the 
severe loss of visual acuity in the fragile X syndrome in larger groups of patients 
is necessary. Specially designed studies about the validity of and yield of 
screening recommendations for comorbidity, behaviour in groups with known 
and unknown diagnoses, and the value of behavioural therapy are needed. 
Whether the outcome of better care indeed leads to better quality should also be 
studied. A nation-wide co-ordination centre can be helpful in registering 
ongoing studies. This centre may be helpful in offering easy access for general 
practitioners and for researchers, and may have a task in the education of 
general practitioners. This centre also may provide new research questions.
2. The implication of a diagnosis for the family should be evaluated. In the present 
study, we asked the parents or legal representatives for participation in this 
study. When a genetic diagnosis was obtained, genetic counselling was offered. 
Studying the psychological effects of these counselling sessions that were 
initiated from the institution can be informative, since normally, it is the parents 
or the general practitioner, who take the initiative for genetic counselling. In the 
present study, no permission was given in 84 of the 591 residents, even after a 
second letter, which contained more information on the investigation, was sent 
to the parents. Other methods, such as personally visiting the parents, may be 
more efficient. Since every person with MR has the right to obtain a diagnosis, 
an ethical question may rise whether the right of the mentally retarded person 
to have a diagnosis in order to prevent associated medical complications, can 
outweigh the right of family members to refuse diagnostic investigations.
3. Having a diagnosis has important consequences for the institution in planning 
medical, paramedical and educational staff. However, only prospective studies 
can measure the true impact of this statement. The cost for the institutions with 
a population of ageing residents is another aspect for future research. 
Decentralisation of institutional residential settings may lead to a different 
co-ordination of medical care. General practitioners are more frequently 
involved in the care program for the patients. Adequate training of general 
practitioners and paramedical staff members should be provided in this area of
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specific problems. The creation and evaluation of multidisciplinary teams 
specialised in the field of MR may contribute towards a solution of this new 
problem.
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A d d e n d u m  
P r o p o s e d  f l o w -c h a r t  o f  g e n e t ic  in v e s t ig a t io n s  in  
in s t it u t io n a l is e d  m e n t a l l y  r e t a r d e d  a d u l t  p a t ie n t s
1 D ia g n o s t ic  a p p r o a c h
1.1 D iagn ostic  ap proach: first step: co llab oration  o f  gen era l p ractition er , 
sp ecia lised  in  M R  and  c lin ica l g en etic ist
1. W ritten  p erm ission
2. C o llection  o f  c lin ica l data: 
H istory
A. Family history:
Three generation pedigree (stillbirths and miscarriages) - familial MR - sporadic 
patients - consanguinity - clinical photographs of relatives 
$ . Medical history:
Pregnancy - perinatal period - neonatal period (seizures - regression)
Clinical and behavioural follow-up since childhood - early biometric data - major 
events (surgery - specialist visiting) - hearing / vision - puberty - X-rays - laboratory 
- IQ tests - clinical photographs over time
C lin ica l exam in ation
Biometric values (length, weight, head circumference, span, outer canthal distance 
(OCD), inner canthal distance (ICD), total hand length (THL), finger III length, ear 
length)
General aspect - craniofacial appearance (dysmorphic features) - thorax - abdomen - 
extremities - genitalia - neurology
C lin ica l p h o tograp h s
Standard: face, profile, general view, hands and feet 
Other structures on indication.
B eh av iou ra l exam in ation
Interpretation of the standardised tests performed by the educational psychologist.
242 Part 3
T ech n ica l in vestiga tion s
A. Chromosomal investigation (GTG-banding)
B. DNA studies (based on clinical working diagnosis):
Fragile X syndrome (positive family history / clinical features)
Angelman syndrome (clinical features / neurology)
Prader-Willi syndrome (obesity / hyperphagia / history of neonatal hypotonia) 
Rett syndrome (neurodegenerative problems / hand movements)
1.2 D iscu ssion  w ith  an  exp ert team
Clinical geneticist - neurologist - other specialists
1.3 A d d ition a l in vestiga tion s on  ind ica tion
•  Special chromosomal investigations of blood (reverse-banding, high resolution 
banding, microdeletions (Fluorescence in situ hybridisation)) or investigations 
of other tissues
•  Neuro-imaging: MRI or CT-scan (neurological problems - macrocephaly - 
microcephaly - cranial contour abnormalities - epilepsy)
•  X-rays: e.g. hands - feet - skull (only if a specific syndrome or abnormality is 
suspected)
•  Basic metabolic screening (neurodegenerative problems)
•  Specialist visits
2 Im p l ic a t io n  o f  d ia g n o s is : g e n e t ic  c o u n s e l l in g  a n d  f o l l o w -u p
2.1 C ou n sellin g  o f  fam ilies - p ren a ta l cou n selling
2 .2  F o llow -u p  o f  the p atien t
•  Clinical re-evaluation: to study syndrome-related comorbidity or diagnostic 
re-evaluation.
•  Behavioural re-evaluation
•  New technical investigations such as:
microdeletion studies 
non-specific XLMR studies
•  Discussion with collegues (meetings).
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S u m m a r y
Mental retardation (MR) affects 2 to 3% of the population. The definition of 
MR, proposed by the American Psychiatric Association include 3 criteria: 1. 
Significantly sub-average general intellectual functioning (IQ<70), 2. Significant 
limitations in adaptive functioning in at least two of the following skill areas: 
communication, self-care, ability to live independently, social and interpersonal 
skills, use of public services, decision taking, functional academic skills, work, 
leisure, health and safety, 3.Onset before the age of18  years.
More male than female individuals have MR. The male to female ratio shows 
an excess of males in severe MR of 20% and in mild MR of 40 to 80%, probably 
due to sex-linked genetic factors. The cause of MR remains unknown in almost 
50% of the cases. In severe MR a single cause can be found in 50% and in mild MR 
in less than 20%, but this group has an increased percentage of familial MR. 
Chromosomal abnormalities (1.8%  to 41.6%), with more than 80% trisomy 21, are 
the best recognised common cause of severe MR. Mutations in a single gene - 
monogenic disorders - account for 20 to 25% of severe and 5 to 10% of mild MR. 
X-linked mental retardation is estimated to affect 20 to 25% of all mentally retarded 
males and 10% of mildly mentally retarded females, and are categorised 
non-specific (MRX) or syndromic (MRXS). The fragile X syndrome is the most 
frequent MRXS. Few mentally retarded patients with central nervous system 
malformations have been reported, probably due to few brain-imaging studies 
carried out on them. Acquired disorders account for 30 to 35% of severely and 15% 
of mildly mentally retarded patients, but this figure is probably an overestimation. 
A systematical etiologic-diagnostic survey was carried out in the Institution Huize 
Assisië - Stichting Prisma in the southern part of the Netherlands and resulted in the 
description and follow-up of several patients with dysmorphic features.
In part 1 a general overview of the results in this population of 471 older 
mentally retarded institutionalised patients is presented (mean age 46 years; 92.6% 
males). Chromosomal abnormalities were found in 100 patients (21.2%). Of these, 
87 had numerical autosomal abnormalities (all Down syndrome), 7 structural 
autosomal abnormalities and 6 numerical abnormalities of sex chromosomes. 
Monogenic disorders were diagnosed in 61 patients (13%) (14 autosomal dominant, 
25 autosomal recessive and 22 X-linked conditions). In 1.7% (n=8) of the patients 
a central nervous system (CNS) malformation was considered the cause of the 
mental handicap. Acquired CNS disorders were diagnosed in 69 patients (14.6%) 
(prenatal cause (n=15), perinatal cause (n=27), postnatal cause (n=27)). In 233
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patients (49.5% of the total sample; 215 males and 18 females) an idiopathic type 
of mental retardation was present. In this group several parameters were recorded: 
1. positive family history of mental retardation (n=73), with special attention to 
patients with pedigree data compatible with X linked mental retardation (n=35, 
from 32 families); 2. dysmorphic features (n=41), which were associated with the 
severity of the MR; 3. neurological abnormalities (n=47); 4. epileptic seizures 
(n=78), which were positively correlated with the level of MR; 5. combination of 
microcephaly and micro-orchidism (n=3), which was higher than expected; 6 . 
combination of macrocephaly and macro-orchidism (n=5), which was statistically 
significantly increased; 7. Consanguinity (n=9).
In p a r t 2, attention was focused on the biomedical approach in older mentally 
retarded patients and on the natural history of different syndromes in this ageing 
group.
In the first part of chap ter 1 the population of patients with Down syndrome 
(DS) (n=96) is described. More than two third of the patients (i.e. 73%) were older 
than 40 years. A high percentage of mosaic trisomy 21 (12.6%) was found. Special 
attention was given to the patient who presented with Down-Turner phenotype 
(45,X/46,X,+21/47,XY,+21) and who was the oldest one in this population with 
DS. Most patients (82%) were moderately or severely mentally retarded. Dementia 
occurred up to 42.4% above the age of 50 years. One third of the patients had at 
least moderately reduced vision and this increased with age. A moderate, severe or 
very severe hearing loss was present in 70% of the patients. Thyroid dysfunction 
with increased (48%) or decreased (1%) TSH level was found in 49% of the patients 
examined for thyroid functions. A regular screening of all adult ageing patients with 
DS with special attention to the group of patients who are severely to profoundly 
mentally retarded is recommended in order to diagnose at an early stage dementia, 
depression, hypothyroidism or early loss of visual acuity and hearing.
In the second part of chap ter 1, patients with other chromosomal abnormalities 
are described. In the Cri du chat syndrome the clinical phenotype becomes less 
striking with ageing. Some of the clinical characteristics become more evident such 
as long face, macrostomia and scoliosis. Most patients had periods of destructive 
behaviour, self mutilation and aggression. The patient with a deletion of the distal 
part of the long arm of chromosome 13 (13q deletion syndrome) was severely 
mentally retarded, had no major organ malformations, and had normal limb 
development with normal thumbs. The phenotype of Angelman syndrome (AS) is 
well known in childhood and adolescence, but in adulthood the phenotype can be 
rather aspecific. We noted severe neurological complications such as severe tremor,
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spasticity and inco-ordination with severe loss of function in adults with AS.
In chap ter 2, the clinical phenotype and follow-up data of the group of males 
with X-linked mental retardation (n=57) is described. The fragile X syndrome 
(FRAXA) was diagnosed in 16 and X-linked mental retardation with marfanoid 
habitus (Lujan-Fryns syndrome) in 2 patients. Non-specific XLMR (MRX) was 
diagnosed in 3 male sibs of a family, carrying a mutation in the IL-1 receptor 
accessory protein-like gene, and one male patient member of the MRX-44 family. 
In 35 other patients, from 32 families, with idiopathic MR, the family history, and 
pedigree data were compatible with non-specific XLMR.
In chapter 3 the group of patients with metabolic disorders is described: 1. 
metabolic disorders as the cause of MR (i.e. phenylketonuria (PKU) (n=5), 
S-sulfocysteinuria (n=3), mucopolysaccharidosis type III (Sanfilippo A) (n=1) and 
GM1-gangliosidosis type 3 (n=1)), 2. metabolic disorders not explaining the MR 
(i.e. mucopolysaccharidosis type VII (Sly) (n=1), Niemann-Pick type B (n=1), 
cystinuria (n=1) and hyperprolinemia type 1 (n=3)), and 3. metabolic abnormalities 
of unknown significance. This study confirms that patients with idiopathic MR in 
combination with aberrant behaviour, neurodegenerative problems or dysmorphic 
features are candidates for performing metabolic screening tests.
In chapter 4 patients with recognisable dysmorphic syndromes are reported (i.e. 
Zimmermann-Laband, Fountain and Björnstad syndromes). Further delineation of 
the clinical features and, where possible, follow-up data of these syndromes are 
presented. Special attention was given to the group of patients with dysmorphic 
features, but without a clinical diagnosis, and microdeletion studies with a selected 
panel of subtelomeric probes were performed.
In the first part of part 3 the diagnostic approach in institutionalised older 
mentally retarded patients is discussed. Clinical features and behavioural phenotype 
are usually well known in childhood and adolescence, but may change with 
advancing age. A standard cytogenetic examination on cultured peripheral 
lymphocytes was performed in all patients. In a selected group of patients 
fluorescence in situ hybridisation (FISH) were performed based on the presence of 
specific clinical features. DNA studies for the fragile X syndrome (expansion of the 
CGG repeat in the FMR-1 gene) was done in the group of patients with clinical 
features of the syndrome and/or with a positive history of familial MR (maternal 
MR). Metabolic studies were systematically performed in 306 of the 471 
investigated mentally retarded patients. The yield of screening for other metabolic 
disorders besides PKU and the clinically recognisable lysosmal storage disorders, 
which were previously diagnosed, was thus low in this institution. Based on the
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experience in the present institution, screening of metabolic disorders in older 
institutionalised mentally retarded adults can be restricted to those patients with 
neurodegenerative features or behavioural problems. Brain imaging studies were 
done in a small number of patients, and even in this highly selected group few 
abnormalities were found and none of these were diagnostic.
In the second part of part 3 medical and behavioural problems of ageing in the 
general population of mentally retarded adults, and diagnosis-related problems are 
discussed. Persons with more serious levels of MR are at a higher risk for health 
problems. Cerebral palsy, visual and hearing loss, mobility problems, epilepsy, 
language difficulties, emotional and/or mental problems are frequently reported 
among the elderly mentally retarded persons and add a new dimension to ageing. 
These problems result in limiting social contacts and often result in behavioural 
problems such as aggressive behaviour and self mutilation in the severely to 
profoundly mentally retarded. Moderately mentally retarded persons may react with 
maladaptive behaviour and are candidates to develop depression. Comorbidity is, 
besides in Down syndrome, not well described in other genetic syndromes. In this 
institution we studied medical and behavioural problems in Down syndrome as well 
as in other diagnostic subgroups of patients. Recommendations are formulated for 
the care for mentally retarded adults.
In addendum a flow-chart of genetic investigations in mentally retarded adult 
patients is proposed.
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Sa m e n v a t t in g
Mentale retardatie komt voor bij 2-3% van de bevolking. Volgens de "American 
Psychiatric Association" spreekt men van mentale retardatie wanneer voldaan wordt 
aan 3 criteria: 1. Wezenlijke beperkingen in het huidig functioneren met een IQ < 
70; 2. Belangrijke beperkingen in minstens 2 van de volgende gebieden van 
adaptief gedrag: communicatie, zelfzorg, huishoudelijke vaardigheden, sociale 
vaardigheden, maatschappelijke vaardigheden, zelfbepaling, functionele schoolse 
vaardigheden, werk, vrije tijd, gezondheid en veiligheid; 3. Een aanvang voor het 
18e levensjaar.
Er zijn meer mannen met mentale retardatie dan vrouwen. De man-vrouw 
verhouding toont een mannenoverschot van 2 0% in de groep ernstig verstandelijk 
gehandicapten, en 40-80% in de groep licht verstandelijk gehandicapten, 
waarschijnlijk als gevolg van geslachtsgebonden genetische factoren. In de helft van 
de gevallen van mentale retardatie is de oorzaak onbekend. In de groep ernstig 
verstandelijk gehandicapten wordt in de helft van de gevallen één enkele oorzaak 
gevonden. In de groep licht verstandelijk gehandicapten wordt één enkele oorzaak 
in minder dan 2 0% van de gevallen gevonden, maar komt er een hoger percentage 
familiale verstandelijke handicap voor.
Chromosomale afwijkingen (1.8-41.6%) vormen de belangrijkste oorzaak in de 
groep ernstig verstandelijk gehandicapten en hiervan heeft méér dan 80% trisomie 
21 (Down syndroom). Bij 20-25% van de ernstig verstandelijk gehandicapten, en 
5-10% van de licht verstandelijk gehandicapten zijn mutaties in één enkel gen - 
monogene afwijkingen - verantwoordelijk. X-gebonden mentale retardatie is 
verantwoordelijk voor 20-25% van alle mentale retardatie bij mannen en voor 10% 
van de licht mentale retardatie bij vrouwen. X-gebonden mentale retardatie wordt 
in 2 groepen onderverdeeld: de niet-specifieke (MRX) en de syndromale (MRXS). 
De meest voorkomende syndromale vorm is het fragiele X syndroom. Slechts een 
gering aantal verstandelijk gehandicapten met centraal zenuwstelsel afwijkingen 
werd gerapporteerd, waarschijnlijk omdat weinig beeldvormend onderzoek van de 
hersenen wordt uitgevoerd bij verstandelijk gehandicapten. Verworven 
aandoeningen worden verantwoordelijk geacht bij 30-35% van de ernstig mentaal 
en bij 15% van de licht mentaal gehandicapten, doch hier vormen de cijfers 
waarschijnlijk een overschatting.
Een systematisch etiologisch-diagnostisch onderzoek werd uitgevoerd in het 
instituut voor verstandelijk gehandicapten Huize Assisië - Stichting Prisma in 
Zuid-Nederland. Dit resulteerde in de beschrijving en follow-up van verschillende 
verstandelijk gehandicapten.
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Deel 1 beschrijft het algemeen overzicht van de resultaten van deze 
geïnstitutionaliseerde populatie van 471 oudere verstandelijk gehandicapten 
gegeven (gemiddelde leeftijd: 46jaar; 92.6% mannen). Bij 100 patiënten (21.2%) 
werd een chromosomale afwijking gevonden met een numerieke afwijking bij 87 
(allen Down syndroom), een structurele afwijking bij 7, en bij 6 patiënten een 
numerieke afwijking van de geslachtschromosomen. Monogene afwijkingen 
werden gediagnosticeerd bij 61 patiënten (13%) (autosomaal dominant (n=14), 
autosomaal recessief (n=25) en X-gebonden (n=22)). Bij 8 patiënten (1.7%) was 
een afwijking van het centraal zenuwstelsel de oorzaak van de verstandelijke 
handicap. Een verworven aandoening vormde de verklaring bij 69 patiënten 
(14.6%) (prenatale oorzaak (n=15), perinatale oorzaak (n=27), en postnatale 
oorzaak (n=27)). In de resterende groep van 233 patiënten (49,5%; 215 mannen en 
18 vrouwen) werd geen echte diagnose gevonden (idiopathische mentale retardatie). 
In deze groep werd een associatie met bepaalde factoren verder nagekeken: 1. 
Familiaal voorkomen van mentale handicap (n=73), waarvan 35 met X-gebonden 
mentale retardatie; 2. De aanwezigheid van dysmorfe kenmerken (n=41); deze 
waren bovendien gecorreleerd met de ernst van de mentale handicap; 3. Het 
voorkomen van neurologische afwijkingen (n=47); 4. Aanwezigheid van epilepsie 
(n=78), hetgeen bovendien gecorreleerd was met de ernst van de verstandelijke 
handicap; 5. Het voorkomen van microcefalie samen met micro-orchidie (n=3), 
hetgeen frequenter was dan verwacht; 6 . De aanwezigheid van de combinatie 
macrocefalie en macro-orchidie (n=5), hetgeen eveneens significant meer 
voorkwam; 7. Consanguiniteit (n=9).
In deel 2 wordt de aandacht gevestigd op de biomedische aanpak bij oudere 
verstandelijke handicapte personen en op het natuurlijk proces van veroudering bij 
verschillende syndromen.
In het eerste gedeelte van hoofdstuk 1 wordt de populatie patiënten met Down 
syndroom (DS) beschreven (n=96). Meer dan twee derde van deze patiënten (73%) 
was ouder dan 40 jaar. Een hoog percentage patiënten (12.6%) had trisomie 21 
mosaicisme. Speciale aandacht werd geschonken aan een patiënt met het 
Down-Turner syndroom (45,X/46,X,+21/47,XY,+21), die tevens de oudste was van 
de totale groep DS patiënten. De meeste patiënten (82%) waren matig tot ernstig 
verstandelijk gehandicapt. Boven de leeftijd van 50 jaar kwam dementie voor tot 
42.4%. Eén derde van de patiënten had minstens matig verminderde visus en dit 
percentage nam toe met de leeftijd. In 70% van de patiënten was matig, ernstig of 
zeer ernstig gehoorsverlies aanwezig. Bij de patiënten die een schildklier-onderzoek 
ondergingen werd een gestoorde schildklierfunctie gevonden bij 49% met verhoogd
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(48%) of verlaagd (1%) TSH. Regelmatig onderzoek van alle ouderwordende 
volwassen DS patiënten, met speciale aandacht voor de groep patiënten met ernstige 
en diepe verstandelijke handicap, is aanbevolen om vroegtijdig dementie, depressie, 
hypothyroidie of vroegtijdig verlies van visus en gehoor op te sporen.
In het tweede gedeelte van dit hoofdstuk worden patiënten met andere 
chromosomale afwijkingen beschreven. Bij het Cri du chat syndroom wordt het 
fenotype over het algemeen minder duidelijk met toename van de leeftijd. Sommige 
klinische kenmerken echter worden duidelijker zoals het langwerpige gezicht, 
macrostomie en de scoliosis. De meeste patiënten hadden periodisch destructief 
gedrag, automutilatie en agressie. De patiënt met een distale deletie van de lange 
arm van chromosoom 13 (13q deletie syndroom) was ernstig verstandelijk 
gehandicapt maar hij had geen majeure orgaanafwijkingen. De ledematen en 
duimen waren normaal ontwikkeld. Het fenotype bij het Angelman syndroom (AS) 
is goed gekend bij kinderen en adolescenten, echter bij volwassenen kan het 
fenotype atypisch zijn. Bij onze volwassen AS patiënten werden ernstige 
neu ro lo g isch e  com plicaties m et ernstige trem or, sp as tic ite it en 
coördinatieproblemen leidend tot een ernstig functieverlies waargenomen.
In hoofdstuk 2 wordt het klinisch beeld en de follow-up gegevens van de groep 
mannen met X-gebonden mentale retardatie (XLMR) (n=57) beschreven. Het 
fragiele X syndroom (FRAXA) werd gediagnosticeerd bij 16 patiënten en 
X-gebonden mentale retardatie met marfanoide habitus (Lujan-Fryns syndroom) bij
2 patiënten. Niet-specifieke XLMR (MRX) werd gediagnosticeerd bij 3 broers uit 
één familie, waar een mutatie in het "IL-1 receptor accessory protein-like gene" 
werd gevonden, en bij één mannelijk lid van de MRX-44 familie. Bij 35 andere 
patiënten, afkomstig uit 32 families, met idiopathische MR stemden familiale 
anamnese en stamboomgegevens overeen met niet-specifieke XLMR.
Hoofdstuk 3 beschrijft de groep patiënten met een metabole ziekte met de 
volgende classificatie:
1. Metabole ziekten die de verstandelijke handicap verklaren: Fenylketonurie 
(PKU) (n=5), S-sulfocysteinurie (n=3), muco-polysaccharidose type III (Sanfilippo 
A) (n=1), en GM1-gangliosidose type 3 (n=1); 2. Metabole ziekten die de 
verstandelijke handicap niet verklaren: mucopolysaccharidose type VII (Sly) (n=1), 
Niemann-Pick type B (n=1), cystinurie (n=1), en hyperprolinemie type 1 (n=3); 3. 
Metabole afwijkingen met onbekende betekenis. Deze studie bevestigt dat patiënten 
met idiopathische verstandelijke handicap gecombineerd met afwijkend gedrag, 
neurodegeneratieve problemen of dysmorfe kenmerken kandidaat zijn voor verder 
metabool nazicht.
In hoofdstuk 4 worden patiënten met herkenbare syndromen beschreven:
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Zimmermann-Laband syndroom, Fountain syndroom en Björnstad syndroom. De 
klinische kenmerken worden verder beschreven en de follow-up gegevens worden 
waar mogelijk meegedeeld. Speciale aandacht werd gegeven aan de groep patiënten 
met dysmorfe kenmerken zonder diagnose, waar microdeletie studies met een 
geselecteerd panel probes werd uitgevoerd.
In het eerste gedeelte van deel 3 wordt de diagnostische aanpak bij 
geïnstitutionaliseerde oudere patiënten besproken. De klinische kenmerken en de 
gedragskenmerken zijn meestal goed gekend bij kinderen en adolescenten, maar 
deze kunnen wijzigen met toenemende leeftijd. Een standaard cytogenetisch 
onderzoek op gekweekte perifere lymfocyten werd uitgevoerd bij alle patiënten. Bij 
een groep patiënten, geselecteerd op basis van specifieke klinische kenmerken, 
werden fluorescentie in situ hybridisatie (FISH) technieken uitgevoerd. DNA 
onderzoek naar het fragiele X syndroom (expansie van de CGG repeat in het 
FMR-1 gen) werd uitgevoerd in de groep patiënten met klinische kenmerken van 
het syndroom en/of met een positieve anamnese van familiale verstandelijke 
handicap (maternele MR). Metabool onderzoek werd systematisch verricht in 306 
van de 471 onderzochte verstandelijk gehandicapte patiënten. Naast PKU en de 
klinisch herkenbare lysosomale stapelingsziekten, die voorheen reeds waren 
gediagnosticeerd, was de opbrengst van het metabool onderzoek in dit instituut 
gering. De ervaring in dit instituut leert dat screening naar metabole ziekten bij 
oudere geïnstitutionaliseerde volwassenen kan beperkt blijven tot die groep 
patiënten met neurodegeneratieve aandoeningen of gedragsproblemen. Ofschoon 
beeldvorming van de hersenen werd uitgevoerd in een kleine groep streng 
geselecteerde patiënten, werden weinig afwijkingen gevonden en was geen enkele 
diagnostisch.
In een tweede luik worden de medische en gedragsproblemen bij het verouderen 
in de algemene populatie verstandelijk gehandicapten besproken, evenals specifieke 
problemen gerelateerd aan de diagnose. De ernst van verstandelijke handicap speelt 
een belangrijke rol bij gezondheidsproblemen waarbij een hoger risico wordt 
gevonden bij ernstigere niveaus. Spasticiteit, visus en gehoorsverlies, motorische 
beperkingen, epilepsie, spraakproblemen, emotionele en/of mentale moeilijkheden 
worden vaak vermeld bij oudere verstandelijk gehandicapten en voegen een nieuwe 
dimensie toe aan het verouderingsproces. Deze problemen resulteren in een 
beperking van de sociale contacten en leiden vaak tot gedragsproblemen, zoals 
agressief gedrag en automutilatie, in de groep ernstig tot diep verstandelijk 
gehandicapten. Matig verstandelijk gehandicapten kunnen reageren met 
onaangepast gedrag en kunnen depressie ontwikkelen. Comorbiditeit is, afgezien
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van het Down syndroom, weinig beschreven bij andere genetische syndromen. In 
dit instituut bestudeerden wij de medische en gedragsproblemen bij Down 
syndroom evenals bij andere groepen patiënten met een diagnose. Aanbevelingen 
werden geformuleerd voor de zorg bij verstandelijk gehandicapten.
In een addendum worden richtlijnen voor genetische onderzoeken bij volwassen 
verstandelijk gehandicapten geformuleerd.
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